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A b s t r a c t
The prostate is the most common site of disease in the human male. An 
understanding of its normal growth and development is required in order to 
elucidate the underlying mechanisms of prostatic diseases, namely benign 
prostatic hyperplasia (BPH) and prostate carcinoma. The prostate epithelium 
consists of three distinct cells types: basal, luminal and neuroendocrine cells. 
Several authors have postulated that there is a putative stem cell population in the 
prostate epithelium that gives rise to all three of these cell types. The stem cells 
are thought to reside in the basal cell layer and upon cell division give rise to an 
intermediate, transit amplifying (TA) cell. TA cells undergo rapid proliferation 
before undergoing terminal differentiation into a luminal or neuroendocrine cell. 
Despite accumulating evidence for the existence of prostatic stem cells, the 
regulation of cell growth and differentiation in the normal and diseased prostate is 
poorly understood.
The aims of this research project are to identify genes that are involved in 
the regulation of growth and differentiation in the normal human prostate. As a 
model for investigating epithelial cell differentiation, a conditionally immortalised 
prostate epithelial cell line was employed. BPH cells were conditionally 
immortalised using a SV40 construct containing the large T antigen to give rise to 
the prostate epithelial cell line PrE2.8 (Daly-Bums et a l , in preparation). These 
cells exhibit a basal phenotype at the permissive temperature of 33°C and are 
highly proliferative. When switched to 39°C, growth of the PrE2.8 cells is 
inhibited and they begin to differentiate. Using the differential display technique 
and microarray analysis, changes in gene expression between a proliferative and a 
non-proliferative phenotype were investigated. The protein expression of genes 
of interest were then confirmed in prostate tissue using immunohistochemistry. 
These genes may represent early markers of prostate epithelial cell differentiation 
and may also play a role in the progression of BPH and prostate cancer.
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1 Introduction
1 In t r o d u c t io n
The prostate gland is an organ associated with the genitourinary system and is the 
most common site of pathological disease in the human male. This pathology is 
most commonly manifested as either of two distinct conditions: benign prostatic 
hypertrophy (BPH) or adenocarcinoma. Both give rise to a significant level of 
morbidity and adenocarcinoma is the 2nd most common cause of mortality 
amongst males in the developed world (Parkin et al., 1999). Despite the 
prevalence and incidence of this disease, only in recent years has there developed 
a level of interest, similar to that which has been traditionally focused on breast 
and colorectal carcinomas, in understanding the underlying mechanisms in the 
development of this disease.
From its embryonic development until the age of approximately 35 years, 
the prostate is generally considered to be free from abnormalities. However, from 
this point onwards an age-associated increase in abnormalities occurs. This is 
commonly manifested as the non-malignant overgrowth known as BPH. BPH 
occurs in the transition zone and results in a progressive constriction of the 
urethra. Unless treated, either by using drugs or by the procedure known as 
transurethral resection of the prostate, this gives rise to a progressive difficulty to 
urinate and ultimately to kidney failure.
Carcinoma of the prostate is a multi-focal entity and by the age of 50 years, 
some 30% of males will have latent forms of this disease present. By the age of 
85 years, almost 100% will. In a smaller proportion of individuals, latent 
carcinoma of the prostate will become clinically invasive disease. The challenge 
is to identify those individuals most susceptible to developing this life-threatening 
condition. In order to achieve this, a better understanding of the underlying 
molecular events involved in the progression of normal prostate cells to a 
malignant phenotype is required. Such an understanding may facilitate earlier 
treatment of the disease with better prognostic outcomes or the development of 
prevention strategies.
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1.1 The Anatomy of the Prostate
In the young adult male, the normal prostate is 20ml ±6 in size and weighs 
approximately 10-15 g. The organ is composed of both fibromuscular and 
glandular components and lies beneath the bladder surrounding the urethra 
(Figure 1-1). The anatomy of the human prostate was the subject of debate for 
many years since its first detailed description in 1912 (Lowsley, 1912). The 
anatomy and morphology of the prostate has since been studied in detail by 
several investigators. Of these, the work of McNeal (McNeal, 1980; McNeal, 
1981a; McNeal, 1981b; McNeal, 1984; McNeal, 1988) (McNeal, 1968, 1978, 
1980, 1981, 1983, 1988) is the most widely accepted. McNeal’s model of the 
prostate is based on dissections and embryological considerations of hundreds of 
autopsy prostates of all ages. He identified for the first time, the existence of 
histological heterogeneity in the glandular tissue of the prostate. It was proposed 
that the prostate is made up of four different regions, or zones, which are tightly 
fused together. Each zone makes contact with a specific portion of the prostatic 
urethra, which is used as the primary anatomical reference point in McNeal’s 
model. As the urethra passes through the prostate, it is divided into a proximal 
(from the bladder neck to the verumontanum) and distal segment (from the 
verumontanum to the external sphincter), forming a 35° angle at the 
verumontanum (Figure 1-2). The verumontanum lies entirely in the distal 
segment. Ejaculatory ducts drain into the urethra at this point. A cylindrical 
sphincter of smooth muscle, known as the preprostatic sphincter, surrounds the 
urethra from the upper end of the verumontanum, proximally to the bladder neck. 
Together with the internal sphincter located at the bladder neck, the preprostatic 
sphincter helps prevent retrograde ejaculation.
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Figure 1-1: Anatomical position of the prostate: frontal and sagittal sections.
Central zone (CZ), peripheral zone (PZ), transition zone (TZ) and anterior 
fibromuscular stroma (AFS). From Timms (1997).
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E
UD
Figure 1-2: Sagittal diagram of the human prostate.
The figure illustrates the distal urethra (UD), proximal urethra (UP) and 
ejaculatory duct (E) in relation to the zones of the prostate: CZ, central zone; PZ, 
peripheral zone and TZ, transition zone. From McNeal, 1988.
McNeal (1988) described the four zones of the prostate in detail (Figure 
1-3). Three glandular regions were described, each of which drains into a specific 
segment of the urethra. The central zone comprises approximately 25% of the 
normal human prostate gland. It contacts the urethra only at the upper end of the 
verumontanum and surrounds the ejaculatory ducts along their entire course 
through the prostate. Histologically, the central zone is identified by the presence 
of relatively large, round acini with irregular contours. These acini are lined by 
cuboidal and columnar epithelium, the cells of which have a granular cytoplasm 
and large, pale nuclei packed irregularly at different levels from the basement 
membrane. The smooth muscle stroma of the central zone is dense and compact. 
The ducts of the central zone open into the urethra at the verumontanum on either 
side of the ejaculatory ducts. The histological features of the central zone 
resemble those of the seminal vesicle suggesting that they are of the same
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wolffian duct origin. This was confirmed more recently in studies carried out by 
Laczko et a l , (2005); the histology and immunohistochemistry of the zones of the 
prostate were compared with the seminal vesicles. Using a panel of lectins and 
antibodies, immunohistochemistry was carried out on normal prostate sections 
from nine organ donors. The study revealed identical staining patterns in the 
seminal vesicle and central zone, with significant differences from the peripheral 
zone. In addition, over 70% of epithelial cells in the seminal vesicle stained 
positive for lactoferrin, compared with 31.2% of cells in the central zone and 
2.1% in the peripheral zone. Prostate nuclear antigen (PNA) staining was present 
in luminal cells in all zones but there was distinctive basal staining in the 
peripheral zone alone (Laczko et al., 2005). These observations lend further 
support to the theory that the central zone and seminal vesicle share a common 
embryological origin from the Wolffian duct.
The peripheral zone in the normal adult human prostate gland comprises 
approximately 70% of the total glandular tissue. It surrounds the central zone and 
extends around the posterolateral peripheral aspects of the gland from its apex to 
its base. The histological appearance of this region is characterised by small, 
round acini with smooth walls, which are lined by tall columnar secretory 
epithelial cells. In contrast to the epithelium of the central zone, the peripheral 
zone epithelial cells have a clear cytoplasm, with basally located small, dark 
nuclei. The muscle fibres of the stroma in the peripheral zone are arranged in a 
more random manner and have a looser texture than the stroma of the central 
zone. The ducts of the peripheral zone drain into the distal urethra on either side 
of the verumontanum
The transition zone comprises around 5% of the normal prostate and is 
composed of two bilaterally symmetrical lobules found on the two sides of the 
prostatic urethra. The ducts of the region empty bilaterally into the urethra at the 
base of the verumontanum. Histologically, the acini of the transition zone are 
identical to those of the peripheral zone. However, the surrounding stroma of this 
transition region is more dense and compact and is similar to that of the central 
zone.
The anterior fibromuscular stroma, which comprises approximately one 
third of the prostatic volume, covers the entire anterior surface of the prostate. The 
stroma lacks any glandular elements, and surrounds the urethra proximally at the
5
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bladder neck. It is composed of smooth and striated muscle, elastin and collagen 
fibroblasts. The function of the prostatic stroma may be to enhance the emptying 
of the prostatic secretions into the urethra at the time of ejaculation.
The histological differences of the zones of the prostate suggest biological 
or functional differences between the regions. For example, it has been reported 
that pepsinogen II, a major proteolytic enzyme of the seminal fluid, is produced 
by cells in the central zone, rather than those of the peripheral zone (Reese et al., 
1986). The zonal anatomy of the prostate is also of clinical significance in terms 
of the development of benign prostatic hyperplasia (BPH) and prostate cancer. 
The majority of BPH arises within the transition zone; malignancies may also 
arise in this region, although this is rare. In contrast, the majority of cancers, 
around 70%, originate within the peripheral zone. In contrast, only about 1-5% of 
cancers arise in the central zone. The differences in incidence of prostatic disease 
observed between the zones may be related to their cell kinetics. In studies using 
normal prostate sections from nine organ donors, it was reported that the 
proportion of Ki-67-positive epithelial cells was 50% lower in the central zone 
and seminal vesicles compared with the peripheral and transition zones (Laczko et 
al., 2005). The proportion of apoptotic cells between the zones also differed, with 
approximately 2% of epithelial cells in the transition and peripheral zones being 
apoptotic compared with 1 % in the central zone. The increase in cell turnover in 
the peripheral and transition zones may therefore play a role in the susceptibility 
of these zones to prostate cancer and BPH.
There is a rich blood supply entering the prostate with its arterial supply 
arising from the inferior vesical artery which divides into two main branches as it 
approaches the gland. The arteries extend throughout the prostate distributing a 
blood supply to the glandular and stromal elements of the organ. The prostate also 
receives sympathetic and parasympathetic nerve fibres. Parasympathetic nerves 
end at the acini on cholinergic receptors and promote secretion; sympathetic 
nerves end on alpha2 receptors on blood vessels and on alpha 1 receptors on 
muscle fibres causing contraction of the smooth muscle.
6
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Central zone
Anterior fibromuscular stroma
Figure 1-3: The diagram shows the zonal anatomy of the prostate as 
described by McNeal, 1978.
1.2 Embryology and Development of the Prostate
Embryogenesis of both the male and female gonads are initially identical, a stage 
known as the indifferent stage where the gonads are morphologically 
undifferentiated. During this stage of development, the Wolffian and Mullerian 
ducts and their openings into the urogenital sinus (UGS) develop as precursors of 
the inner genital organs. Male embryonic development is initiated by genes 
located on the Y chromosome, which influence the medullary sex cords of the 
embryonic gonad to differentiate into secretory Sertoli cells. From the seventh 
week onwards, the Sertoli cells secrete anti-Mullerian hormone or Mullerian - 
Inhibiting Substance (MIS), a glycoprotein which causes involution of the 
Mullerian ducts, the female sexual organ precursors, and switches differentiation 
down the male pathway. MIS also stimulates the production of testosterone by the 
Leydig cells of the embryonic testis from around the eighth to ninth week of 
gestation and induces the first stage of testicular descent.
Under the influence of testosterone, the Wolffian ducts differentiate into the 
epididymis, vas deferens, seminal vesicles and ejaculatory ducts. Penile, scrotal 
and prostatic development requires the presence of a third hormone, 
dihydrotestosterone (DHT), a metabolite of testosterone. During the third foetal
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month, mesenchymal tissue associated with the UGS responds to DHT produced 
from foetal testosterone, through the action of the enzyme 5a-reductase, and 
induces outgrowths of the adjacent urothelium of the UGS to form the prostate. At 
about the tenth week of gestation, the budding of prostatic glandular epithelium 
from the UGS occurs in response to binding of DHT to androgen receptors which 
are localized in the mesenchyme (Sinowatz et al., 1977) Sinowatz et a l , 1994). 
These outgrowths begin as solid epithelial buds that arise on the posterior side of 
the UGS on both sides of the verumontanum and invade the mesenchyme to form 
the prostate. Initially, five epithelia ducts form in a paired manner, and it is during 
this stage of development that ductal lumina appear and definitive basal and 
luminal cells are distinguishable. The top pairs of buds form the inner zone of the 
prostate and appear to be of mesodermal origin, while the lower buds form the 
outer zone of the prostate and appear to be of endodermal origin.
By around the 15th week of gestation, the prostate is composed of 
approximately 70 ducts surrounded by stromal components that arise from the 
mesenchyme. Secretory epithelial cells are functional at this stage and produce 
prostate-specific antigen (PSA); well-differentiated basal and NE cells are also 
present (Aumuller et al., 1990). In distal regions of the prostate however, the cells 
of solid epithelial ducts remain undifferentiated. By the 16th week of gestation, the 
undifferentiated mesenchymal cells take on the differentiated phenotype of stroma 
which consists of both smooth muscle cells and fibroblasts.
Maturation of the gland continues during embryonic development when 
testosterone levels are high (Bentvelsen et al., 1995). However, at birth, the gland 
enters a quiescent state of growth and this arrangement persists until puberty 
when there is an increase in prostate weight and size due to a further rise in 
testosterone levels. The epithelium differentiates fully into basal, secretory 
luminal and NE cells in all parts of the gland, as well as an increase in the 
diameter of the lumen of the ducts. The luminal cells also express androgen 
receptors (AR) and begin to secrete PSA and prostatic acid phosphatase (PAP). 
During development of the prostate, there is a close reciprocal interaction between 
the stromal and epithelial tissue components that remains important for normal 
growth and maintenance of the gland throughout life (Cunha, 1994).
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1.3 Prostate Epithelium
The adult human prostatic epithelium is composed of three distinct epithelial cell 
types: basal cells, luminal cells (Figure 1-4A) and neuroendocrine (NE) cells 
(Figure 1-4B). These three cell types are found irrespective of the region of the 
prostate gland. They can be distinguished morphologically, as well as on the basis 
of specific phenotypic features.
The most common cell type in the epithelium of the prostate is the secretory 
luminal cell and these represent more than 75% of the total epithelial cell 
population (Bonkhoff et al., 1994a). The luminal cells are highly differentiated, 
tall and columnar in shape and are connected to each other by cell adhesion 
mediated attachments such as desmosomes and tight junctions. The nucleus lies at 
the base of the cell below a clear zone of abundant golgi apparatus, and the upper 
cellular cytoplasmic area is rich in secretory granules and enzymes. Luminal cells 
require continuous exposure to androgens for their maintenance and survival 
(Aumuller et al., 1983). They contribute a variety of products to the seminal fluid 
such as PSA, PAP and other enzymes such as leucine amino peptidase (Aumuller 
et al., 1983). They can also be distinguished by expression of the androgen 
receptor and keratins 8 and 18. These epithelial cells circle the periphery of the 
acinus and luminal secretions drain into the ducts that connect to the urethra. Due 
to their terminally differentiated phenotype, luminal cells have a finite life span at 
the end of which they are removed through the process of programmed cell death.
Secretory luminal cells are separated from the basement membrane and 
stroma by a layer of basal cells. These cells are undifferentiated, flattened or 
cuboidal in shape and lie parallel to the basement membrane. They have slender, 
cigar-shaped, dark nuclei and little cytoplasm which is more dense than that of 
Jnminal cells (McNeal, 1988). They stain positive for the high molecular weight 
keratins 5 and 14 (Isaacs, 1984) as well as Bcl-2 (McDonnell et al., 1992). They 
lack expression of the major prostatic secretory proteins, such as PSA and PAP. 
Low levels of androgen receptor have been observed in these cells also (Bonkhoff 
and Remberger, 1993). Basal cells are thought to serve a proliferative role as 
demonstrated by experiments carried out by Bonkhoff and Remberger (1996) in 
which three well-characterised proliferating agents, Ki-67, proliferating cell 
nuclear antigen (PCNA) and MIB-1, were investigated in normal and benign
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prostate tissue. Seventy percent of positive staining was found in cells of a basal 
phenotype. Taking into account the ratio of basal to luminal cells (1:3) in the 
normal prostate gland, the proliferative activity in the basal cell layer exceeds that 
of the luminal cells by a factor of up to ten (Bonkhoff and Remberger, 1996; 
Hudson et al., 2001). Compared with luminal cells, basal cells are less vulnerable 
to apoptosis induced by androgen withdrawal (English et al., 1987). This is 
probably due to the presence of Bcl-2 in basal cells, which inhibits apoptosis (Lu 
et al., 1995). Additional studies have shown that isolated basal cells are capable of 
generating luminal cells in both monolayer and 3-dimensional cultures (Hudson et 
al., 2001; Liu et al., 1999; Robinson et al., 1998). And so, although their specific 
role in prostate biology is not fully known, basal cells are now widely accepted as 
the precursors of secretory luminal cells (Robinson et al., 1998).
Early ultra-structural studies identified a third cell type co-localised in the 
basal cell compartment. This cell is rich in electron-dense, round granules of 
different sizes (Biagini et al., 1982). It is now clear that these cells are prostate NE 
cells. The human prostate contains the largest number of NE cells of any 
genitourinary organ (di Sant'Agnese, 1992). Morphologically, two types of NE 
cells can be identified in the prostate: open, flask-shaped cells with long slender 
extensions towards the glandular lumen, and closed cells with dendritic luminal 
extensions, but often displaying horizontal or oblique processes (di Sant'Agnese, 
1992). Differences in the distribution of NE cells between the zones of the 
prostate have recently been reported (Laczko et al., 2005). The frequency of NE 
cells in the central zone was reported to be approximately 50% lower than in the 
transition and peripheral zones.
NE cells are known to produce a number of neuropeptides such as 
chromogranin A, serotonin, neuron-specific enolase (NSE), calcitonin, thyroid- 
stimulating hormone-like peptide, gastrin-releasing peptide and somatostatin (di 
Sant'Agnese, 1992); (Wu et al., 1996). The exact functions of these substances in 
the prostate is not clearly understood, but they are thought to induce a variety of 
intracellular events including changes in ion flux and depolarisation, activation of 
calcium release, from intracellular stores and activation of ATP formation (Xue et 
al., 1998b). There is now a growing consensus that prostate NE cells may play a 
fundamental role in the regulation of normal growth and gland development 
(Abrahamsson, 1996). Prostate NE cells may contain neurosecretory granules of
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more than one type, and the distribution of different NE cells may indicate their 
various biological functions. Recently, reports have revealed that receptors for 
some NE products are present in prostate NE cells. For example, Wu et a l , (1996) 
identified the presence and location of calcitonin receptor mRNA in the normal 
prostate using RT-PCR and in situ hybridisation. These experiments demonstrated 
that the luminal, exocrine cells were positive for the calcitonin receptor, and that 
some calcitonin receptor expressing cells also had a calcitonin secreting function. 
This suggests that the neuropeptides produced by the prostatic NE cells may also 
act in an autocrine/paracrine fashion.
Figure 1-4: Cross sections of adult human prostate glands showing different 
epithelial cell types.
(A) Brown staining (DAB labelling) indicates basal cells stained for keratin 5 
while luminal cells are negative. (B) Immunofluorescent staining in which basal 
cells are detected by positive staining for keratin 14 (FITC, green) and the 
neuroendocrine (NE) cell is stained for Chromogranin A (TRITC, red).
11
1 Introduction
1.4 Stem Cell Self Renewal and Differentiation
Tissue stem cells (SC) form the cellular basis for organ homeostasis and repair. In 
the adult, SCs are responsible for the generation and maintenance of terminally 
differentiated cell populations in tissues that undergo continuous turnover. The 
prevailing view is that SCs are slow-cycling cells with the capacity for unlimited 
or prolonged self-renewal and that they can produce at least one type of 
differentiated progenitor cell (Till and Me, 1961). A SC division can either give 
rise to two daughter SCs via a ‘symmetrical division’ leading to an increase in SC 
number, or it may undergo asymmetric division producing one identical daughter 
and another cell that is committed to differentiate (Till and Me, 1961). The 
committed daughter cell then enters a transient state of rapid proliferation giving 
rise to transiently amplifying (progenitor) cells that are able to undergo a limited 
number of cell divisions before finally undergoing terminal differentiation (Figure 
1-5) (Potten et al., 1979). SCs are believed to reside in most organs of the body 
and in most tissues. They form a minority subgroup, usually fewer than 1-2% of 
the total cell population of the tissue. Because relatively undifferentiated, in most 
tissues they are unable to carry out the specialist functions their progeny are 
designed to.
Several theories have been proposed to explain the methods of lineage 
determination: extrinsic (through growth factors, stroma or external influences), 
intrinsic (for example, nuclear factors) or a combination of both. The external, or 
extrinsic, signals that control stem cell fate collectively make up its 
microenvironment, or ‘niche’ (Quesenberry and Becker, 1998). A niche is a 
subset of tissue cells and extracellular substrates, which, in vivo, favours the 
existence of the SC in the undifferentiated state and controls its self-renewal and 
progeny production. Interaction with other cell types and the components of the 
extracelluar matrix are believed to influence the survival and development of cells 
committed to terminal differentiation. In addition, several signalling pathways are 
known to be important in regulation of SC self-renewal and cell fate 
determination and these include the Notch (Lowell et al., 2000), Sonic hedgehog 
(Shh) (Kim et al., 2003) and Wnt signalling pathways (Lako et al., 2001).
Differentiation pathways have been studied in many adult organs and a 
number of markers and regulatory pathways of SC self-renewal and
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differentiation have been identified. There remains, however, a clear need for 
further markers to distinguish stem from transit cells as well as the identification 
of potential cascades of gene expression that specify particular differentiation 
pathways. This is in order to understand how these pathways are disrupted during 
disease. Towards this end, considerable progress has been made in understanding 
the lineage pathways of many adult tissues such as the skin, intestine and most 
extensively, the hematopoietic system (Baum et al., 1992; Spangrude et al., 1988).
Stem  Transit Am plifying Term inal D ifferentiation
I n creased Di fferen t iat i on
Increased Proliferative Capacitj
Figure 1-5: Schematic representation of a stem cell differentiation hierarchy.
1.4.1 H aem atopoiesis
Blood cells can be classified into two main types: lymphoid cells (T, B, and 
natural killer cells) and myeloid cells (granulocytes, monocytes, erythrocytes and
13
1 Introduction
megakaryocytes). All blood cells have a limited lifespan: several hours for 
granulocytes, several weeks for red blood cells and up to several years for 
memory T cells. Therefore, vast numbers of blood cells must be continually 
generated in order to keep up with this extremely high rate of cell turnover. It has 
been established that all blood cells are derived from a small population of 
pluripotent cells called haematopoietic SCs (HSCs) that are located in the bone 
marrow (BM). The first evidence for HSCs came from experiments in mice in 
which BM cells from healthy mice were found to generate myeloerythroid 
colonies in the spleens of hosts that had been lethally irradiated (Till and Me, 
1961). These clonogenic cells gave rise to cells that could be transferred to 
secondary hosts where they were able to reconstitute all the differentiated blood 
cell types in the host (Siminovitch et al., 1963). More recent experiments by 
Morrison & Weissman (1994) have identified two classes of HSCs: long term 
(LT-HSCs) and short term (ST-HSCs) SCs. The LT-HSC cell self-renews for the 
life of the host while the ST-HSC retains self-renewal capacity for approximately 
eight weeks (Morrison and Weissman, 1994). In adult life, HSCs constitute a very 
small compartment in the BM with estimates varying from less than 0.05% to as 
much as 0.5% of cells (Gunsilius et al., 2001). The generation of mature blood 
cells from these pluripotent HSCs involves a highly regulated progression through 
successive stages from intermediate cells, which are committed to a specific cell 
lineage, to terminal differentiation of lineage-restricted progenitor cells, growth 
arrest and apoptosis.
The identification of cell surface markers for HSCs has allowed for the 
isolation of cell populations with the ability to restore haematopoiesis in recipients 
receiving myeloablative doses of chemoradiotherapy (Gunsilius et al., 2001). 
HSCs do not express any markers of either granulocyte, macrophage, B or T cell 
lineages but have the phenotype Lin_/lovv/Thy-1 low/c-kithl8h/Sca-1+ in the mouse 
(Morrison et al., 1995) and LinVThy-17CD347CD38 ^  in humans. The CD34 
cell surface antigen is able to identify a cell population that contains HSCs as well 
as lineage-committed haematopoietic cells. In humans, 1-4% of the marrow cells 
express the CD34 antigen compared with 0.1-0.2% in peripheral blood and 0.8- 
1.2% in umbilical cord blood. This CD34+ fraction contains the stem cells as well 
as lineage-committed progenitor cells. Another surface antigen which defines 
haematopoietic stem and progenitor cells is CD 133. This antigen is selectively
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expressed on CD34-bright haematopoietic stem and progenitor cells derived from 
human foetal liver, BM and blood (Yin et al., 1997). HSCs isolated on the basis of 
these cell surface markers are used in the treatment of a number of blood diseases 
such as leukemias, myelodysplastic syndromes, severe aplastic and sickle cell 
anaemias and beta-thalassemia, to restore the patients hematopoietic system.
1.4.2 Epidermis
The mammalian epidermis provides a barrier to protect the body from 
dehydration, injury and infection. As the first line of defense against various 
physical traumas of the environment, including exposure to mutagenic ultraviolet 
radiation, the skin is continually being renewed throughout life and therefore 
exhibits a high rate of cell turnover. This cell renewal process is accelerated in 
response to injuries such as bum or wounding. The rate of cell turnover in the 
human is estimated at about 60 days and around 7 days in mice (Potten, 1981).
The skin consists of an outer layer known as the epidermis, a stratified 
squamous epithelium, and an inner layer known as the dermis. The epidermis and 
dermis are separated by a basement membrane. The epidermis is composed 
almost entirely of epithelial cells known as keratinocytes. The layer of 
keratinocytes directly contacting the basement membrane is termed the basal 
layer. The basal cells are relatively undifferentiated, proliferative cells consisting 
of a network of keratin intermediate filaments (IF). They are also believed to be 
the progeny of SCs, which are thought to reside in the basal layer (Potten, 1981). 
As the population of basal cells increases through cell division, some cells detach 
from the basement membrane and begin to move towards the skin surface. As 
these cells leave the basal layer they increase in strength through the synthesis of 
new sets of keratin filaments linked to tightly adhesive desmosomes. As these 
differentiating, transit amplifying cells near the outer surface of the skin, they 
produce proteins, which organise into bilayers through cross-linking to form the 
comified envelope. Terminally differentiated cells that reach the skin surface are 
enucleated, flattened squames that are subsequently sloughed and are 
continuously replaced by new cells differentiating and moving up towards the 
surface from the basal layer [Potten, 1981 #5343].
Although SCs have been identified in the basal layer of the epidermis, it is 
now believed that the upper portion of the hair follicle known as the bulge,
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constitutes the SC compartment (Oshima et al., 2001). Oshima and colleagues 
demonstrated that when the bulge from a normal mouse follicle was surgically 
replaced with bulge tissue from a mouse ubiquitously expressing lacZ, the 
chimeric follicles produced /acZ-positive cells contributing to all the 
differentiation lineages of the hair follicle and also produced progeny that 
differentiated into sebocytes of the sebaceous gland and the epidermis. It has 
therefore been suggested that bulge SCs migrate downwards from the bulge to the 
base of the hair follicle where their progeny give rise to the outer root sheath inner 
root sheath and hair shaft. In addition, bulge cells may also migrate upwards to 
populate the basal layer of the epidermis and the sebaceous gland.
Molecular markers that differentiate epidermal SCs from transit amplifying 
cells are essential to further the understanding of lineage pathways of cellular 
maturation. The most useful cell surface markers of human epidermal SCs are the 
B1 integrins, receptors that bind extracellular matrix proteins. All basal 
keratinocytes express B 1 integrin, however, cells thought to be SCs within the 
basal layer, express two to three fold higher levels of the protein. In addition, it 
has been shown that as cells leave the basal layer, they down-regulate its 
expression. B 1 integrin can therefore be used to enrich for SCs in the epidermis 
(Hertle et al., 1995). Other proteins have been identified as markers of epidermal 
SCs such as keratin 19 (Michel et al., 1996), keratin 15 (Lyle et al., 1998) and 
p63, a homologue of the p53 tumour suppressor gene (Pellegrini et al., 2001). 
Although these markers provide additional information about epidermal SCs and 
differentiation pathways, they are of limited use in isolating particular cell 
populations, as they are intracellular proteins.
1.4.3 Intestine
"  The mammalian intestinal mucosa is a rapidly proliferating tissue and provides an 
additional model for the study of proliferative hierarchies, regulation of cell 
division and differentiation. The tissue is lined by a simple columnar epithelium, 
which is continually being replaced as cells are shed into the gut lumen. The 
epithelium is folded to form a number of invaginations, or crypts that are 
embedded in the connective tissue; each crypt is composed of around 250 simple 
epithelial columnar cells. In the small intestine, several crypts surround the base 
of finger-like luminal projections called villi. Epithelial cells produced in the
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lower part of the crypt migrate up the crypt onto an adjacent villus where they 
perform their differentiated absorptive function before being shed, into the lumen.
It is widely accepted that SCs are located near or at the base of each crypt 
and are responsible for maintaining tissue homeostasis in the intestine. Estimates 
of SC number vary widely from 0.4-0.6% of the crypt cells, with the smallest 
value implying that a single SC is located in each crypt. As in other regenerative 
tissue models such as the epidermis, SCs in the intestine are thought to give rise to 
intermediate, transiently proliferating committed progenitors. These progenitor 
cells migrate up the crypt towards the surface and subsequently differentiate into 
either the absorptive brush border enterocytes, mucus-secreting goblet cells, or the 
peptide hormone secreting enteroendocrine cells of the villi. Differentiated cells 
eventually die and are shed from the villi into the lumen of the gut approximately 
5-7 days after the onset of cell division. Additionally, a number of progenitor cells 
migrate down to the base of the crypt to become the fourth cell type, the Paneth 
cells. These cells synthesize and secrete antimicrobial peptides, digestive enzymes 
and growth factors and are eventually cleared from the crypt by phagocytosis 
(Cheng and Leblond, 1974). It has also been suggested that the intermediate 
progenitor cells are of two types: short lived cells that give rise to one or two cell 
types and long lived progenitors that give rise to all epithelial cell types (Bjerknes 
and Cheng, 1999). However, the search for markers differentiating stem from 
intermediate progenitor cells is ongoing.
Evidence for the existence of SCs within the intestinal epithelium came 
from radiation experiments where following radiation-induced cell death, 
surviving proliferative cells were able to form a regenerative crypt containing all 
cell lineages, (enterocytes, goblet cells, Paneth cells and endocrine cells) (Cheng 
and Leblond, 1974). In addition, subcutaneous injection of single cells from rat 
colonic adenocarcinoma into mice can give rise to tumours containing all cell 
lineages (Cox and Pierce, 1982). However, unlike the epidermis and 
hematopoietic system, molecular markers of intestinal SCs have not yet been 
identified and they are instead defined by their characteristics. Recently however, 
Musashi-1 (Msi-1) has been identified as a putative marker of intestinal stem and 
early lineage progenitor cells. The Msi-1 gene is also thought to be involved in the 
early asymmetric divisions that generate differentiated cells from neural SCs or
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progenitor cells since it was found to be expressed by neural SCs but was down 
regulated in the differentiated progeny (Kaneko et al., 2000).
1.4.4 Mammary Gland
In humans the epithelium of the mammary gland consists of a network of ducts 
that branch and invade the mammary fat pads. The ducts are made up of a basal 
layer of myoepithelial cells that express keratins 5 and 14, and a luminal layer of 
specialised epithelial cells expressing keratins 8, 18 and 19. It has been suggested 
that the breast epithelium houses a population of cells with properties resembling 
those of SCs and it is these cells that maintain tissue homeostasis (Daniel and 
Young, 1971). The search for breast SCs has gained potential in recent years and 
there have been many further studies investigating the isolation and 
characterisation of the putative mammary SC.
The adult mammary gland is a dynamic organ that undergoes significant 
changes in morphology during developmental periods such as pregnancy and 
lactation. During puberty, ductal outgrowth rapidly increases under hormonal 
stimulation resulting in side branching. Full development of mammary epithelium 
occurs only during pregnancy and lactation, when numerous lobulo-acinar 
structures containing the milk-secreting alveolar cells are formed through 
extensive proliferation, followed by terminal differentiation. Cessation of 
lactation following weaning is accompanied by massive apoptosis and tissue 
remodelling, and the gland returns to a structure resembling that before 
pregnancy. This cycle of pregnancy-associated proliferation, differentiation, 
apoptosis and remodelling can occur many times during the reproductive lifespan 
of mammals, suggesting the presence of a cell population with high proliferative 
potential and differentiation ability, a description that fits the definition of stem or 
progenitor cells (Dontu et al., 2003b).
While mammary SCs have not as yet been isolated and characterised, there 
is strong evidence for their existence. Studies in mice and rats demonstrated that 
an entire mammary gland could be generated from fragments, or even single cells, 
of breast epithelium. Removal of the endogenous mammary epithelium from a 
mammary fat pad created a cleared pad that was used as a site of transplantation. 
Cells from normal mammary epithelium were able to grow and fill the empty fat 
pad. Serial transplantation of epithelial fragments regenerated the entire functional
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gland reaching growth senescense after several generations. Furthermore, any 
portion of the normal mammary parenchyma was able to regenerate a complete 
mammary gland, over several transplant generations, suggesting the existence of 
cells capable of reproducing new mammary epithelium through several rounds of 
self renewal (Daniel and Young, 1971).
Recently, ultrastructural studies of mouse mammary epithelial explants, 
from various stages of development, revealed the existence of a population of pale 
or light staining cells and it was only these cells that entered mitosis when the 
mammary explants were cultured. These pale cells were undifferentiated but were 
able to differentiate towards secretory cells in vitro. Two forms of 
undifferentiated pale cells were recognised: small light cells (SLC) and 
undifferentiated large light cells (ULLC). The SLC were found to have a basal 
location and did not touch the lumen. They contained few organelles and showed 
little evidence of specialised function (Smith and Chepko, 2001). By contrast, 
ULLC made contact with the basement membrane and the lumen. The cytoplasm 
contained some mitochondria, sparse endoplasmic reticulum and an inactive 
Golgi complex. Both SLC and ULLC displayed condensed mitotic chromosomes 
suggesting an ability to replicate. During pregnancy, the rapidly proliferating 
mammary epithelium revealed a number of partially differentiated ULLC, or 
differentiating large light cells (DLLC). It was suggested that the DLLC 
represented the transit amplifying epithelial cells committed to differentiation to a 
secretory cell type. Furthermore, mitotic chromosomes were not observed in 
differentiated cells suggesting a state of terminal differentiation. Based on these 
observations, a hypothetical pathway of differentiation in the human mammary 
gland was suggested whereby the pale-staining or light cells are situated between 
the luminal and myoepithelial cell layers and give rise to all cells types of the 
mammary gland (Smith and Boulanger, 2003).
The isolation of mammary SCs has been hindered by the lack of suitable 
systems that maintain these cells in culture in an undifferentiated state, and by the 
lack of defined SC markers. Dontu et al (2003) studied human mammary 
epithelial cells isolated from reduction mammoplasties cultured on a non-adhesive 
substratum. The vast majority of cells underwent apoptosis. However, a small 
number of cells were able to survive and proliferate and form multicellular 
spheroids, which were highly enriched in undifferentiated cells. Single cells from
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the spheroids were able to generate multilineage colonies when cultured in the 
presence of serum on a collagen substratum, and gave rise to myoepithelial, ductal 
epithelial and alveolar epithelial cells (Dontu et al., 2003a). Several attempts to 
isolate mammary SCs have been made through the utilisation of cell surface 
markers and several candidate SC markers have thus been reported. For example, 
it was suggested that cells situated in an intermediate position between the 
myoepithelial and basal layers, the putative SCs, that do not contact the lumen, 
would not express apical membrane-specific sialomcin MUC-1 but would express 
the luminal epithelial-specific antigen (ESA). It was subsequently demonstrated 
that these ESA+/MUC-1- cells were able to produce both luminal and 
myoepithelial cell types in vitro, whereas ESA+/MUC-1+ cells were restricted in 
their ability to differentiate into multiple lineages (Gudjonsson et al., 2002). 
Similarly, studies with mouse mammary epithelial cells isolated based on their 
cell surface expression of Sca-1, showed that these cells were able to reconstitute 
the mammary glands of host mice cleared of endogenous tissue; transplantation of 
Sca-1 negative cells resulted in poor ductal outgrowths. Sca-1 is a GPI-anchored 
membrane protein expressed by murine bone marrow and muscle SCs and has 
therefore been suggested to be a potential marker of mammary stem/progenitor 
cells (Welm et al., 2002).
It has been postulated that the side population (SP) is a universal phenotype 
of SCs and these cells are characterised by their differential uptake of Hoechst 
dye. Using flow cytometric analysis, SP populations of SCs have been identified 
in haematopoietic and muscle cells (Goodell et al., 1996; Zhou et al., 2001). 
Recently, Alvi et al (2003) identified the presence of a SP of SCs within the 
human and mouse mammary glands. The mammary SP cells comprised of an 
undifferentiated subpopulation of cells that in vivo, generated ductal and lobular 
structures which contained both myoepithelial and luminal epithelial cell types. 
Freshly isolated SP cells expressed low levels of differentiated markers for 
luminal (K19) and myopeithelial cell types (K14). Oestrogen receptor was also 
detected in SP cells, suggesting they have the capacity to respond to the 
proliferative effects of oestrogen (Alvi et al., 2003). In addition, expression of the 
telomerase catalytic subunit was detected in mammary SP cells compared with 
non-SP cells; telomerase has been associated with SC compartments in other 
tissues (Kolquist et al., 1998). Furthermore, the mammary SP cells expressed the
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haematopoietic SC marker Sca-1. The search for further markers of mammary 
SCs, and thus a better understanding of the differentiation pathway in this organ, 
is ongoing.
1.5 Models of Differentiation Lineages in the Human 
Prostate
All models of prostate epithelial cell differentiation and cell lineage are based on a 
stem cell theory and several models of epithelial cell differentiation in the human 
prostate have been postulated by a number of authors (Bonkhoff, 1996; Collins et 
al., 2001; English et al., 1987; Hudson et al., 2000; Isaacs and Coffey, 1989; 
Wang et al., 2001) in which a pluripotent stem cell located within the basal cell 
layer is postulated to give rise to the terminally differentiated secretory luminal 
cells and NE cells.
1.5.1 Evidence for prostate stem cells from in vivo studies
There is accumulating evidence derived from experiments carried out in the rat 
supporting the prostate stem cell hypothesis (English et al., 1987; Evans and 
Chandler, 1987; Kyprianou and Isaacs, 1988). The majority of adult prostatic 
epithelial cells are androgen dependent for growth and survival. For example, 
castration of the male rat via androgen ablation, leads to involution of the prostate 
with a loss of approximately 80-90% of total epithelial cells through apoptosis 
(Kyprianou and Isaacs, 1988). The remaining prostate tissue remains androgen 
responsive since the subsequent administration of exogenous androgens to the 
castrate rat results in the induction of cell proliferation and regeneration of the 
prostate to its original adult size and morphology (English et al., 1987). This 
process of involution and subsequent androgen-induced regeneration of the 
prostate can be repeated numerous times (English et al., 1987) supporting the 
existence of a stem cell population in the adult prostate that is androgen 
independent for survival but remains androgen responsive, and is responsible for 
generation of all epithelial cell lineages of the prostatic epithelium.
Verhagen et al (1988) also observed a decline in thickness of the epithelial 
layer of the acini which was seen upon androgen ablation, and which seemed to 
be caused mainly by a reduction of the luminal cell compartment. A very thin 
luminal layer was left and the basal cell compartment seemed to be mostly
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unaffected, as was determined by keratin expression patterns. The residual 
luminal layer consisted of cells with morphological luminal characteristics but 
displayed a keratin expression pattern of both basal and luminal cell types. 
Testosterone administration to 14-day castrated rats caused rapid regeneration of 
the prostate resulting in restoration of the normal morphology of the luminal cell 
layer and the epithelium regaining its normal thickness (Verhagen et al., 1988).
Castration-related changes have also been reported for the expression of 
telomerase. The enzyme telomerase is responsible for maintaining the length of 
telomeres at the ends of eukaryotic chromosomes. Adult somatic cells do not 
contain functional telomerase. Thus with each complete cell division, a cell’s 
telomeric length is shortened by about 50-100 bp (de Lange, 1994). When cells 
attain a critically short telomere length, they reach the Hayflick limit of cell 
replication and undergo senescence. However, there are certain cell types that do 
not appear to undergo this phenomenon. These are the germ-line cells, some stem 
cells and many malignant tumour cells. These cells differ from somatic cells in 
that they express functional telomerase and thus display an immortal phenotype, 
i.e. unlimited replicative potential (Kim et al., 1994; Lansdorp, 1995; Wright et 
al., 1996). Telomerase is undetectable in the normal adult prostate gland of the rat. 
However, following castration, the residual prostate gland expresses high levels of 
telomerase. Activity of the enzyme disappears again following testosterone- 
induced regeneration of the prostate. This suggests that stem cells are rare in the 
normal prostate. Also, since their survival is androgen-independent, the number of 
stem cells in the prostate may be increased as a result of castration, allowing 
telomerase detection (Meeker et al., 1996). This may be due to an increase in stem 
cell numbers but is most likely to be due to the loss of differentiated hormone 
dependent cells, leading to an increase in the relative proportion of cells being 
stem cells.
Studies using tissue recombination models, such as those of Kinbara et al 
(1996), also support the existence of stem cells within the prostate. Segments of 
adult rat prostate from the dorsal, lateral type 1 and lateral type 2 prostatic ducts, 
were removed and combined with mesenchyme from embryonic urogenital sinus, 
neonatal seminal vesicle or neonatal bulbourethral gland. The tissue recombinants 
were grafted under the renal capsule of syngeneic male hosts. The mesenchyme 
induced abundant epithelial cell growth, new ductal branching morphogenesis and
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changes in prostate lobe identity that depended on the type of mesenchyme 
inducer. This result indicates that the adult prostate contains cells with a high 
proliferative capacity and the potential for multiple differentiation pathways, 
properties akin to those of stem cells (Kinbara et al., 1996). Adult urinary bladder 
epithelium has also been induced by urogenital sinus mesenchyme to undergo 
prostatic development, resulting in prostatic ductal morphogenesis, secretory 
cytodifferentiation, expression of epithelial AR, prostate-specific secretory 
proteins and androgen dependence for growth (Cunha et al., 1983; Cunha et al., 
1980).
1.5.2 Evidence for prostate stem cells from in vitro cell culture 
studies
In cell culture, the ability of single cells to develop colonies is associated 
with stem cell and transit amplifying cell properties. Primary cultures of prostate 
epithelial cells have been studied for their colony-forming ability (Peehl and 
Stamey, 1986; Peehl et al., 1988) and it has been shown that at low plating 
densities (100 cells per 5 cm Petri dish), approximately 5% of adult prostate 
epithelial cells, cloned directly from biopsies and primary cultures, formed 
colonies, some of which were very large. These findings were extended to further 
characterize the putative stem cell-like properties of primary adult prostate 
epithelial cells (Hudson et al., 2000). The majority of primary epithelial cells 
(cloned directly from biopsies of benign prostatic hyperplasia) formed small 
irregular shaped colonies containing up to 8,500 cells. When stained for 
cytokeratin markers, the majority of cells in these colonies were positive for both 
K14 and K8, with few cells expressing only K14 or K8, indicating both 
undifferentiated and differentiated cells within these colony types. A small 
_  population of epithelial cells (approximately 0.5% of the cells plated) formed very 
large more tightly packed colonies containing between 8,000 and 40,000 cells. 
These colonies were mainly composed of K 14-positive cells with little or no 
luminal cell-specific K8 expression. It was suggested that these larger colonies 
were founded by stem cells. Since one property of stem cells is the ability 
regenerate the different cell types of the tissue in which they reside. The ability of 
these epithelial cells to regenerate prostate epithelium was determined. When 
these colonies were grown in matrigel, three-dimensional spherical structures with
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side branching formed which when sectioned and stained revealed a well- 
organised basal layer with one or more luminal layers surrounding a lumen partly 
filled by single cells. The outer layer of basal cells were positive for K5, K14 and 
CD44, where as the luminal cells expressed K8 as well as K17, K19 and weak 
K14; androgen receptor was expressed by cells within the lumen (Hudson et al., 
2000).
The findings of Hudson et al (2000) were further extended to provide 
additional evidence for the existence of stem cells in the adult prostate by Collins 
and colleagues, (2001). By pre-selecting CD44-positive cells, basal epithelial cells 
were isolated and assessed for stem cell properties. Epidermal stem cells are 
known to express higher levels of integrins a  2 (31 and a  3 (31 than transit 
amplifying cells and also rapidly adhere to type I collagen in culture. Prostate 
epithelial cells were shown to share these properties of epidermal stem cells with 
3% of the total basal population adhering to type I collagen within 5 minutes. 
These rapidly adherent cells were also alpha2-integrin bright suggesting that these 
cells represented the prostate stem cells. By grafting this integrin-bright cell 
population together with human stromal cells, into athymic male mice, their 
ability to regenerate the different cell types of the prostate was investigated. 
Indeed following 42 days of growth, a fully formed epithelium was observed with 
variable gland formation. The epithelium consisted of a layer of flattened cuboidal 
cells expressing basal cell specific markers K5 and K14. Columnar cells found 
facing the lumen were positive for PAP, PSA and AR. These findings lend further 
support to the hypothesis that a stem cell population located within the basal cell 
layer of the prostate is the progenitor of the luminal cell population.
Bonkhoff et al (1994) demonstrated through immunohistochemical 
experiments that not only basal and luminal, but also NE cells may be linked in a 
precursor-progeny relationship. In the normal and hyperplastic prostate, the co- 
expression of basal cell-specific cytokeratins and PSA in a sub-population of 
basal cells was observed, indicating the existence of epithelial cell types with both 
basal and luminal features. Tissue sections of hyperplastic prostate revealed a 
small number of cells expressing both the NE cell marker chromogranin A and 
PSA. Furthermore, co-expression of chromogranin A and basal cell-specific 
cytokeratins were focally observed in some NE cells in the hyperplastic and
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normal prostate. Bonkhoff thus proposed (from this and basal proliferation studies 
and basal cell AR expts) that luminal cells originate from androgen-responsive 
basal cells via intermediate cell types (Bonkhoff et al., 1994a).
As in other adult tissues of the body where the existence of stem cells has 
been established, such as in the skin, gastrointestinal tract and haematopoietic 
system, the differentiation of stem cells in the prostate is also most likely a 
hierarchical process characterised by the presence of intermediate, transiently 
amplifying, progenitor cell types. Several authors have documented the existence 
of such intermediate cells, that co-express basal and luminal cell markers, in the 
human prostate, as candidates for a transit amplifying population, suggesting a 
hierarchical pathway of differentiation (Bonkhoff et al., 1994a; Nagle et al., 1991; 
Peehl et al., 1996; Robinson et al., 1998; Sherwood et al., 1990; van Leenders et 
al., 2000; Verhagen et al., 1988; Verhagen et al., 1992; Xue et al., 1998a). For 
example, the AR and PSA are found exclusively within the luminal population. 
However, it has been documented that a small number of basal cells in the normal 
and hyperplastic prostate also express nuclear AR and PSA, indicating 
differentiation intermediate between the basal and luminal cell types (Bonkhoff 
and Remberger, 1993; Bonkhoff et al., 1994b). These subsets of basal cells are 
suggested to be potentially androgen responsive and consequently, to be the 
precursors of the luminal secretory cells (Figure 1-6), with the differentiation 
pathway from basal to luminal cell types being an androgen-induced process 
(Bonkhoff and Remberger, 1996).
The simultaneous detection of numerous keratins in a single cell, has 
allowed the features of intermediate cells to be better characterised leading to 
further models of differentiation in the adult prostate. Van Leenders et al (2000) 
identified a subset of cells in the basal cell layer that expressed low levels of K18 
together with K5 and K14 (K5++/K14++/K18+). It was proposed that this subset 
of cells represented the stem cells of the human prostate epithelium. These cells 
gradually lose expression of K14 leading to an intermediate basal cell type 
expressing K5 and K18 (K5++/K18+). By proliferation and translocation, a 
second intermediate cell type arises in the luminal layer (K5+/K18++). Terminal 
differentiation of the intermediate/transiently proliferating cells results in fully 
differentiated luminal cells (K18++) and NE cells (Figure 1-7) (van Leenders et 
al., 2000; van Leenders and Schalken, 2001).
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Figure 1-6: Diagramatic representation of the model of prostate epithelial 
cell differentiation as described by Bonkhoff & Remberger (1996).
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Figure 1-7: Diagramatic representation of the model of prostate epithelial 
cell differentiation as described by Van Leenders et al (2000).
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By broadening the range of cytokeratins, Hudson et al (2001) proposed that 
cells with an intermediate basal and luminal phenotype expressed the additional 
cytokeratins K15, K17 and K19 to varying degrees depending on their location 
and degree of differentiation leading to the following theoretical pathway of 
differentiation within the prostate epithelium (Figure 1-8): a relatively 
undifferentiated population containing prostate stem cells is located in the basal 
layer and expresses K5 and K14 only. An intermediate cell arises in the basal 
layer from this stem cell population that shows K5 and K14 expression, together 
with K15, K17 or K19. Further differentiation of these cells leads to another type 
of intermediate cell located in the basal layer that express K5 and K15 with K17 
or K19, but in the absence of K14. These cells differentiate further and translocate 
to the luminal layer showing a K8/K18/K19 phenotype. Terminal differentiation 
of these intermediate cell populations results in terminally differentiated luminal 
and NE cells (Hudson et al., 2001).
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Figure 1-8: Diagramatic representation of the model of prostate epithelial 
cell differentiation as described by Hudson et a l , 2001.
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An alternative model of differentiation lineage in the human prostate has 
recently been proposed based on studies of foetal prostate (Wang et al., 2001). 
The adult prostate originates from the embryonic urogenital sinus epithelium 
(UGE). Immunohistochemical staining of human, mouse and rat UGE, prior to the 
growth of prostatic buds, which appear at week ten of gestation in the human 
foetus (and at days 17 and 19 in the rat and mouse respectively), revealed uniform 
expression of luminal cell markers K8 and K18 as well as basal cell markers K14 
and p63. In addition, expression of K19, a proposed marker of an intermediate (or 
transit amplifying) cell type, and expression of GSTpi was also observed in the 
UGE at this stage of development. As prostatic buds appear, solid cords and 
canalised ducts develop; solid epithelial cords and early development of prostatic 
ducts revealed a similar differentiation marker profile to that seen in the 
embryonic UGE. However, as the canalised ducts develop further, a defined 
lumen appears in which two epithelial cell layers can be distinguished. 
Immunohistochemical staining of these cells revealed three distinct epithelial cell 
populations in all three species: a subgroup of cells that appear to be fully 
differentiated luminal cells expressing only K8 and K18; partially differentiated 
luminal cells expressing the luminal cell-specific K8 and K18, as well as K 19 and 
GSTpi; a third cell population expressing the full range of basal and luminal cell 
markers (K8, K18, K5, K14, p63, K19 and GSTpi). The adult prostate consists of 
a well-defined epithelium with clear basal and luminal cell layers. The majority of 
luminal cells showed positive immunohistochemical staining for K8 and K18, 
however, a small number of cells within the luminal layer also revealed K19 and 
GSTpi staining but were negative for K5, K14 and p63. The basal layer of the 
adult prostate contained cells that expressed K5, K14, p63, GSTpi and K19 but 
were negative for the luminal markers K8 and K18. Interestingly, however, a 
small fraction of cells within the basal compartment co-expressed the full range of 
luminal and basal cell markers resembling embryonic UGE cells. This UGE-like 
cell population represented approximately 0.6% of basal cells. Based on these 
observations, Wang et al (2001) proposed that this sub-group of cells, expressing 
the full complement of basal and luminal cell markers, represent the stem cells of 
the adult prostate. Through loss of expression of K5, K14, K19 and GSTpi, these
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stem cells give rise to fully differentiated luminal cells and conversely loss of K8 
and K18, the stem cells also give rise to basal cells (Figure 1-9).
K8/18K19/8/18 
GSTpi
Luminal
Layer
Basal
Layer
K14/5/19 K14/5/8/18/19
p63/GST pi p63/GSTpi
Figure 1-9: Diagramatic representation of the model of prostate epithelial 
differentiation as described by Wang et a l , 2001.
1.6 Markers of Differentiation
Advances in our understanding of normal and aberrant prostate epithelial 
development will require the identification of lineage-specific markers. To date, 
the most commonly used markers of epithelial cell differentiation are the keratins. 
Additional proteins are also emerging as differentiation markers (e.g. p21), 
however there remains the need for markers of more specific stages of the 
epithelial differentiation process in order to elucidate the underlying mechanisms 
of disease.
1.6.1 Keratins
The ability of eukaryotic cells to adopt a variety of shapes and to carry out 
coordinated and directed movements depends on a complex network of protein 
filaments that extends throughout the cytoplasm, known as the cytoskeleton. All 
eukaryotic cells contain a cytoskeleton composed of three types of structurally 
dynamic proteins that reorganise continuously as the cell changes shape, divides 
and differentiates. These are the actin microfilaments, the microtubules and the 
intermediate filaments (IF). The intermediate filaments are rope-like fibres able to 
polymerise into 8-12nm thick filaments (between the diameter sizes of actin and 
tubulin) and are expressed in nearly all cells of the body. Actin and tubulin are
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important for cell shape, movement and cell division whereas IFs have a role in 
cell and tissue strength. The IF proteins are very diverse and show cell type 
specific expression. The major types of IFs are vimentin filaments in 
mesenchymal cells, desmin filaments in muscle cells, neurofilaments in neuronal 
cells, glial fibrillary acidic protein (GFAP) in glial cells and astrocytes and keratin 
filaments in epithelial cells.
The keratins are a group of proteins that play a crucial role as scaffolding 
filaments within epithelial cells (Fuchs, 1988). They exist as a complex array in 
cells forming an elaborate, cage-like network around the nucleus, and emanating 
cables (tonofilament bundles) throughout the cell which impact the cell periphery 
at specialised junctions, such as desmosomes and hemidesmosomes. The keratin 
proteins constitute the major component of the cytoskeleton in epithelial cells 
providing structure and mechanical support to the cells and their nuclei (Fuchs 
and Cleveland, 1998). These filaments are also highly dynamic structures 
continuously exchanging protein throughout their length in response to different 
phases of the cell cycle, cell movement and epithelial cell differentiation (Steinert 
and Bale, 1993).
The keratin proteins are alpha helical polypeptides that have a central 310- 
amino acid alpha-helical rod domain that is interrupted by three short non-helical 
linker segments (Hanukoglu and Fuchs, 1982). The rod domain consists of four 
alpha-helical units designated 1A, IB 2A and 2B and the linker segments are 
known as LI, L I2 and L2. The end domains are divided into subdomains based 
on homologous (H), variable (V) and end (E) sequences. E l, VI and, in type II 
only, HI, make up the non-helical head domains and V2, E2, and in type II only, 
H2, comprise the non-helical tail domain (McLean and Lane, 1995) (Figure 1-10).
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Figure 1-10: Schematic diagram representing the secondary structure of type 
I and type II keratins.
(Adapted from McLean and Lane, 1995).
The keratins are a large multigene family encoding over thirty different 
proteins (Lane and Alexander, 1990; Steinert and Bale, 1993) and are expressed 
in epithelial cells. They have been subdivided into two groups (Type I and Type 
II) according to their physio-chemical characteristics such as isoelectric point (pi, 
as determined by 2D electrophoresis), molecular weight, amino acid sequence 
homology and studies involving reactivity towards monoclonal antibodies AE1 
and AE3 recognising acidic and basic proteins respectively (Galvin et al., 1989). 
Type I cytokeratins are small (Mr 44-65 KDa), acidic (pI:4-6) and comprise of 
cytokeratins K9-K20. Type II represents the large (Mr 50-70 Kda) neutral/basic 
(pI:6-9) keratins K1-K8 (Lane and Alexander, 1990). Epithelial cells of different 
tissues will express a defined pair of a type I, acidic, and a type II, basic/neutral 
Jceratin, which is characteristic for that particular epithelium. These pairs of type 
II and type I keratins are expressed differentially in most epithelial cells at various 
stages of development and differentiation (Fuchs and Green, 1980; Wu et al., 
1982). The type of keratin synthesised and the stage of cell differentiation are so 
tightly linked that this has lead to the keratins being widely used markers of 
various stages of epithelial cell differentiation, e.g. progenitor and differentiating 
cells express different sets of keratins. Figure 1-11 is a summary of specific 
keratin pair expression in different epithelial tissues. K8 (type II) and K18 (type I)
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are the first keratin pair to be expressed during embryonic development (Bosch et 
al., 1988), and in adults they continue to be expressed in single layered epithelia 
such as hepatocyte, kidney, which may also express K7, K19 and K20 (Moll et 
al., 1982). Complex epithelia of trachea, lung, mammary gland, bladder and the 
prostate gland also express K8 and K18 (Zehner, 1991) as well as K5 and K14 in 
their basal cell layers (Purkis et al., 1990).
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Figure 1-11: Summary of the pairwise expression of keratins in different 
epithelial types.
Molecular weights are given underneath each keratin in kilodaltons (kDa) 
(Adapted from Lane and Alexander, 1990).
1.7 Cellular Composition and Differentiation in Prostate  
Cancer
Prostate carcinoma is predominantly composed of cells with a luminal phenotype 
(i.e. staining positive for K8, K18, PSA), and dispersed amongst these cancer cells 
are cells of a neuroendocrine phenotype. Loss of the basal layer in neoplastic foci 
is a hallmark of the disease; reactivity of the 34|3E12 antibody (anti-Kl, 5, 10 14)
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has therefore been used to distinguish between atypical benign lesions to 
determine whether adenocarcinoma might be present. As a consequence of these 
observations, it is thus generally believed that prostate cancer arises from luminal 
cells.
However, during the last decade, a number of researchers have found 
expression of high molecular weight keratins in prostate tumours. Expression of 
K5 has been reported in primary prostate carcinomas (Verhagen et al., 1992) and 
reactivity with the antibody 34j3E12 has been encountered in up to 54% of 
prostate cancer metastases (Googe et al., 1997; Yang et al., 1999b). A more in 
depth analyses of cellular markers, carried out by van Leenders et al (2001), 
examined the expression of keratins 5, 14, 18 and chromogranin A in tissues from 
prostate cancer metastases, and also investigated the cellular composition of 
regressed and hormone-refractory prostate cancer. Phenotypic characterisation of 
prostate cancer cell lines was also carried out. Three epithelial cell types present 
in prostate carcinoma were identified: the predominant cell population were 
phenotypically luminal cells (K 18-positive); an additional cell population was 
characterised by expression of Chromogranin A, indicating the presence of 
neuroendocrine cells; and a third cell type was identified by the expression of K5 
in the absence of K14 (Van lenders et al , 2001). Interestingly, keratin 5- 
expressing cells were found in tumour cell emboli localised in vessels close to 
lymph nodes. Furthermore, the median cell number of K5-expressing cells was 
significantly increased in hormone-escaped prostate cancer samples compared 
with androgen-dependent prostate cancer. Androgen deprivation did not affect 
expression of K18. Keratin 14 expression was not observed in the prostate cancer 
specimens analysed. Ch A expression was also observed in prostate cancer 
metastases, however its expression did not differ significantly between regressed 
and hormone-escaped prostate cancer.
As prostate cancer is considered a monoclonal expansion of a transformed 
epithelial cell type, its heterogeneous cellular composition requires further 
investigation and understanding. Because of the different phenotypical 
characteristics of cells found in adenocarcinoma of the prostate, there is some 
debate regarding exactly which cell type gives rise to prostate cancer. Likely 
candidates include the stem cell, the intermediate transiently proliferating cell and
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the terminally differentiated luminal cell. The presence of distinct epithelial cell 
types suggests that one cell type is very possibly the progenitor of the other two 
cell populations. Consequently, it has been proposed that malignant 
transformation in the prostate may arise from a neoplastic intermediate amplifying 
cell population, that retains the ability to differentiate into more committed cells. 
These finally undergo terminal differentiation into K 18-expressing luminal cells 
(Isaacs and Coffey, 1989).
With regards to cells expressing low levels of keratin 5, others have 
postulated that early intermediate cells express K5 whilst more committed late 
intermediate cells lose K5 expression, and that it is from these, late, more 
committed cells that prostate cancer is derived (van Leenders et a l , 2001). In 
support of this hypothesis, studies carried out by Verhagen et al (1992), 
demonstrated that K5 expression was more often observed in well-differentiated 
primary prostate carcinomas (Gleason sum 2-4), whilst K5 was completely absent 
from tumours with the worst grade of differentiation, Gleason sum 8-10. It was 
thus postulated that the degree of differentiation of the initially transformed cell 
type influences the growth pattern of prostate tumours (Verhagen et a l , 1992).
Irrespective of the molecular pathway leading to cells phenotypically 
resembling intermediate cells, analysis of this specific cell population might 
contribute to a better understanding of androgen-independent prostate cancer 
progression (van Leenders et a l , 2001).
1.8 In Vitro Prostate Epithelial Cell Models
Cellular proliferation, lineage-specific differentiation, migration and apoptosis are 
highly coordinated processes that occur within tissues or in vitro cell systems in a 
"  sequential and spatially organised manner. However, deregulation of one or more 
of these coordinated processes in the human prostate may lead to aberrant 
proliferation and differentiation; these are characteristics of two of the most 
common prostatic diseases, BPH and prostate carcinoma. The underlying factors 
that regulate these processes remain to be fully understood. Therefore elucidating 
such underlying mechanisms involved in normal prostate epithelial cellular 
homeostasis is imperative towards then understanding the pathogenesis of these 
diseases and their subsequent treatment. To date, such research has been
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somewhat hindered by a lack of suitable in vitro models for the study of normal 
prostate epithelial cell differentiation.
1.8.1 Immortalised human prostatic epithelial cell lines
A number of non-tumourigenic immortalised human prostate cell lines have been 
established. These cell lines have been derived by transfection with different viral 
immortalising genes of DNA viruses, SV40 (Cussenot et al., 1991; Iype et al., 
1998; Kaighn, 1980; Kaighn et al., 1989; Webber et al., 1996b), Human 
Papilloma Virus-16 (HPV-16) (Bright et al., 1997; Lechner et al., 1978; Schwab 
et al., 2000) or HPV-18 (Bello et al., 1997; Weijerman et al., 1994). Cells 
immortalised by SV40 include the PNT1 cell line (Cussenot et al., 1991) and 
pRNS-1-1 (Lee et a l , 1994). The PWR-1E cell line was derived by transfection 
with the adenovirus 12-simian virus 40 hybrid virus (AD12-SV40) (Webber et al., 
1996a). Cells immortalised by human Papillomavirus include the PZ-HPV-7 cell 
line (Weijerman et al., 1994) and the RWPE-1 cell line (Bello et al., 1997). None 
of the above cell lines form tumours in nude mice. However, only the PWR-1E 
and RWPE-1 cell lines have been reported to express both the androgen receptor 
(AR) and prostate-specific antigen (PSA) (Bello et al., 1997; Webber et al., 
1996a). Although such cell lines are useful for the study of the progression from a 
normal to malignant phenotype, they represent a differentiated state and cannot be 
manipulated to mimic stages of normal prostate epithelial cell differentiation.
Amongst the best characterised and studied prostatic carcinoma cell lines 
are DU 145 derived from a metastatic central nervous system lesion (Stone et a l , 
1977) and PC3 which was derived from a bone metastasis (Kaighn et al., 1978). 
Both these cell lines are androgen insensitive and independent and do not secrete 
PSA. Another widely used prostate cancer cell line is LNCaP which was derived 
"  from a lymph node metastasis (Horoszewicz et al., 1980). This cell line expresses 
AR and responds to androgens that stimulate their growth. In addition, the cell 
line expresses prostatic acid phosphatase (PAP) and PSA.
Other prostatic carcinoma cell lines that have been established include TSU- 
Prl (Iizumi et al., 1987), PPC-1 (Brothman et al., 1989), JCA-1 (Muraki et al., 
1990) ND-1 (Narayan and Dahiya, 1992), ALVA-31 (Loop et al., 1993), ALVA- 
41 (Nakhla and Rosner, 1994), LAPC-4 (Klein et al , 1997) and PC-346C 
(Romija et a l , 1995). With the exception of LNCaP, most of the prostate cancer
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cell lines available to date are of limited value as in vitro models of prostate 
cancer since many prostate-specific characteristics, such as AR and PSA 
expression, are lost. Thus there is a further need for more, well characterised 
prostate cell lines.
1.8.2 SV40 immortalisation of human ceils
Many cell lines have been derived through immortalization using the SV40 
genome. The SV40 genome is a covalently closed, circular, double stranded 
DNA. This viral genome is divided into early and late regions dependent on when 
in the infection cycle these genes are transcribed. The early region of the SV40 
genome encodes two nonstructural proteins, the large T antigen (T-ag) and the 
small t antigen. The late region genes encode for viral coat proteins (Bryan and 
Reddel, 1994). Of the early genes, the large T-ag is required for immortalisation 
of human cells. It is an essential replication protein that initiates viral DNA 
synthesis and also stimulates host cells to enter S phase and undergo DNA 
synthesis. Because of this ability to override cell cycle control, it represents the 
major transforming protein of SV40.
Normal human fibroblasts or epithelial cells transfected with the SV40 
genome have an extended lifespan of 20-30 population doublings compared with 
untransfected cells (Ide et al., 1984). They then enter a period known as crisis, 
which may last from weeks to months. During this period, cell numbers become 
static before gradually declining. There are also gross karyotypic abnormalities 
and apparently failed mitosis (Sack, 1981). Occasionally however, a cell may 
escape crisis and acquire the ability to multiply without limit, i.e. become 
immortal (Wright et al., 1989). The frequency of human cell immortalisation 
obtained using this method is around 1 per 107 cells.
Temperature-sensitive mutants of the A gene encoding the T-ag of SV40 
(tsA mutants) have been constructed (Tegtmeyer, 1975) and used to conditionally 
immortalise cells. Cells immortalised using tsA mutants exhibit temperature- 
dependent growth. They are able to proliferate at the permissive temperature of 
33°C since the T-ag remains active. However, at the non-permissive temperature 
of 39°C, the T-ag is conformationally inactivated and the cells are no longer 
driven to replicate, thus allowing the cells to differentiate (Jat and Sharp, 1989). 
This method has been used to conditionally immortalise several cell types
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including embryonic fibroblasts and mammary epithelial cells (Kim et al., 1998; 
Radna et al., 1989; Small et al., 1982; Stamps et al., 1994).
The mechanism of T-ag-induced immortalisation has been deduced. The T- 
ag of SV40 forms complexes with the tumour suppressor proteins p53 and pRb 
and abolishes their normal functions in cell growth control. The cell cycle control 
of pRb depends upon its phosphorylation state, with under-phosphorylation of 
pRb preventing cells from entering S phase (Goodrich et al., 1991). T-ag binds 
preferentially to under-phosphorylated pRb (Ludlow et al., 1989), suggesting that 
this is one such mechanism by which T-ag confers immortality. The T-ag also 
binds to the p53 tumour suppressor gene. Wild-type p53 senses DNA damage and 
either causes the cell to pause in late Gr phase for DNA repair or directs the cell 
through the apoptotic pathway if repair is not possible (Levine, 1997) T-ag 
binding sequesters p53 and allows cells to enter the S phase. The tsA58 mutant of 
T-ag, fails to bind p53 at the non-permissive temperature and binds pRb with 
lower affinity.
Transgenic mice have also been generated (Weis et a l , 1983) that harbour 
the SV40 strain tsA58 early region coding sequences. These genes are under the 
control of the mouse major histocompatability complex H-2Kb class I promoter 
which is active in almost all tissues of the body. Furthermore, the promoter can be 
induced to higher levels of expression in all cells by interferons (IFNs) (Wallach 
et al., 1982). Cells derived from such transgenic mice proliferate continuously 
when cultured at the permissive temperature (33°C) in the presence of IFN-y. 
When cells are grown at the non-permissive temperature (39°C) and without IFN- 
y they stop dividing and exhibit the capacity to differentiate. This method has 
been utilised to generate a variety of conditionally immortal cell lines including 
skin fibroblasts as well as thymus epithelial cells (Jat et al., 1991). It is 
considered that this manner of generating immortalised cell lines is superior in 
that the crisis period is omitted in comparison to the aforementioned in vitro 
methods of viral-induced immortalisation. This method has also been very useful 
in developing cell lines from cells that have previously proved very difficult to 
establish in culture such as normal intestinal epithelial cells (Whitehead et al., 
1993).
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1.8.3 The PrE2.8 cell line as a model for the study of human 
prostatic epithelial differentiation
Although many of the prostate cell lines described above provide useful tools for 
identifying genes that may play a role in carcinogenesis, many of these 
immortalisations have produced cell lines that have either a secretory luminal 
(Cussenot et al., 1991; Iype et al., 1998; Kaighn, 1980; Kaighn et al., 1989; 
Webber et al., 1996b), or a non-secretory intermediate luminal phenotype 
(Hayward et al., 1995). Thus, cell lines suitable for studying normal prostate 
epithelial cell differentiation are limited in terms of translation to the real 
situation. An appropriate model would prove an invaluable asset towards 
elucidating the control mechanisms of epithelial cell differentiation and hence 
towards understanding diseases such as BPH and prostate adenocarcinoma. 
Therefore, an immortalised cell line, PrE2.8 (Daly-Bums et a l , in preparation), 
that maintained characteristics of proliferative prostate cells, while also being 
capable of undergoing differentiation and growth arrest, was used in this study as 
a means of identifying genes involved in the regulation of normal prostate 
epithelial cell growth and differentiation.
The PrE2.8 cell line was derived from BPH tissue and immortalised by 
transfection of epithelial cells with a temperature-sensitive SV40 Large T 
construct (Jat and Sharp, 1989); Daly-Bums et a l , in preparation). This allows the 
cells to proliferate at a permissive temperature of 33°C. However, when incubated 
at the non-permissive temperature of 39°C, the Large T antigen is inactivated, the 
cells cease to proliferate (Figure 1-12 (b)) and undergo genotypic and phenotypic 
changes consistent with prostate epithelial cell differentiation. PrE2.8 cells grow 
as small, tightly packed colonies at 33°C and exhibit a homogenous cobblestone 
appearance; the mean diameter of cells at this growth temperature is 40//m. At the 
non-permissive temperature of 39°C, PrE2.8 cells become less tightly packed and 
increase in size to a mean diameter of 52//m (Figure 1-12 (a)). Also, at 39°C, the 
cells become vacuolated and some are shed from the medium. The epithelial 
origin of the cells has been confirmed by positive staining for K14, K17 and K8. 
The keratins were also used to examine the morphological changes related to 
differentiation in the PrE2.8 model. The basal cell marker K14 was down- 
regulated at the non-permissive temperature, as determined by FACS analysis. In 
addition, expression of K8, a marker of differentiated luminal cells, was increased
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from occasional staining at 33°C to over half of all cells grown at 39°C expressing 
the protein (Figure 1-12 (a)). These staining patterns are consistent with the fact 
that in the prostate, as well as in other epithelial tissues, K14 is expressed by basal 
cells whereas K8 is a marker of differentiated luminal cells. Furthermore, K19 
and K17, also expressed by more differentiated epithelial cells, were undetected in 
PrE2.8 cells at 33°C but were expressed by a small number of cells grown at 
39°C.
33oC
Temperature dependent inhibition of cell proliferation
Cell so 
Number 
(X10s) “
1 2 3 4 5 6 7 • 9 10 11 12 13 14 15 16 17 16 19 20 21 22
Culture time in days
Figure 1-12: Growth characteristics of the PrE2.8 cell line.
(a) shows the growth and marker expression of PrE2.8 cells. Images show 
cultures of PrE2.8 cells incubated at permissive (33°C) and non-permissive (39°C) 
growth temperatures. At 33°C, the cells are small, densely packed and show 
occasional K8 (brown) expression. An altered cell morphology is observed at 
39°C with an increase in cell size as well as a vacuolated appearance. This is 
accompanied by an increase in K8 expression levels, (b) shows growth curves for 
PrE2.8 cells incubated at 33°C (red) and 39°C (blue). At the permissive 
temperature, exponential cell proliferation is observed over time, whereras at 
39°C, little or no cell proliferation is observed.
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In addition to the keratins, other markers of differentiating cells were also 
examined. For example, expression of p21Wafl/Cipl, a gene involved in cell cycle 
control and differentiation, was undetectable at 33°C but expression levels rose in 
a time-related fashion in the presence of a subsequent increase in growth 
temperature. Cellular factors that determine whether cells continue to proliferate 
or cease dividing and differentiate appear to function during the first gap phase 
(Gj) of the cell cycle. Progression through the Gr phase and initiation of DNA 
synthesis (S phase) during the mammalian cell division cycle are cooperatively 
regulated by several classes of cyclin-dependent kinases (CDKs) whose activities 
are in turn constrained by CDK inhibitors (CDKIs). There are two classes of CKIs 
based on their structure and CDK targets. The first class is known as the INK4 
proteins due to their ability to specifically inhibit the catalytic subunits of CDK4 
and CDK6; these include the proteins p l6INK4a, p l5 INK4b, p l8INK4c and p l9 INK4d. The 
second class of CKIs belong to the Cip/Kip family, which inhibit the activity of 
cyclin D-, E- and A-dependent kinases that are involved in Gr S transition. These 
proteins include p21Wafl/Cipl, p27ICipl and p57Kip2, which share significant sequence 
homology in their amino-terminal portions that enable them to bind to cyclins and 
CDKs.
p21 Wafi/Cipi was t^e fy-gt cyclin-dependent kinase CDKI to be identified and 
was found to have multiple functions including that of being a mediator of p53- 
induced growth arrest (el-Deiry et al., 1993), a direct regulator of CDK activity 
(Harper et al., 1993), and a gene whose expression is induced at cellular 
senescence (Noda et al., 1994). p2lWafl/Cipl interacts directly with cyclins through a 
conserved region close to its N-terminus. This region also has a separate CDK2 
binding site. The unique carboxy-terminal domain of p 2 lWafl/Cipl associates with 
proliferating cell nuclear antigen (PCNA) and can inhibit DNA replication 
directly, without affecting DNA repair (Li et al., 1994b). CDK inhibition by 
p2 jWafi/ciPi resuits jn dephosphorylation of the retinoblastoma protein (pRb) and 
the inhibition of E2F transcription factors that regulate many genes involved in 
DNA replication and cell cycle progression (Nevins, 1998).
Besides the functions of p2 lWafl/Cipl in cell cycle control, it also plays a role 
in differentiation. Differentiating cells exhibit a prolonged Gj-phase of the cell 
cycle and inhibition of Gr S transition (Clegg et al., 1987). Expression of
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p21Wafl/Cipl is increased in a variety of differentiating cells (Steinman et al., 1994). 
In the skin as well as the intestinal epithelium, expression of p2 lWafl/Clpl is induced 
in postmitotic cells immediately adjacent to the proliferative compartment, but is 
decreased in cells further along the differentiation pathway (el-Deiry et al., 1995; 
Gartel et al., 1996; Ponten et al., 1995). A similar down modulation of p21Wafl/c,pl 
expression occurs in cultured epidermal cells at late stages of differentiation (Di 
Cunto et al., 1998) suggesting that p21Wafl/c,pl is necessary for the early stages of 
the differentiation process in these cell types. In retinoic acid-induced 
differentiation of acute promyelocytic leukaemia cells, p2 lWafl/c,pl has also been 
shown to play a necessary function, which is unlinked to its effects on the cell 
cycle (Casini and Pelicci, 1999). However in this case, unlike the keratinocyte and 
epithelial systems, p2 lWafl/Cipl appears to play a positive promoting role in 
differentiation. Thus, the emerging consensus is that p 2 lWafl/Cipl can play an 
important regulatory function in differentiation, which is not directly linked to its 
effects on the cell cycle, and which can be either negative or positive depending 
on cell type and on specific stages of differentiation. The increase in expression of 
p21 wafi/cipi jn ^  prE2.8 model at 39°C therefore further supports a differentiating 
phenotype of the cells at this temperature.
The expression of prostate stem cell antigen (PSCA) was also observed in 
the PrE2.8 cells. PSCA, a prostate-specific cell surface antigen, was originally 
reported to be restricted to a subset of basal cells, and due to its homology to stem 
cell antigen 2 (SCA-2), it was hypothesised that PSCA may play a role in 
stem/progenitor cell functions such as self renewal or proliferation (Reiter et al., 
1998). More recent studies (Chau et a l , 2002) however, have indicated that PSCA 
is more likely a marker of an intermediate sub-population of epithelial cells in 
transition from a basal to a terminally differentiated luminal phenotype. This is 
supported by the observation that PSCA-positive primary prostate epithelial cells 
show a more differentiated morphology and phenotype than PSCA-negative cells. 
In addition, cells positive for PSCA expressed basal cell markers such as K5, K14 
and CD44, but also the luminal cell marker K18; however, expression of p63, a 
putative stem cell marker, was lost. Also, the PSCA-expressing cells localised 
above the monolayer and expressed PSA and AR transcripts, but not PSA or AR 
protein, indicating early differentiation of this subpopulation. In line with this 
study, expression of PSCA in the PrE2.8 cell line was very low or undetectable at
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33°C, whereas at the non-permissive temperature, PSCA expression was strongly 
detected.
Taken together, the genotypic and phenotypic changes observed in the 
PrE2.8 cell line, when the cells are switched from a permissive to a non- 
permissive temperature, are consistent with the Hudson et al (2001) epithelial 
differentiation pathway model. At 33°C, the PrE2.8 cells exist as small, tightly 
packed, highly proliferative colonies and express the basal cell marker K14. When 
switched to 39°C, the cells cease proliferating, exhibit a larger morphology and 
become vacuolated. In addition, expression of K14 is down-regulated, 
accompanied by up-regulation of cell differentiation-associated markers, 
including K8/17/19, p2 lWaf,/Cipl and PSCA. The cells do not however express PSA 
or AR, markers of terminally differentiated prostate epithelial cells. It is proposed 
therefore, that the PrE2.8 cell line represents prostate epithelial cells undergoing 
early stages of differentiation, representative of an intermediate transit-amplifying 
population (Daly-bums et a l , in preparation). The absence of PSA and AR may 
also be due to the lack of specific signalling factors required for the expression of 
these genes. For example, some authors have speculated that the presence of 
stromal cells (Liu et al., 1997) or testosterone (Peehl et al., 1988) is required for 
PSA/AR expression in primary prostate epithelial cells in culture. Furthermore, 
Hudson et al (2000) performed studies in which primary epithelial cell cultures 
were grown in Matrigel in the presence of Mibolerone and stromal cell- 
conditioned medium. These conditions resulted in the formation of spheroid 
cellular structures consisting of an outer basal cell layer surrounding a luminal 
layer and lumen containing AR-expressing cells. Similarly, the PrE2.8 cells also 
formed small spherical structures with detectable levels of AR transcript, when 
grown in Matrigel in the presence of stromal cells and Mibolerone, however AR 
protein was not detected. Thus, full differentiation, including PSA expression was 
not observed in the PrE2.8 model, suggesting that additional factors may be 
required for terminal differentiation to occur (Daly-Bums et a l , in preparation). 
Nevertheless, the PrE2.8 cell system represents a viable model for the study of the 
early changes in gene expression occurring during the process of prostate 
epithelial cell differentiation.
The PrE2.8 cell line was therefore used in this research project as a model 
system in which to identify genes that may be involved in the process of normal
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prostate epithelial cell differentiation. Although many authors have proposed 
putative models of the normal differentiation pathway in the prostate epithelium, 
the underlying mechanisms controlling this process remain poorly defined. There 
also remains a lack of informative markers representing the distinct cell types 
residing in the prostate epithelium, i.e. stem, basal, “intermediate” and luminal 
cells. The use of in vitro models, such as the PrE2.8 cell line, provide invaluable 
tools for identifying such markers and gaining a global genetic insight into the 
molecular mechanisms controlling prostate epithelial cell growth and 
differentiation. The aim of this research was to identify genes involved in the 
process of normal epithelial cell differentiation using the PrE2.8 cell line as a 
model system. Therefore, a research strategy was followed in order to discover 
genes involved in this pathway. The technique of differential display was used to 
ascertain differences in gene expression between a proliferative and 
differentiating phenotype in the PrE2.8 cell line. A more global approach was 
then implemented, through the use of microarray analysis, to provide additional 
insights into the genetic events that may be involved in the differentiation of 
prostate epithelial cells. This approach led to the identification of a number of 
putative markers of prostate epithelial cell differentiation. An explanation at the 
molecular level to the biological basis of cellular homeostasis in the prostate, and 
moreover, the clinical heterogeneity observed in prostatic diseases is critical to 
their appropriate therapy. Genes identified in this study may therefore provide 
diagnostic and prognostic markers, as well as markers for the targeted therapy of 
diseases such as BPH and prostate cancer.
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2 M a ter ia ls  a n d  M e t h o d s
2.1 Standard Solutions and Media
DNA loading buffer (3x)
20x SSC 
LB medium
LB agar 
LB-Amp 
0.5M EDTA
5M NaCl 
3M Na-acetate
20% SDS
1M Tris-HCl pH8.8 
X-gal solution
0.1% DEPC sdH20
Ampicillin (lOOmg/ml)
1M IPTG
30mM EDTA, 30% sucrose, 0.1% bromophenol 
blue, 0.1% xylene cyanol FF, 1M Tris-HCl 
pH8.
3M NaCl, 300mM sodium citrate, pH7.0. 
lOg Bacto-trytone (Oxoid), 5g Bacto-yeast 
(Oxoid), 5g NaCl dissolved in 1L dH20 and 
autoclaved.
LB media plus 1.5% Bacto agar (Oxoid).
LB media containing lOOpl/ml ampicillin. 
186.52g dissolved in 1L dH20 , pH adjusted to 
8.0 with conc. NaOH then autoclaved.
292.2g in 1L dH20  autoclaved.
246.08g in 1L dH20 , pH adjusted to 5.5 with 
glacial acetic acid.
50g dissolved in 250ml dH20 , autoclaved. 
121.2g in 1L dH20 , pH adjusted to 8.8 with 
conc. HC1, autoclaved.
0.2% X-gal (from 2% stock in DMF), ImM 
MgCl2, 15 0 m M  N a C l ,  3 . 3 m M  
K4Fe(CN)6.3H20 , 3.3mM K3Fe(CN)6, 60mM 
Na2HP04, 40mM NaH2P 04. Filtered through a 
0.2pm pore filter.
5ml DEPC (Sigma) in 5L dH20  stirred at r/t o/n 
and then autoclaved.
2.5g dissolved in 25ml sdH20 , aliquoted into 
5ml bijous and stored at -20°C for long term 
storage.
lg  dissolved in 4.2ml sdH20 , stored as 1ml 
aliquots at -20°C.
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50x TAE
RNase A (lOmg/ml) 
DAB solution 
ABC solution (Dako)
2.5% Trypsin
GTC Stock solution....
3 M NaOAc.....................
Ethidium Bromide (EtBr).
242g/L Tris base, 57.1ml/L glacial acetic acid, 
lOOml/L 0.5M EDTA pH8.
200mg RNase A in 200ml sdH20 , heated to 
100°C for 15 mins, cooled and stored as frozen 
1 ml aliquots.
(Diaminobenzidine tetrahydrochloride). 25mg 
of DAB dissolved in 50ml Tris-HCl pH7.6, then 
250pl 6% H20 2 added.
To 5ml Tris-HCl pH7.6 was added 1 drop of 
reagent A (Avidin in PBS) and 1 drop of 
reagent B (biotinylated horseradish peroxidase), 
mixed well prepared 30 mins before use to 
allow form ation o f avidin-biotinylated 
horseradish complex. This is stable for 5 days 
at 4°C.
2.5g Trypsin dissolved in lx PBS, pH7.0, filter 
sterilised and stored as 5ml aliquots at -70°C. 
When required for trypsinising cells the 2.5% 
solution was diluted 1:10 in sterile lx  PBS and 
stored as 5ml aliquots at -20°C.
To 293 ml of deionised H20  add, 250g 
guanadinium isothiocyanate, 17.6 ml 0.75 M 
sodium citrate pH 7, 26.4 ml 10% Sakosyl. 
Store the solution at 4°C. Before use, make up a 
50 ml GTC solution by adding 360 p i  p 
mercaptoethanol and 500 pi antifoam A. 
Dissolve 408.24 g sodium acetate-3H20  in 800 
ml H20 . Adjust to pH 5.2 with glacial acetic 
acid. Adjust volume to 1 litre with deionised 
H20 . Sterilise by autoclaving and store at room 
temperature.
Prepare stock solution of 10 mg/ml by adding 1 
g EtBr to 100 ml H20 . Stir until the dye has 
completely dissolved. Store in the dark at room 
temperature. During electrophoresis add 0.5-1 
pg per ml of agarose solution.
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10% Ammonium persulphate Dissolve 1 g ammonium persulphate (APS) in
8ml H20 . Adjust volume to 10 ml with H20. 
This solution is stable at 4°C for 2 weeks.
2.2 Oligonucleotide primers synthesised
Primer
Name
Homology/Gene Name Primer Sequence
(5'- 31)
Annealing
Temperature
A2.2S S100 calcium binding protein A8 ctttatcaccagaatgaggaactcc 60°C
A2.2A " ggatgacctgaagaaattgctagag
B9S BAC clone gcatgtttcccaggctgatc 60° C
B9 A n cactcattggatcaatgttc
BIOS Newcastle disease virus 
inducible protein
caggcacacagtcactgaag 60°C
B10 A !l catgagatgaatagagac
C5.1 S Cyclooxygenase 2 ggctgagggaacacaacagag 60°C
C5.1 A ll caggatacagctccaacagcatc
C5.2S Cytochrome c oxidase subunit II aggcgacctgcgactccttg 60°C
C5.2 A if agacgatgggcatgaaactgtg
C6S Human mitochondrial complete 
genome
gtc gc aggatacccctctctc 55°C
C6 A ll gagccccattgtgttgtgg
C8.1 S Arabidopsis thaliana DNA 
chromosome 3 clone
gaggaaataagtagcctttc 60°C
C8.1 A ll gcacgatattgcagtcttgatc
C8.2S PAC clone gaggtttaatggactcacag 60°C
C8.2A If cgatttgaacggtgggagat
C9.2S Human mitochondrial complete 
genome
gaacaggctcctctagagg 55°C
C9.2A ll ggtgacactatgaatactc
C9.3S n agcggacgaagcgcgaag 60°C/65°C
C9.3 A n ggcatttgtggatgagcccag
C14.1 S S.pombe chromosome 3 cosmid ggatacaactttgcaacttggc 60°C
C14.1 A If cttgaggaggaagaatgggttc
C16S Small proline rich protein 1B agcacattctttttggggg 60°C
C16 A N acactccagcaccagccc
C18.1 S Alpha tubulin catgacatgctgcagggc 60°C
C18.1 A " aggaaggc gagttttc agagg
D4S PAC clone cgatatccgttcgagtcgcctag 60°C
D4 A fl gatgagcctaagggtcatccg
D7S Heat shock protein agttcgcccatttctgcttcagg 60°C
D7 A it gaattcgattttggcacgggg
E6S BAC clone gtcgcaggatacccctctctc 60°C
E6 A II gagccccattgtgttgtgg
APA2 Random 10mer gaccacgtgc 40°C
AP A19 n ttcgaccctg 40°C
APB9 N tgggggactc 40° C
AP B10 II ctgctgggac 40°C
AP C5 II gatgaccgcc 40°C
AP C6 II gaacggactc 40°C
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AP C8 tggaccggtg 40°C
AP C9 tggaccggtg 40°C
APC14 tgcgtgcttg 40°C
APC16 cacactccag 40°C
APC18 tgagtgggtg 40°C
AP D4 tctggtgagg 40°C
AP D7 Ttggcacggg 40°C
AP E6 ttggcacggg 40°C
AP E7 aagacccctc 40°C
2.3 Tissue Culture
As a cellular model of differentiation, a conditionally immortalised prostate 
epithelial cell line, PrE2.8, was used (Daly-Bums et a l , in preparation). Briefly, 
prostate tissue was obtained from a patient undergoing transurethral resection of 
the prostate as treatment for BPH. Prostate epithelial cells were isolated and 
conditionally immortalised with an SV40-construct containing a temperature- 
sensitive Large-T antigen. At 33°C, the Large-T antigen is functionally active and 
the cells proliferate. However, at 39°C, the cells stop proliferating due to 
temperature-induced inactivation of the Large-T protein, and undergo 
morphological changes consistent with differentiation.
The PrE2.8 epithelial cell line was maintained in complete PrEGM medium 
(Clonetics). Cells were grown in 75cm3 tissue culture flasks at either 33 °C or 
39°C in a humidified incubator containing a 5% C 0 2 environment. Cells were 
grown at the permissive temperature of 33°C or they were grown at 33°C to ~50% 
confluency prior to being transferred to the non-permissive temperature of 39°C. 
Passage of cells was carried out by the addition of 3 ml of trypsin/versine to the 
flasks followed by incubation at 37°C for 5-10 minutes. Twenty ml of PrEGM 
medium was then added to the flasks and the cell suspension was transferred to a 
50 ml centrifuge tube and centrifuged at 1200 rpm to pellet the cells. The 
supernatant was aspirated and the cells resuspended in 10 ml of PrEGM medium. 
One in ten dilutions were subsequently re-seeded into 75cm3 flasks that had been 
pre-coated with collagen.
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2.4 Primary Cell Culture
Prostate tissue chips freshly collected from a transurethral resection of the prostate 
(TURP) were washed three times in collection medium and transferred into a petri 
dish. Burnt areas of tissue and areas of clotted blood were trimmed using a scalpel 
and the tissue was weighed. It was then finely cut into less than 1mm3 pieces 
using a pair of scalpels. The minced tissue was transferred to a sterile universal 
and resuspended in 20 ml of PBS. Once the tissue had settled to the bottom of the 
tube, the PBS was aspirated in order to remove blood and debris. This process 
was repeated until the supernatant was clear. In order to separate the stroma from 
the acini, the tissue was resuspended in 200 IU/ml collagenase type 1A (Sigma) 
and digested at 37°C with gentle agitation on a R100 Rotatest shaker (Luckham 
Ltd) for 18-20 hours. The digested tissue was centrifuged at 800 rpm for 20 secs, 
the sedimented acini transferred to 20 ml PBS and the process repeated twice. A 
single cell suspension was produced from the acini by digestion of the pellet in 20 
ml 0.25% trypsin/versene in buffered saline at 37°C for 20 mins with agitation. 
The digested acini were centrifuged at 1000 rpm for 5 mins, the trypsin aspirated 
and the pellet resuspended in 10 ml DMEM containing 10% fetal calf serum in 
order to inactivate the trypsin. The pellet was then resuspended in PrEGM 
medium (Clonetics) and cells plated onto collagen type 1 (Vitrogen 100) pre­
coated Petri dishes at 1000 cells per 6 cm dish in the presence of a feeder layer of 
lethally irradiated NIH 3T3 cells. The feeder cells were used to help maintain 
clonal growth of the cells.
2.5 Isolation of Total RNA from Cultured Cells
Total RNA was extracted from primary cultures or from PrE2.8 cells grown at 
33°C when the flasks were ~60-70% confluent, or from PrE2.8 cells 4, 7, 10 and 
14 days after being transferred to 39°C. Culture medium was aspirated and the 
cells were washed with ice cold PBS. Cells were lysed directly in the culture 
flask by the addition of 4 ml of GTC solution and agitation of the flasks for 
approximately 5 minutes until the cell layer was completely dissolved. The cell 
lysates (approximately 4 ml) were then transferred to 15 ml centrifuge tubes to 
which was added a 1/10 volume of 2 M NaOAc pH 4 (400pl), an equal volume of
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phenol pH 4 (4.4 ml) and 2/10 volume of chloroform (1.76 ml). The solutions 
were vortexed and placed on ice for 20 minutes. The samples were then 
centrifuged at 4°C for 20 minutes at maximum speed (4400 rpm) in a Sorval 
bench top centrifuge after which the upper aqueous layer was transferred to a 
fresh centrifuge tube with a sterile Pasteur pipette. An equal volume of 
isopropanol was added to each sample and the RNA was allowed to precipitate at 
4°C for at least 30 minutes. Following the precipitation step, the samples were 
centrifuged at maximum speed (4400 rpm) at 4°C in a Sorval bench top centrifuge 
for 20 minutes. The supernatant was removed and the RNA pellet was 
resuspended in 60 pi of DEPC-treated HzO and transferred to autoclaved, 
nuclease-free microcentrifuge tubes. Samples of RNA were stored at -80°C prior 
to use.
2.6 Differential Display
It is crucial that the total RNA used for mRNA Differential Display (DD) is free 
of DNA contamination. Total RNA (50-100 pg) was DNase-treated following 
isolation according to the manufacturers instructions to remove contaminating 
DNA using a MessageClean kit (Biogene/GenHunter):
2.6.1 DNase I Digestion
Reaction tubes for each sample were set up as follows:
Reagent Amount
Total RNA 50 pi (50-100 pg)
10x reaction buffer 5 .7  pi
DNAse I 1.0 pi
Total volum e 56.7  pi
The samples were mixed well and incubated for 30 minutes at 37°C.
2.6.2 Phenol/CHCI3 (3:1) Extraction
This step is essential to ensure the removal of protein contamination and DNase I 
from the RNA. Following DNase I digestion, 40 pi of Phenol/CHCl3 was added 
to each reaction tube and vortexed for 30 seconds. The samples were then 
incubated on ice for 10 minutes and spun in an Eppendorf microfuge at maximum 
speed (13,000 rpm) for 5 minutes at 4°C. After centrifugation, the upper phase 
was transferred to a new reaction tube.
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2.6.3 Ethanol Precipitation
To each reaction tube, 5 pi of 3 M NaOAc and 200 pi 100% ethanol was added 
and the samples were incubated at -80°C for 1 hour. The samples were then re­
spun at maximum speed (13000 rpm) for 10 minutes at 4°C and the supernatant 
was discarded. The RNA pellet was re-dissolved in 25 pi DEPC-treated H20 .
Total RNA was diluted by adding 5 pi RNA to 995 pi DEPC-treated H20  
and the amount of RNA in each sample quantified by reading the OD260 on a 
spectrophotometer (Beckman). The concentration of total RNA in each sample 
was calculated using the following formula:
RNA concentration = OD260x dilution factor x constant 
Constant = 40 pg/ml = 1 OD260.
2.6.4 Reverse Transcription
Total RNA was reverse transcribed and first strand cDNA was synthesised using 
Superscript II (Stratagene) reverse transcriptase. For each RNA sample (obtained 
from 33°C-incubated cells at day 7 or 39°C at day 7) 1 pg of cleaned total RNA 
was reverse transcribed from each of three single base-anchored oligo dT primers 
(TnG, TnA, ThC). The following components were added to sterile, nuclease- 
free microcentrifuge tubes for each sample:
Reagent Amount
Total RNA 1-5 pg
Oligo dT primer (TnG, T„A  or TniC) 1.0 pi
D EPC -treated sterile H20 To a  final volum e of 12 pi
The samples were then heated at 70°C for 10 minutes and quick chilled on ice, 
after which they were briefly centrifuged (approximately 2-3 secs) to collect the 
contents at the bottom of the reaction tubes. The following components were then 
added to each reaction tube:
Reagent Volume
5x first strand  buffer 4 pi
0.1 M DTT 2 pi
10 mM dNTP mix 1 pi
After gentle mixing, reaction tubes were incubated at 42°C for 2 minutes after 
which 1 pi of Superscript II was added to each reaction tube. The contents were
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mixed by pipetting gently up and down and incubated at 42°C for 50 minutes. 
Reactions were then inactivated by heating at 70°C for 15 minutes. The three 
reverse transcription (RT) reactions with each of the anchor primers were mixed 
(TnM (mixed) = TnG, TnA and TnC) and diluted 5-fold for each sample. 
Reactions were stored at -20°C prior to use.
2.6.5 Differential Display PCR
Following reverse transcription, samples were subjected to DD PCR. Each mixed 
reverse transcription was amplified in a 10 pi PCR reaction with AmpliTaq 
polymerase (Perkin Elmer). These reaction tubes were set up as follows:
Reagent Amount
RT mix 1 pi
10x buffer 1 pi
dN TP (25 pM) 0.8  pi
a -^ S Jd A T P 0.2  pi
T11M primer (2 pM) 1 pi
R andom  primer (2 pM) 1 pi
AmpliTaq (5 units/pl) 0 .2  pi
sd  H20 4.8  pi
Total volum e 10 pi
After gentle mixing, a drop of mineral oil was added to each reaction tube, in 
order to prevent evaporation, prior to being placed into the thermal cycler (Perkin 
Elmer). The following temperature cycles were used for amplification:
94 °C/ 5 min —> 94°C/ 30 sec — > 40°C/ 2 min —> 72°C/ 30 sec ---> 72°C/ 5 
min
I <----------------------- 40 cycles > I
2.6.6 Acrylamide Gel Electrophoresis
After completion of the differential display PCR reactions, PCR products were 
loaded onto acrylamide/urea sequencing gels and electrophoresis was carried out 
using Biorad gel electrophoresis apparatus. Firstly, the glass plates were cleaned 
with acetone and siliconized by covering with approximately 1ml of Sigmacote. 
The glass plates and spacers were then clipped together and the gel was poured 
between the plates. A 6% acrylamide/urea sequencing gel was made by adding 
20 ml of Buffer to 80 ml of Sequal gel 6 monomer (National Diagnostics) and 0.8 
ml of 10% ammonium persulphate. Gels were allowed to set overnight. Once set,
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the gels were pre-run at 1600 V (50 mA, 60 W) to warm the gel to approximately 
50°C. The PCR products (10 pi) were mixed with 3.3 pi of 3X sequencing 
loading buffer, denatured at 80 °C for 2 minutes and 3 pi of product loaded onto 
the sequencing gel. The gels were then run at 1700 V for 3-4.5 hours in IX TBE 
running buffer, blotted onto Whatman 3MM paper and dried in a gel dryer for 
approximately 1 hour at 80°C. The gels were exposed to X-Omat LS X-ray film 
(Kodak) for 1-5 days.
2.6.7 Isolation of Differentially Amplified PCR Products
Bands of interest were identified by overlaying the autoradiographs onto the dried 
gels in order to locate the DNA bands on the gel. The DNA was cut out and eluted 
from the gel as follows. Excised bands were placed into microcentrifuge tubes 
with 100 pi of dH20  and incubated at 37 °C overnight. The samples were then 
boiled for 10 minutes in a water bath and centrifuged at 13,000 rpm for 2 minutes. 
The supernatant was transferred to a fresh microcentrifuge tube and ethanol 
precipitation was carried out by adding to each tube 10 pi 3 M NaOAc (pH 5.2), 
300 pi EtOH and 10 pi glycogen (10 mg/ml). Samples were left to precipitate at - 
20°C overnight after which they were centrifuged at 13,000 rpm for 20 minutes. 
The supernatant was discarded and the DNA pellet re-suspended in 10 pi dH20.
Eluted DNA, representing the differentially expressed bands of interest, was 
then used as a template for re-amplification in a PCR reaction, using the same 
primer pairs used for DD PCR. Reactions were set up as follows:
Reagent Amount
Eluted DNA 1 pi
10x buffer 1 pi
dNTP (2 pM) 0.8 pi
T„M  primer (2 pM) 1 pi
Random  primer (2 pM) 1 pi
AmpliTaq (5 units/ pi) 0.2 pi
sd  H20 5 pi
Total volume 10 pi
After gentle mixing, a drop of mineral oil was added to the reaction tube, in order 
to prevent evaporation, and samples were placed into the thermal cycler (Perkin
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Elmer). The temperature cycles were exactly as used in the differential display 
PCR (see section 2.6.5).
2.6.8 Agarose Gel Electrophoresis
Agarose gel electrophoresis separates and detects different sized fragments of 
DNA following PCR amplification. Re-amplified DNA excised from the 
acrylamide gels was separated and visualised using this method. The gel 
apparatus was set up according to the manufacturers instructions. 1.5 g of 
ultrapure agarose (BDH) was dissolved in 100 ml of IX TAE by heating at full 
power for 2-3 minutes in a microwave. The mixture was cooled to approximately 
50°C, 5 pi 10 mg/ml ethidium bromide (EtBr) was added and the contents were 
swirled gently to mix. The gel mix was then carefully poured into the assembled 
gel cassette with the comb(s) inserted and the gel was allowed to set at room 
temperature for 20-30 minutes. Combs and the ends of the gel casting tray were 
carefully removed before the system was immersed into a reservoir of IX TAE 
buffer. DNA samples were mixed with sucrose loading buffer and 10 pi of sample 
were loaded. The gel apparatus was then connected to a power supply and the 
system was run at 100 V for ~30-45 minutes. After electrophoresis for the 
appropriate time, the DNA was visualised on a UV transilluminator and image 
captured using a gel documentation system (BioRad).
2.6.9 DNA Band Nomenclature
Individual bands representing potential gene candidates were named according to 
the name of the arbitrary primer used to amplify the gene sequences. If more than 
one band was isolated following amplification with the same primer pair, then 
nomenclature was sub-sectioned according to size (Section 2.2).
2.6.10 Cloning of DNA into Plasmid Vector
Re-amplified DNA products were purified and cloned into a pGEM T-Easy vector 
prior to sequencing. The pGEM-T Easy vector has been prepared by adding a 3' 
terminal thymidine (3'-T overhangs) to both ends of the vector. These prevent 
recircularisation of the vector and also provide compatible overhangs for PCR 
products generated by thermostable polymerases such as AmpliTaq. These 
polymerases add a single deoxyadenosine, to the 3'-ends of amplified DNA 
fragments. The vector also contains T7 and SP6 RNA polymerase promoters
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flanking a multiple cloning region within the a-peptide coding region of the 
enzyme (3-gaIactosidase. Successful cloning of an insert into the vector interrupts 
the coding sequence of |3-galactosidase and recombinant clones can thus be 
identified by the production of white colonies whereas vectors that do not contain 
an insert produce blue colonies. The cloning procedure was as follows:
2.6.10.1 PCR Product Purification
DNA re-amplified from excised bands was purified using a QIAquick PCR 
Purification Kit (QLAgen). DNA was purified according to the manufacturers 
instructions.
2.6.10.2 Ligation of Vector to Insert DNA
After the PCR products were purified they were ligated to the pGEM-T Easy 
vector (Promega) system. The following reactions were set up for each purified 
PCR product:
Reagent Standard
Reaction
Positive Control Background
Control
2x rapid ligation 
buffer
5 pi 5 pi 5 pi
Pgem -T  E asy  
vector (50ng)
1 pi 1 pi 1 pi
PCR Product 
(Insert DNA)
3 pi
-
Control insert 
DNA
-
2 pi
-
T4 DNA L igase (3 
units/pl)
1 pi 1 pi 1 pi
sd  H20  to a  final 
volum e of
10 pi 10 pi 10 pi
The components were mixed by pipetting and incubated either for 1 hour at room 
temperature or at 4°C overnight. An aliquot of the ligation reaction mix was then 
taken to be transformed into competent host bacterial cells. The remaining 
ligation mix was stored at 4°C for future use.
2.6.10.3 Plasmid Transformation of E.coli
Frozen aliquots of competent E.coli cells (MAX Efficiency DH5a Competent 
Cells, Gibco Life Technologies), stored at -70°C, were thawed on ice for 15 
minutes. 20 pi of cells were aliquoted into pre-chilled 1.5 ml microcentrifuge
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tubes to which 1 pi of DNA from ligation reactions was added. The tubes were 
mixed gently by tapping and incubated on ice for 30 minutes. The cells were then 
heat shocked for 45 seconds in a 42°C water bath and immediately placed on ice 
for 2 minutes. 200 pi of room temperature LB medium was added to each reaction 
and the transformed cells were incubated at 37°C with shaking (225 rpm) for 1 
hour. The transformation mixtures were then plated onto LB agar plates 
containing 100 pg/ml ampicillin, 15 pg/ml X-Gal and 15 pg/ml IPTG and 
incubated at 37°C overnight. The presence of an insert in the pGEM-T Easy 
vector was tested for by using blue/white selection. The white colonies 
represented correct colonies containing both insert and vector.
2.6.10.4 Confirmation of Correct Insert DNA by Colony PCR
In order to confirm that the white colonies chosen for further analysis did indeed
contain the DNA insert of interest, 10 colonies from each sample were picked at 
random and placed into 100 pi of PBS/0.1% Tween in a microcentrifuge tube, 
boiled for 15 minutes and centrifuged for 2 minutes at 13,000 rpm. The DNA was 
then used as a template for amplification in a PCR reaction. Primers used for 
amplification were complementary to the T7 and SP6 promoter regions flanking 
the multiple cloning region. Reactions were set up as follows:
Reagent Amount
Colony DNA 2 pi
10x buffer 2  pi
dN TP (2 mM) 1 pi
T7 prim er (10 pM) 1 pi
S P 6  prim er (10 pM) 1 pi
AmpliTaq (5 Units/pl) 0.2  pi
sd  H20 12.8 pi
Total volum e 20 pi
The samples were mixed, overlayed with a drop of mineral oil and placed in the 
thermal cycler (Perkin Elmer). The temperature cycles used were as follows: 
94°C/ 5 min —> 94°C/ 30 sec —> 55°C/1 min — > 72°C/1.5 min —> 72°C/ 5 min
I <------------------------ 30 cycles---------------------------> I
Following PCR amplification, DNA products were visualised on agarose gels as 
previously described.
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2.6.10.5 Minipreparation of Plasmid DNA
This method was used to prepare a small amount of DNA from the 
transformations. Six individual colonies from each cloned cDNA, chosen 
following the colony PCR confirmations, were inoculated into 5 ml of LB 
medium containing 50-100 pg/ml ampicillin and grown overnight at 37°C with 
shaking at 225 rpm. The samples were centrifuged at full speed in a Sorval bench 
top centrifuge. The pellet was then used for preparation of DNA using the 
QLAprep Miniprep kit (Qiagen) according to the manufacturers instructions.
The pelleted bacterial cells were resuspended in 250 pi of Buffer PI and 
transferred to a microcentrifuge tube to which was added 250 pi of Buffer P2. 
The tubes were gently inverted 4-6 times to mix the samples. Buffer N3 (350pl) 
was then added to each sample and the tubes were immediately inverted gently 4- 
6 times to mix. The samples were centrifuged at 13,000 rpm for 10 minutes. The 
supernatants were applied to a QIAprep column and centrifuged for 30-60 
seconds and the flow-through discarded. The QIAprep spin column was then 
washed by adding 500 pi of Buffer PB, centrifuged for 30-60 seconds and the 
flow-through discarded. The QIAprep column was washed again by the addition 
of 750 pi of Buffer PE, centrifuging for 30-60 seconds and the flow-through 
discarded. An additional centrifugal step was carried out for 1 minute in order to 
remove any residual wash buffer. The QIAprep column was then placed into a
1.5 ml centrifuge tube and in order to elute the DNA, 50 pi of Buffer EB was 
added to the centre of each column, incubated at room temperature for 1 minute 
followed by a final centrifuge step for 1 minute. The DNA was stored at -20°C 
until ready for use.
2.6.10.6 Restriction Enzyme Digestion of DNA
For analysis of miniprep DNA, 8 pi of DNA was digested with 1 pi of EcoRl
restriction enzyme (Stratagene) in the presence of the appropriate reaction buffer 
supplied with the enzyme (1 pi of 1 OX Buffer) to give a final reaction volume of 
10 pi. The mixture was incubated at 37°C for 1 hour or overnight to ensure 100% 
digestion. The reactions were then mixed with 6X sucrose loading buffer and 
analysed by electrophoresis on a 1% agarose gel.
56
2 Materials and Methods
2.6.11 DNA Sequencing
Sequencing of the miniprep DNA was carried out in order to identify the genes of 
interest selected from differential display analysis. DNA templates were 
sequenced using the dRhodamine Cycle Sequencing Kit (PE Applied Biosystems) 
on an ABI Prism automated sequencer (Perkin Elmer). The Terminator Ready 
Reaction Mix in the kit consisted of:
• A-Dye Terminator labelled with dichloro(R6G)
• C-Dye Terminator labelled with dichloro(TAMRA)
• G-Dye Terminator labelled with dichloro(Rl 10)
• T-Dye Terminator labelled with dichloro(ROX)
• dNTPs (dATP, dCTP, dITP, dTTP)
• AmpliTaq DNA Polymerase, FS, with thermally stable 
pyrophosphatase
• MgCl2
• Tris-HCl buffer, pH 9.0
Cycle sequencing reactions were set up, using both the T7 and SP6 primers for
each sample, as follows:
Reagent Amount
Term inator ready reaction mix 8 pi
PCR product 11 pi
Prim er (T7 or SP6) (5 pM) 1 pi
Total volume 20 pi
Reactions were mixed well and overlaid with mineral oil prior to thermo-cycling. 
The thermo cycles used were as follows:
96°C /1 min —> 96°C/ 30 sec —> 50°C /15 sec —> 60°C/ 4 min —> 4°C
I <------------------------ 25 cycles > I
The cycle sequencing PCR products were then purified by the addition of 80 pi 
H20, 100 pi CHC13 and 100 pi PCIA to each reaction tube which was then 
centrifuged for 10 minutes at 13,000 rpm. The top layer was transferred to a fresh 
microfuge tube and to this was added 10 pi 3M NaOAc pH5.2 and 300 pi EtOH. 
The samples were then allowed to precipitate at -20°C overnight. Following 
precipitation, the samples were centrifuged for 10 minutes and the supernatant
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discarded. Finally the DNA pellet was allowed to air dry, mixed with 3X 
sequencing loading buffer and loaded onto an ABI Prism automated sequencer.
2.6.12 Identification of Gene Sequences
Three sequencing reactions from three separate clones were carried out for each 
gene of interest. In order to identify the genes, the three sequences obtained for 
each gene were compared with the Genbank/EMBL non-redundant nucleotide (nr) 
and expressed sequence tag (EST) databases with the BLAST algorithm (blastn) 
available via the world wide web at the NCBI.
2.6.13 Confirmation of Differential Gene Expression by RT- 
PCR
Semi-quantitative RT-PCR was used as a screen to verify expression of candidate 
genes identified by differential display. 5 pg of total RNA was reverse 
transcribed from an oligo- (dT)12_18 primer essentially as previously described. 
Total RNA was extracted from the PrE2.8 cell line from cells that had been 
incubated at 33°C or 39°C after 4, 7, 10 and 14 days of growth. The resulting 
reactions were diluted 5-fold in DEPC-treated H20  and 2 pi used as a template for 
amplification with primers designed within the DD PCR cloned sequences. 
Primers were designed to be between 18-22 bases in length, G/C clamped at the 3’ 
end, G/C rich (~50%), unique to that sequence (BLAST) and to have a Tm of 
>60°C. PCR was performed in a 50 pi reaction volume as follows:
Reagent Amuont
RT reaction 2 pi
10x buffer 5 pi
dNTP (10 mM) 1 pi
S e n se  primer (10 pM) 1 pi
A ntisense primer (10 pM) 1 pi
AmpliTaq (5 units/pl) 0 .5 pi
sd  H20 39.5  pi
Total volume 50 pi
The reactions were mixed and a drop of mineral oil was added to each tube. 
The temperature cycles used were:
94°C/ 5 min —> 94°C/ 30 sec —> 55-65°C/1 min —> 72°C/1.5 min —> 72°C/ 5 min
I <---------------------- 25-35 cycles------------------------- > I
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Control amplifications were performed with GAPDH-specific primers. 
After completion of the PCR reactions, 10 pi of each PCR product was mixed 
with 6X loading buffer and resolved on 1.5% agarose gels after different cycle 
numbers. Ten pi of a 50 pi reaction were removed from RT-PCR amplifications 
after different numbers of PCR cycles with each of the specified primer pairs and 
analysed by agarose gel electrophoresis as previously described in section 2.6.8.
2.7 Immunocytochemistry
2.7.1 Preparation of prostate tissue sections and cultured cells 
for immunohistochemistry and Immunocytochemistry
Cells were grown, as described in section 2.4, on 2cm2 glass cover slips and
washed three times with PBS. They were fixed in either 1 ml cold 
methanol/acetone (1:1) solution or formaldehyde at 4°C for 10 mins and stored in 
PBS at 4°C until required. Paraffin-embedded prostate tissue sections were 
incubated at 60°C for 20 mins and deparaffinated in the following solutions: 
Xylene 3 mins - x2; 100% EtOH 1 min -  x2; 70% EtOH 1 min. The sections were 
rinsed in dH20  before antigen retrieval. Antigen unmasking solution (Vector) was 
prepared by adding 15 ml of the solution to 1,600 ml of dH20 . This was heated in 
a microwave to 100°C after which the tissue sections were added and the solution 
heated on full power for a further 30 mins. The solution was allowed to cool to 
room temperature and the tissues were washed in PBS for 5 mins. A wax pen 
(Dako) was used to draw around the edges of the tissues in order to prevent 
spreading of antibody solutions over the microscope slide.
2.7.2 Immunohistochemistry and Immunocytochemistry
Endogenous peroxidase activity was quenched by incubation in 3% hydrogen
peroxide solution for 10 mins at room temperature followed by washing in PBS 
for 5 mins. Non-specific antibody binding was blocked by incubating the tissue 
sections or cells in normal horse serum for 20 mins. These were then incubated 
overnight at 4°C with the primary antibody diluted as appropriate in normal horse 
serum followed by three washes in PBS for 5 mins. Biotinylated secondary 
antibody was added for 30 mins at room temperature followed by three washes 
with PBS. This procedure was followed by incubation with biotin-streptavidin- 
peroxidase complex for 30 mins and three 5 min washes in PBS. The tissues/cells
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were then incubated with diaminobenzidine tetrahydrochloride (DAB) solution 
for 2 - 1 0  mins and washed in running tap water for 5 mins. Cells were 
counterstained with Harris haematoxylin for approximately 10 secs and mounted 
onto microscope slides in a drop of DPX mounting medium. Tissues were 
counterstained with Harris haematoxylin for 1 min, washed in running tap water 
for 3 mins and placed into 1% acetic acid for 10 secs followed by a further wash 
in running tap water for 2 mins. They were then dehydrated in ethanol solutions 
(70% EtOH-15 secs, 2X 100% EtOH 30 secs) and cleared in xylene before being 
carefully mounted under glass coverslips in a drop of DPX mounting medium 
avoiding air bubbles. The slides were then examined and photographed under a 
light microscope.
2.7.3 Immunofluorescence
Non-specific antibody binding was blocked by incubating tissues or cells in 
normal horse serum for 20 mins at room temperature. Primary antibodies were 
incubated overnight at 4°C and slides washed in PBS for 5 mins three times. The 
sections/cells were incubated with Fluoroscein isothiocyanate (FITC)- or 
tetramethyl rhodamineisothiocyanate (TRITC)-conjugated secondary antibodies 
for 30 mins followed by three 5 minute washes in PBS. Nuclei were stained by 
incubation with a 1 fxg/ml solution of Hoechst 33258 (Sigma) for 5 minutes. 
Negative control tissue sections/cells were treated in an identical manner, but 
omitting the primary antibody. The tissue sections were then carefully mounted 
under glass cover slips and mounted onto microscope slides in a drop of Gelvatol 
mounting medium. The slides were examined under an Hg-arc Zeiss Axiophot 
fluorescence microscope. The microscope was coupled to a Coolview 12 cooled 
charge-couple device (CCD) camera (1024 x 1024, 12-bit pixels; Photonic 
Science, Robertsbridge, UK) controlled by Image Pro-Plus software v3.0; Media 
Cybernetics, Rockville, MD).
2.8 Western Blotting
2.8.1 Lysate preparation
Cells were grown to approximately 70-80% confluence in T75 culture flasks. The 
medium was removed and the cells washed three times in PBS. One ml of 
extraction buffer was added to the flask, the cells were scraped and placed into 1.5
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ml eppendorf tubes and incubated on ice for 15 mins. The samples were then 
centrifuged at 13,000 rpm at 4°C, the supernatant was transferred to a fresh tube 
and the cell pellet was discarded.
2.8.2 Measurement of protein content
In order to measure the protein concentration of the cell extracts The Bradford 
assay (BioRad) was employed according to the manufacturers instructions.
2.8.3 Polyacrylamide gel electrophoresis
Protein samples (30 pg) were loaded onto polyacrylamide gels and 
electrophoresis was carried out using BioRad electrophoresis apparatus. The gel 
apparatus was assembled according to the manufacturers instructions and 0.5mm 
or 1.5mm thick resolving gels of the required percentage were prepared and 
overlayed with 1 ml of water to ensure a level surface of the gel. The resolving gel 
was then allowed to set for at least 1 hour after which the water was poured off 
and a stacking gel poured on top. A comb was quickly inserted and the gel was 
left to set for approximately 30 mins. The composition of the gels were as 
follows:
Reagent Resolving Gel Resolving Gels Stacking Gel
7.5% 12% 4%
1.5M Tris pH 8.8 1.25 ml 1.25 ml -
1M Tris pH 6.8 - - 500  pi
10%  SD S 50 pi 50 pi 4 0  pi
50%  glycerol 100 pi 100 pi -
0.5M EDTA 20 pi 20  pi 16 pi
Acrylamide 830 pi 1.992 ml 530  pi
dHpO 2.695 ml 1.533 ml 2 .89  ml
10% AMPS 50 pi 50 pi 4 0  pi
TEMED 5 pi 5 pi 10 pi
The protein samples were prepared by mixing with 2x loading buffer and 
denatured at 100°C for 5 mins prior to loading onto the gel. One of the lanes was 
loaded with 5 [il of Rainbow high molecular weight marker (Amersham 
International). Electrophoresis was carried out at 100 V for 2 hours in IX running 
buffer.
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2.8.4 Protein transfer and blotting
Once electrophoresis was complete, the apparatus was dismantled, the stacking 
gel discarded and the resolving gel carefully removed and placed into transfer 
buffer for at least 10 mins. Immobilon-P (Millipore) membrane was prepared by 
wetting in 100% methanol for a few seconds followed by washing in dH20  for 2 
mins and then allowed to equilibrate with the transfer buffer for at least 10 mins. 
Two pieces of Whatman 3MM paper were cut to exact gel size and also soaked in 
transfer buffer. The resolving gel was then assembled in the transfer apparatus 
(BioRad) as shown in Figure 2-1. Proteins were transferred at 45 V overnight at 
4°C. The apparatus was dismantled and the membrane was blocked in 5% 
skimmed milk powder (Marvel)/0.1% Tween 20 (Sigma) in PBS for 30 mins at 
room temperature. Immunodetection of specific proteins was performed by 
incubation with primary antibody for 1 hour at room temperature, in PBS 
containing 2% skimmed milk powder/0.1% Tween 20 (Sigma). Membranes were 
then incubated with peroxidase-conjugated anti-mouse IgG for 45 minutes at 
room temperature. Membranes were washed in PBS with 0.1% Tween 20 between 
antibody incubations. Antibody binding was detected using the ECL 
chemiluminescence kit (Amersham Pharmacia Biotech) according to the 
manufacturers instructions. Membranes were then wrapped in Saran Wrap and 
exposed to Hyperfilm MP autoradiography film (Amersham Pharmacia Biotech) 
for various lengths of time (2 secs to 10 mins) for visualisation.
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Transfer Membrane
Support Pad
Positive Electrode
< Support Pad
3M Filter Paper
Figure 2-1 Western blotting protein transfer apparatus set up.
2.9 Microarray Analysis
To compare differences in gene expression between PrE2.8 cells grown at 33°C 
and at 39°C for 4 days, cDNA microarray analysis was employed.
2.9.1 Cy-dye labelling and reverse transcription of total RNA
Four pg of total RNA from each sample (RNA extracted from cells grown at 33°C
(control sample) and 39°C (test sample)) was simultaneously reverse transcribed 
and labelled with either cy-3 or cy-5 fluorescent dye. Reactions were set up for 
-^each sample as follows:
R eag en t A m ount
Total RNA 4 p g
Random primer 2 pi
sd H20 8 pi
Samples were incubated at 65°C for 5 mins followed by a further incubation at 
28°C for 1 min. The following reactions were then set up for each sample:
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Reagent Amount
5x reaction buffer 4 pi
10xdN T P  mix (low dCTP) 2 pi
Cy (3 or 5)-labelled dC TP (1 mM) 2 pi
DTT (0.1 mM) 2 pi
Superscrip t II (200 units/pl) 2 pi
Reactions were incubated at 25 °C for 10 mins followed by a further incubation at 
37°C for 18-20 hours.
2.9.2 Purification of Samples
Reactions were purified to remove any un-incorporated dyes and prevent non­
specific hybridisation. The following reagents were added to each sample:
Reagent Amount
EDTA (0.5 M) 3.75 pi
CoT 1 DNA (1pg/pl) 12.5 pi
NaOH (1 M) 3  pi
Reactions were heated at 70°C for 10 mins after which 400 pi of 0.5X SSPE was 
added and they were then transferred to a 0.1 pm Ultrafree-MC spin column 
(Millipore) and spun at 6,500 rpm in a microcentrifuge. The solutions were then 
transferred to Microcon YM-30 spin column (Millipore) and spun at 13,000 rpm 
in a microcentrifuge for 7 mins, plus additional short spins of 30 secs until the 
reaction volume was approximately 30 pi. This was followed by a further 
addition of 400 pi of 0.5X SSPE and the samples were re-spun at 13,000 rpm to a 
volume of approximately 30 pi. Samples were then used immediately or stored at 
„  -4°C until required.
2.9.3 Pre-hybridisation
Poly-L-Lysine-coated (Sigma) glass microscope slides were pre-hybridised by 
incubation in hybridisation buffer at 65°C for 18-20 hours in a humid box. The 
slides were then washed as follows:
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Solution Temperature Incubation Time
2x SSC 32°C 1 min
2x SSC 32°C 2 min
1x SSC Room  tem peratu re 1 min
Form am ide/2x S S C 65°C 3 min
This was followed by short washes for a few seconds each in a series of graded 
alcohol solutions at room temperature: 70% EtOH (X2); 80% EtOH (XI); 100% 
EtOH (XI). The slides were then dried using an invertible air duster followed by 
incubation at 37 °C until ready for hybridisation.
2.9.4 Hybridisation Reactions
The following components were added to the purified samples:
Reagent Amount
EDTA (500 mM) 1.25 pi
20x S S P E  (pH 7.4) 15 pi
2%  Tween 2.5 pi
The control and test samples were then combined and mixed by pippetting. They 
were then heated to 99°C for 2 min followed by a 3hour incubation at 65°C in a 
Hybaid PCR machine. The samples were then placed into a 0.1 Ultrafree-MC spin 
column and centrifuged at 3,000 rpm for 5 min. The samples were then re-heated 
at 99°C for 2 min followed by 65°C for 10 min and 37°C for 20 min. The sample 
was then placed onto a glass microscope slide, containing an array of 5,800 genes, 
and a 22x66 mm Hybrislip that had been pre-warmed at 37°C and treated with an 
antistatic gun was placed on top. This was placed into a sealed hybridisation 
chamber and hybridised in a water bath at 65°C for 48 hours.
Following hybridisation the slides were washed as follows, after which the 
array slide was rapidly dried with canned air prior to analysis:
Solution Temperature Wash Time
2x SSC 32°C 1 min
2x SSC 32°C 2 min
1x SSC /50 nM EDTA Room tem peratu re 1 min
0.05x SSC Room tem peratu re 1 min
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2.9.5 Microarray Image Analysis
The microarray slide was placed into a Genepix microarray scanner (Axon 
Instruments, Foster City, CA) and the image analysed using the Genepix Pro 3.0 
image analysis software (Axon Instruments, Foster City, CA) according to the 
manufacturers instructions.
2.9.6 Microarray Data Analysis
Following image analysis the resulting data were analysed using the Significance 
Analysis of Microarrays (SAM) software (Stanford University, CA) according to 
the manufacturers instructions.
2.9.7 Verification of Significant Gene Expression by RT-PCR
Genes found to be significantly over- or under-expressed were verified by RT 
PCR and immunocytochemistry.
3 Identification of Differentially Expressed Genes in the PrE2.8 Cell Line
3 Id e n tif ic a tio n  o f  
D iffe r e n tia lly  Ex p r e s s e d  
G en es  in  t h e  P r E 2.8 C ell L in e
3.1 Introduction
Differential gene expression has important functional implications in normal cell 
growth, differentiation, and in pathological conditions. In order to identify 
candidate genes that may be involved in prostate epithelial cell differentiation, 
differential display (DD) (Liang and Pardee, 1992) was employed using a model 
cell culture system, the PrE2.8 prostate epithelial cell line (Daly-Bums et a l , in 
preparation). The cells were grown at the permissive and non-permissive 
temperatures for a period of 7 days after which total RNA was extracted and 
differential gene expression was analysed.
Differential display is a useful tool for identifying and cloning differentially 
expressed genes and was first described by Liang and Pardee (1992) as a method 
for analysing gene expression in eukaryotic cells and tissues. This method 
involves the reverse transcription of the mRNAs with oligo-dT primers anchored 
to the beginning of the ploy(A) tail. The anchored primers used in this study 
employ one ‘anchoring’ base (A, C and G) at the 3'-end, to anneal to specific 
subsets of mRNAs. This generates three different cDNA fractions corresponding 
to the presence of either a U, G or C respectively, immediately upstream of the 
poly(A)+ region. Reverse transcription was followed by the PCR reaction in the 
presence of a second lOmer, arbitrary in sequence. The amplified cDNA 
subpopulations of 3’ termini of mRNAs, as defined by this pair of primers, were 
then ‘displayed’ side by side on a high resolution denaturing gel so that 
differential gene expression was immediately visible (Figure 3-1). By changing 
primer combinations using all the anchored oligo-dT primers with 80 arbitrary 
lOmers would statistically cover the majority of mRNAs in a eukaryotic cell
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(Liang and Pardee, 1992). Furthermore, DD can examine several different RNA 
samples simultaneously and so is ideal for time course, dose-response and 
multiple treatment studies. Other advantages of DD include its simplicity, 
sensitivity, reproducibility and speed.
Following DD PCR, bands of interest, corresponding to potentially up and 
down-regulated genes were excised from the denaturing gels, re-amplified and 
cloned. The cloned genes were then sequenced in order to identify them and this 
was followed by RT-PCR in the PrE2.8 cell line in order to confirm the 
differential expression of the identified genes.
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RNA expressing gene of 
interest Matched RNA (control)
AAAAAAAAAAAAAAAA
Reverse Transcription
GTTTTTTTTTTT
AT(ll)
C T (ll)
with tagged oligo dT primer
Subset of reverse transcribed cDNAs ending in G, A or C 
NNNNNNNN --------------------------►
AAAAAAAAAAAAAAAA
PCR amplification of cDNA mRNA
A T (ll)
C T (ll)
hybrid with internal random 10-mers
Resolve labelled cDNA products on a standard 
sequencing gel
positive negative
Up-regulated
m R N A
Common mRNA
Down-regulated
mRNA
Figure 3-1: Schematic of Differential Display PCR.
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3.2 Results
3.2.1 Differential Display Analysis of Changes in Gene 
Expression of the PrE2.8 Cell Line
Total RNA was isolated from the PrE2.8 cells, which had been incubated at 
growth temperatures of either 33°C or 39°C for 7 days. Changes in gene 
expression induced by a proliferative or non-proliferative phenotype, were 
investigated using DD analysis. DD PCR was performed using the anchored 
oligo-dT primers TnG, TnA and TnC, which were mixed together as TnM, in 
combination with a total of 83 arbitrary lOmers. PCR reactions were carried out 
in triplicate for each sample (obtained at 33°C on day 7 or 39°C day 7) in order to 
minimise the risk of identifying false positive bands. 35S-dATP was incorporated 
into the DD PCR reactions and after the PCR products were resolved on 
polyacrylamide gels, these were dried under vacuum and exposed to X-ray film 
for at least 1 day. If required, the gels were exposed for periods of up to 5 days 
until the majority of products could be visualised. DD PCR products were 
resolved on 6% polyacrylamide sequencing gels which are able to resolve 
sequences of between 200 -  500 bases in length. Figure 3-2 shows typical 
examples of autoradiographs of PCR products resolved on polyacrylamide gels. 
In other experiments bands representing genes that were either up or down- 
regulated following incubation of the PrE2.8 cells at either 33°C or 39°C were 
identified. If differences in expression levels appeared to occur across triplicate 
bands then these were taken to represent potential candidate genes for further 
analysis.
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33,°C 39,°C
-m * e .
Figure 3-2: Autoradiographs of polyacylamide gels showing DD PCR 
products.
To assess reproducibility, the cDNA representing each sample was synthesised in 
three independent reactions. DD PCRs were carried out for each sample (33°C at 
day 7 or 39°C at day 7) using the T nM primer in combination with an arbitrary 
10-mer. Autoradiographs are shown for PCRs using the primers TnM and the 
lOmers C6 (A), C8 (B) and CIO (C).
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3.2.2 Identification and Isolation of Differentially Expressed 
PCR Products
The autoradiographs of the polyacrylamide gels as shown in Figure 3-2, 
illustrating the banding patterns of the DD PCR products, were carefully 
examined in order to identify bands representing genes that were differentially 
expressed by the PrE2.8 cell line incubated at the two growth temperatures. A 
total of 25 differentially expressed bands were chosen for further analysis. Once 
candidate bands were identified, the autoradiographs were carefully positioned 
over the original dried polyacrylamide gel using fluorescent markers in order to 
assist orientation. By piercing a pin through the autoradiograph and 
polyacrylamide gel, the position of the band on the gel was located and a razor 
blade was used to cut the band of interest from the gel. In order to verify that the 
appropriate band had been removed, the polyacrylamide gel, was re-exposed to X- 
ray film. Figure 3-3A shows typical examples of experiments where candidate 
genes of interest were identified on autoradiographs. Following location of the 
appropriate bands on the polyacrylamide gels and the excision of these bands, re­
exposure verified their removal.
The DNA excised from the polyacrylamide gels was then re-amplified using 
PCR and resolved on agarose gels. Figure 3-3B shows bands, named by the 
arbitrary primer that was used to amplify them, run on 1.5% agarose gels 
alongside a lkb DNA marker. This revealed the sizes of the amplified cDNA 
products and whether the re-amplification PCR had been successful.
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(A)
33°C 39°C 33°C 39°C 33!C 39°C 33;C 3§°C 331C 39;C 3 & C 3 9 Q
l * V   > t------  ------ 1------   > '  'I I  T
TUM, C5 T,,M, C8 T,,M, C9.3
I kb  A2.1 A 2.2
(B)
I kb D4 B 8 J  B8.2 B8.I 0 . 2  D TI O J C I 8 . I  C5.2 B18.I C8.2 C I4 .2
Figure 3-3: Excision of differentially expressed DNA from polyacrylamide 
gels (A) and re-amplification of putative differentially expressed cDNAs (B).
(A) Autoradiographs of differentially expressed bands before and after excision 
are shown and primer pairs used to amplify the DNA fragments are indicated. 
Putative differentially expressed bands were cut from dried polyacrylamide gels 
and precise excision of the appropriate fragment confirmed by re-exposing the 
dried gel to x-ray film. (B) Extracted DNA extracted was re-amplified using the 
same primer pair as used in the DD PCR and resolved on 1.5% agarose gels.
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3.2.3 Cloning of Differential Display cDNA Fragments
The successfully amplified DNA fragments were subcloned into a pGEM-T Easy 
cloning vector. This vector is a convenient tool for the cloning of PCR products. 
The addition of a 3’ terminal thymidine to both ends of the insertion site greatly 
improves the efficiency of ligation of a PCR product into the plasmid by 
preventing the recircularisation of the vector and providing a compatible overhang 
for PCR products generated by thermostable polymerases, such as AmpliTaq 
DNA polymerase. This enzyme adds a single deoxy-adenosine, in a template- 
independent fashion, to the 3’-ends of the amplified fragments.
The cloned PCR products that were transfected into E. coli were grown on 
LB agar plates. The presence of an insert was tested for by using blue/white 
selection. White colonies indicated the presence of a correct colony containing 
both insert and vector. Colony DNA was then amplified by PCR in order to 
verify that these white colonies contained inserts. Ten colonies from each sample 
cloned were picked at random for the PCR screening. Primers complementary to 
the T7 and SP6 promoter regions flanking the multiple cloning site of the pGEM- 
T Easy vector were used for amplification. Figure 3-4 shows examples of cloned 
cDNA for the C16 and A2.2 DD bands that were successfully transfected as 
revealed by expression across 10 clones. This analysis revealed which clones 
contained an insert and therefore could be used for further analysis.
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Colony H
I kb I 2 3 4 5 6 7 8 9 10
C16
■
A2.2
Figure 3-4: Colony PCRs of cloned cDNA fragments.
A total of 10 colonies for each cloned PCR product were selected for screening by 
colony PCR. This screen was carried out in order to verify the presence of insert 
DNA prior to minipreparation of DNA for sequencing.
3.2.4 Minipreparation of Cloned cDNA Fragments
Of the ten colonies per sample screened by PCR for the presence of inserts, 6-8
were then chosen for minipreparation of DNA to be sequenced. The miniprep 
DNA was digested with the EcoK\ restriction enzyme which allowed release of 
.the insert from the multiple cloning region. Digested samples were visualised on 
1.5% agarose gels. Figure 3-5 shows examples of cloned DNA for the D7 or A2.2 
bands that were digested with the EcoRI restriction enzyme. The larger bands 
represent the vector DNA whilst the smaller bands represent the insert DNA 
obtained from the previous DD analysis. This revealed w hether the 
minipreparation of DNA had been successful and if so, whether the insert DNA 
had been successfully digested from the vector.
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Colony H
I kb I 2 3 4 5 6 7 8
Figure 3-5: M inipreparation and restriction analysis of the cDNA clones.
(A) Miniprepped DNA samples were run on 1.5% agarose gels. (B,C) Restriction 
endonuclease patterns of independent clones from the same target band which 
have been digested with EcoRI. Restriction enzyme digests were carried out in 
order to identify colonies containing DNA inserts.
3.2.5 Sequencing and Identification of Differentially Expressed 
cDNA Clones
Successfully digested miniprep DNA was sequenced in order to identify the 
differentially expressed genes. Three clones for each candidate gene were 
sequenced in both forward and reverse directions using the T7 and SP6 promoter 
sequences as primers for the sequencing reaction. These forward and reverse 
sequences were aligned using the Autoassembler software package. Sequencing 
was carried out from three separate clones for each gene in order to verify 
identification. If initial attempts were unsuccessful, sequencing of cDNA clones 
was repeated until a good, readable sequence was obtained. For a number of genes 
a readable sequence was not obtained and these candidate genes were therefore 
not selected for further investigation. Successful DNA sequencing of the cDNA 
clones revealed the EcoRI restriction site, the poly(A) tail of the gene and the 
primers used in both the sequencing and the original DD PCR reaction.
Figure 3-6 shows the DNA sequence of the DD PCR product C l4.2. The 
three sequences obtained for this gene, and others, were compared with the 
Genbank/EMBL non-redundant nucleotide (nr) and expressed sequence tag (EST) 
databases with the BLAST algorithm (blastn) available via the world wide web at
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the NCBI. This enabled the sequences obtained for these candidate genes to be 
identified. Table 2 lists the genes identified, their respective sizes, the results of 
BLAST searches and the up- or down-regulation of gene expression in the PrE2.8 
cell line.
TT AAGCTTTTTTTTTTT ACAT AAGTTTT ACAAGAT AAT ACATTTTT ACAG 
T GACCT GAT GT GGAT ACAACTTT GCAACTT GGCAAAAAGCAAAT CTT AAC 
TT ACATTATAATTAATTT GCTGCTACACAT CT CTGATTCT CAATTTT GGC 
AAGT ACAACAGGTT AAGGGTT CT ATTT AGT GT CCCCTT CT GAT GAAT AT G 
AT GAT CTT GAACCCATT CTT CCT CCT CAAGCACGCAAATCGAATTC
Figure 3-6: DNA sequence of the DD PCR product C14.2.
The sequence of the above PCR product was determined using cycle sequencing 
on an automated ABI Prism sequencer. A BLAST search revealed homology to 
S.pombe chromosome III cosmid. The EcoKl restriction sites in the multiple 
cloning region of the pGEM-T Easy vector are shown in blue. The sequence of 
the primers used for DD PCR and subsequent re-amplification (T,,A and the 
arbitrary lOmer, C l4) are shown in red.
3.2.6 Confirmation of Differential Gene Expression by RT-PCR
In order to verify that the bands isolated from the DD polyacrylamide gels
represented differentially expressed genes, primers were designed to the 
sequences obtained and RT-PCR was carried out using reverse transcribed RNA 
from the PrE2.8 cell line grown at either 33°C or 39°C over a time course of 4, 7, 
10 and 14 days of growth. RT-PCR confirmation of differential gene expression 
revealed that only 3 of the 25 genes identified by sequencing were differentially 
expressed (Table 1). Two genes found to be up-regulated at 39°C in the PrE2.8 
cell line, when the cells appear to be differentiating, were the S I00 calcium 
binding protein A8 (S100A8) and the small proline-rich protein IB (SPR IB). A 
gene found to be down-regulated at 39 °C was cyclo-oxygenase 2 (COX 2) (Figure
3-7).
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Table 1: Summary of putative differentially expressed genes.
DD band names, sizes of re-amplified DNA products, BLAST search results and 
RT-PCR confirmation results are listed.
DD Size of Blast Search Result Confirmation of
Band Re­ Differential
Name amplified 
DNA (bp)
Expression
A2.1 400 H um an m yosin regulatory light chain No ch a n g e
A2.2 390 S 1 0 0  calcium  binding protein A8 U p-regulated
A19 -
B8.1 610 Not se q u e n c e d  d u e  to lack of m aterial
B8.2 590 Not se q u e n c e d  d u e  to  lack of m aterial
B8.3 400. Not se q u e n c e d  d u e  to  lack of m aterial
B9 360 BAC clone No ch an g e
B10 345 H um an N ew castle  d is e a s e  virus 
inducible protein
No ch an g e
C5.1 500 C yclo-oxygenase 2 D ow n-regulated
C 5.2 400 H um an cytochrom e c  ox idase  subunitll No ch an g e
C6 396 H um an mitochondrial com plete  g en o m e No ch an g e
C8.1 510 A rabidopsis thaliana  DNA chrom osom e 3 
clone
No ch an g e
C 8.2 290 PAC clone No ch an g e
C9.1 -
C 9.2 490 Hum an m itochondrial com plete  g en o m e No ch a n g e
C 9.3 250 Small nuclear ribonucleoprotein 
polypeptide B
No ch a n g e
C14.1 300 S. pom  be  ch rom osom e III cosm id No ch an g e
C 14.2 250 BAC clone No ch a n g e
C 16 350 Small proline-rich protein 1B U p-regulated
C18.1 310 Alpha tubulin No ch a n g e
C 18 .2 200 Alpha tubulin No ch a n g e
D4 345 PAC clone No ch an g e
D7 290 H eat shock  protein No ch an g e
E6 150 BAC clone No ch an g e
E7 -
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Days at 39°C:
1Kb 0 4 7 10 14
Days at 39°C:
1Kb 0 4 7 10 14
SPR1BS100A8
Figure 3-7: Confirmation of differentially gene expression by RT-PCR.
In order to verify that the bands identified through differential display were 
differentially expressed in the PrE2.8 cell line, RT-PCR was performed using 25- 
35 cycles on reverse transcribed RNA from cells incubated at 33°C or 39°C after 
4, 7, 10 and 14 days of culture. Amplifications are shown for genes showing 
differential expression following confirmation by RT-PCR: S100A8 (calcium 
binding protein S100A8), SPR1B (small proline-rich protein IB) and COX2 
(cyclo-oxygenase 2). GAPDH was used as a control. The last lane of each RT- 
PCR shown represents a negative PCR control.
3.3 Discussion
Changes in gene expression between a proliferative and a differentiated 
phenotype in the PrE2.8 cells were investigated using differential display. Twenty 
J iv e  bands, representing potentially up- and down-regulated genes, were chosen 
for further analysis. These genes were cloned and sequenced for identification and 
differential gene expression was then confirmed using RT PCR. However, this 
revealed that only three of the genes were truly up-, or down-regulated using this 
technique. These discrepancies may have been due to a number of features of the 
differential display technique.
A major drawback of the technique is the generation of a relatively large 
number of ‘false positives’ as was demonstrated in this study. A false positive
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occurs when the expression pattern of a clone isolated from a differentially 
expressed cDNA band on a polyacrylamide gel cannot be reproduced using 
independent techniques such as RT-PCR. Differential display is a multi-step 
process where false positives can be generated at several stages, from the running 
of the experimental model and RNA extraction, through to cloning of candidate 
genes and confirmation of differential expression. False positive results in part 
could be attributed to degraded RNA or contaminating DNA. Although DNAse I 
treatment was applied to the mRNA prior to DD PCR, a trace amount of DNA 
may remain. In some cases, during the PCR process, contaminating DNAs of the 
same size as the band of interest may be produced and amplified that cannot be 
removed by gel purification. These contaminating DNAs may clone and amplify 
more efficiently than the band of interest, since they may be more abundant, 
resulting in the differentially expressed mRNAs to be obscured and the DD band 
to be scored as a false positive. There is also increasing evidence in the literature 
that single bands with differential appearance on gels, represent a mixture of 
several cDNA fragments of identical size but different sequence (Li et al., 1994a; 
Vogeli-Lange et al., 1996). Thus the cDNA clones obtained from one particular 
differential may be derived from several different mRNAs, including both 
differentially and constitutively expressed ones. Also, despite the advent of better 
gel systems with improved resolution, it is still possible to unintentionally excise 
more than one band from the polyacrylamide gel and thus re-amplify and clone a 
mixture of cDNAs.
In some instances the candidate bands excised from polyacrylamide gels fail 
to re-amplify, as was the case with DD bands A 19, C9.1 and E7. Re­
amplification problems can be caused if the gel is not sufficiently washed, causing 
excess urea and acrylamide to inhibit the PCR reaction. It is also recommended 
that the DD bands of interest should be excised and re-amplified as soon as 
possible so as to minimise degradation of DNA. Despite the majority of candidate 
genes in this study being established as false positives, three candidate genes were 
confirmed as being differentially expressed in the PrE2.8 cell line. Two genes 
found to be up regulated during differentiation of the cells at 39°C, were 
identified as the SI00 calcium binding protein A8 (S100A8) and the small proline 
rich protein IB (SPR1B). These genes are both located on chromosome lq21.
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This region consists of a collection of genes known to play an important role in 
terminal differentiation of the human epidermis and has been designated the 
epidermal differentiation complex (EDC) (Mischke et al., 1996). In addition, the 
lq21-23 region is deleted in uterine and bladder adenocarcinomas and is the target 
for translocation in breast adenocarcinoma (Solomon et al., 1991).
SPR1B belongs to the first family of EDC genes. This family consists of 13 
genes, involucrin, loricrin and the three classes of small proline rich proteins 
comprising 2 SPR1 and 8 SPR2 genes as well as 1 SPR3 gene. These encode 
structural proteins of the human epidermis (Gibbs et al., 1993). The second 
family of the EDC consists of profilaggrin and trichohyalin. These genes encode 
intermediate filament associated proteins that are synthesised in the granular layer 
of the epidermis and adjoin the keratin filaments of keratinocytes during 
comification (Fietz et al., 1992). The third family of genes of the EDC is 
comprised of the SI00 family of calcium binding proteins named which has at 
least 19 members. They were initially characterised as low molecular weight (10- 
12 kd) acidic proteins and named by their solubility in 100% ammonium sulphate 
(“S100”). These genes are thought to play a part in signal transduction and cell 
cycle progression during terminal differentiation of keratinocytes. The calcium 
binding proteins S100A7, S100A8 and S100A9 have been shown to be up 
regulated in psoriatic epidermis and primary human keratinocytes undergoing 
aberrant differentiation (Hoffmann et al., 1994; Saintigny et al., 1992). Other 
proteins of this family are abnormally expressed in various tumours such as breast 
carcinomas as well as tumours of the bladder and colon (Lee et al., 1992; 
Pedrocchi et al., 1994). The S100 proteins are involved in numerous functions 
ranging from the control of cell cycle progression and cell differentiation to 
enzyme activation and regulation of muscle contraction (Schafer and Heizmann, 
1996). Thus they appear to have a wide variety of functions in normal and 
diseased states and are expressed in a cell- and disease-specific manner.
A third gene found to be differentially expressed in the PrE2.8 cell line is 
cyclooxygenase 2 (COX-2) whose expression was decreased upon differentiation 
of the cells. Two cyclooxygenase genes have been cloned (COX-1 and COX-2) 
that share >60% identity at the amino acid level. Both enzymes catalyse the 
conversion of arachidonic acid to prostaglandins. COX-1 is constitutively 
expressed in many mammalian tissues and is involved in the physiological
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production of prostaglandins for maintaining normal homeostasis. On the other 
hand, expression of COX-2 is low or not detectable in most healthy tissues, but 
can be highly induced in response to cell activation by hormones, pro- 
inflammatory cytokines, growth factors and tumour promoters. The expression of 
COX-2, but not COX-1, has been found to be increased in a variety of tumours 
including bladder, colorectal, breast and prostate tumours.
This study has identified changes in gene expression in the PrE2.8 cell line 
between a proliferative and a non-proliferative phenotype, through differential 
display analysis. The genes SPR1B and S100A8 are up regulated at 39°C and 
may be early markers of normal epithelial cell differentiation in the human 
prostate. To date these genes have not been previously studied in this tissue. 
COX-2 is down regulated in the cell line at 39°C and is known to show increased 
expression in prostate cancer. However, its role in normal prostate epithelial cell 
differentiation is not fully understood. In vivo analysis of these genes in prostate 
tissue will further elucidate their role in normal prostate epithelial cell 
differentiation.
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4 Ex p r e s s io n  o f  CD44 in  P r E2.8  
CELLS AND PROSTATE TISSUE
4.1 Introduction
Differential display analysis of changes in gene expression between a proliferative 
and differentiated phenotype in the PrE2.8 cells revealed only three genes with 
confirmed differential expression (discussed in chapter 3). In order to further 
investigate the PrE2.8 cell line as a model of prostate epithelial cell 
differentiation, a candidate gene approach was employed. Among the genes 
investigated, CD44 revealed an intriguing pattern of gene expression in the PrE2.8 
cells, exhibiting an interesting pattern of alternatively spliced isoforms between 
the proliferative and non-proliferative phenotype. CD44 expression was therefore 
further investigated in this model system.
CD44 is a transmembrane glycoprotein that is widely expressed in virtually 
all cell types. It functions as an extracellular matrix receptor and is involved in 
cell-cell and cell-matrix interactions. CD44 may also participate in growth 
regulation by presenting growth factors to their cell surface receptors (Lesley et 
al., 1993). The CD44 protein is encoded by a single gene, located on chromosome 
1 lp l3 , that consists of 20 exons. However, through extensive alternative splicing 
of exons 6-14 (also referred to as exons v2-vl0), the extracellular membrane 
domain is highly variable, producing multiple protein isoforms that are expressed 
in a tissue specific manner (Screaton et al., 1992; Tolg et al., 1993). The shortest 
isoform of CD44 (CD44s) lacks all variable exons. It has a wide tissue 
distribution, and is the most common form expressed on haematopoietic cells. 
Larger splice variants dominate on several normal epithelia and tumours (Fonseca 
et al., 2000; Heider et al., 1995; Hudson et al., 1995; Hudson et al., 1996; 
Matsumura and Tarin, 1992). Additional diversity of CD44 isoforms results from 
post-translational m odifications with N -  and O -linked sugars and 
glycosaminoglycan side chains (Skelton et al., 1998).
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CD44 has been implicated in a number of normal and disease processes, 
including intracellular adhesion and tumour metastasis. Normal human salivary 
gland was found to be negative for the v4/5 isoform but positive for the variant 
exons v3 and v6, where it might be involved in the regulation of growth and 
renewal of the tissue (Fonseca et al., 2000). Keratinocytes express various CD44 
isoforms, including forms containing exons v2-vl0, v3-vl0, v4-vl0, v6-vl0 and 
v8-vl0 (Brown et al., 1991; Hudson et al., 1995).
Expression of variant isoforms has been implicated in various human 
malignancies, including colorectal (Heider et al., 1993b), stomach (Heider et al., 
1993a), breast (Matsumura and Tarin, 1992), squamous cell carcinoma (Hudson et 
al., 1996) and prostate cancer (Nagabhushan et al., 1996). In the prostate, CD44s 
and v6 expression is inversely correlated with tumour stage, grade and ploidy 
(Nagabhushan et al., 1996). In addition, there have been reports that loss of CD44 
s and v6 may be useful prognostic markers in prostate cancer patients treated by 
radical prostatectomy (Kallakury et al., 1998; Noordzij et al., 1997). Further 
studies have revealed reduced CD44 expression in prostate cancer metastasis as 
well as in the corresponding primary tumours (Noordzij et al., 1999). More 
recently, (Iczkowski et al., 2003) demonstrated an increase in expression of 
variants v7-v9 in prostate cancer. In rat, expression of the v4-v7 isoform is 
involved in pancreatic carcinoma and metastasis (Gunthert et al., 1991).
Previous reports of CD44 expression in non-malignant human prostate have 
shown that basal and intermediate epithelial cells express CD44 (Heider et al., 
1995; Noordzij et al., 1997; Tran et al., 2002) but little is known about changes in 
expression of variant isoforms during different stages of epithelial differentiation. 
The aim of this experiment was to investigate the expression of CD44 in the 
PrE2.8 conditionally immortalised cell line. At the permissive temperature they 
display basal cell characteristics where as at the non-permissive temperature the 
cells may be undergoing differentiation towards a luminal cell type. It would 
therefore be of interest to study the expression of CD44 in the PrE2.8 cells at the 
two growth temperatures, since it is a marker of the basal cell population. RT- 
PCR revealed a very interesting expression pattern of the CD44 gene in the 
PrE2.8 cells. Several isoforms of the gene were expressed by the cells and these 
were identical at the two growth temperatures. However, the largest of the CD44
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isoforms showed a significantly higher level of expression at 39°C than at 33°C. 
This suggested that this isoform may play a role in the differentiation of the 
PrE2.8 cells and this was investigated further in these cells, as well as in primary 
prostate epithelial cell cultures and in prostate tissue.
4.2 Results
4.2.1 CD44 isoforms expressed by the prostate epithelial cell line 
PrE2.8
The expression of the CD44 isoforms in the PrE2.8 cell line were investigated 
using RT-PCR. Total RNA was isolated from the PrE2.8 cells, which had been 
incubated at growth temperatures of either 33°C or 39°C for a period of 4, 7, 10 
and 14 days. This was reverse transcribed and RT-PCR was carried out using 
primers positioned at exons 3 and 18 (designated PI and P2), which flank the 
variable region of the CD44 gene. A schematic diagram of the gene is shown in 
Figure 4-1 A. The amplified PCR products were electrophoresed on a 1.5% 
agarose gel and are shown in Figure 4-1B). All lanes show a band of 
approximately 500 bp, corresponding to the standard form of the CD44 gene, 
which lacks all variable exons and is 549 bp in length. Three further major CD44 
isoforms are expressed at the two growth temperatures. However, there is an 
increase in the relative expression levels of the largest isoform at the non- 
permissive temperature.
In order to identify the CD44 exons expressed in each isoform, exon- 
specific RT PCR was carried out using a forward primer designed for the 5' side 
of the constant region of the CD44 gene (primer PI) together with a 3' primer 
designed for each of the variant exons vl-vlO (Figure 4-lB(b)). From the number 
_ o f bands per lane and the stepwise increase in band size, it is possible to deduce 
which CD44 isoforms are expressed. No product was seen with the vl primer, but 
all other lanes contained one or more PCR products. The PCR product labelled (i) 
in Figure 4-1 appears to contain exons v2-vl0. Band (ii) contains exons v6-vl0, 
since it is absent from the vl to v5 lanes and the band labelled (iii) contains exons 
v8-vl0, as it is absent from lanes vl-v7. Band (iv) represents the standard isoform 
of CD44. The composition of the bands was confirmed by sequencing of the PCR 
products and a schematic of the variant forms identified is shown in Figure
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4-lA(i-iv). Sequencing of band (ii) revealed that this product actually contains v3- 
vlO and not v2. There is therefore an additional minor band containing v2. 
Because variant exons v3-v5 were observed only in the largest band, v3-vl0, v5 
was chosen as a marker for this isoform as any positive staining for v5 would 
indicate cells expressing this variant.
A.
Exon #
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
rrn~nnm m i-H-
v l v2 v3 v4 v5 v6 v7 v8 >9 vlO
V3 v4 v5 v6 v7 v8 vlO
I I I  I I I D - O - D - D - D -
V6 v7 >-8 vlO
iii
iv
Davs at 39°C:
•° I---------------- 1
- 1 0 4 7 10 141 14
B .
Figure 4-1: RT PCR analysis of CD44 in PrE2.8 cells.
PCR products were resolved on a 1.5% agarose gel. (A) Schematic representation 
of the CD44 gene and the variant isoforms expressed by the PrE2.8 cells and 
primary cultures of BPH based on sequencing of CD44 PCR products (i-iv). (B) 
Isoform expression of CD44 expressed in the PrE2.8 cells at 33C and at 39C over 
a 14-day time course (C). RT PCR of PrE2.8 cells grown at 39C for 14 days, 
using internal primers for each variant exon with the common primer PI. Band i 
represents expression of variant exons v3-10, band ii, variant exons v6-10, and 
band iii variant exons v8-10. Band iv represents the standard form of CD44.
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4.2.2 CD44 protein expression in Pre 2.8 and BPH cell cultures
Cell extracts of PrE2.8 and primary cultures of BPH were resolved on SDS-PAGE 
gels, transferred to Immobilon P membrane and probed with E l/2 , which 
recognises all isoforms of CD44. Equal amounts of protein (30 pg) were loaded 
in all lanes. Very weak expression of the standard 90 kDa, CD44s was observed 
in all samples (Figure 4-2B arrow) although in some cases it was only seen on 
longer exposure of the autoradiograph. Three other CD44 isoforms were 
expressed at 33°C by the Pre 2.8 cells. The most abundant form has a molecular 
mass of approximately 160 kDa with the least abundant variant being 
approximately 250 kDa. As the cells differentiate at 39°C, there is a shift in the 
levels of CD44 protein expression with the largest isoform being more abundant 
at this temperature and by day 14 this is the major CD44 variant expressed 
(Figure 4-2A). The CD44 isoforms also have an altered electrophoretic mobility 
with a reduction in apparent molecular weight at 39°C than at 33°C. A 
comparison of the bands produced by PrE2.8 with primary epithelial cell culture 
from BPH tissue revealed a similar pattern of isoforms, with 3 variant bands and 
the standard form. The variant bands were expressed at similar levels to each 
other and they had the same apparent molecular weight as PrE2.8 cells at 33°C 
(Figure 4-2).
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Figure 4-2: CD44 protein expression in PrE2.8 and BPH cells.
(A) Western blotting analysis of CD44 protein (E l.2, anti-total CD44) in PrE2.8 
cells grown at 33’C and 39#C. At 39°C the larger protein isoform (~250 kD) is 
expressed more abundantly than at 33#C, where the smallest variant isoform is the 
major band. At 39#C the CD44 isoforms have an altered electrophoretic mobility 
with a reduction in apparent molecular weight. (B) CD44 protein expression in 
PrE2.8 cells compared with BPH cells. Primary BPH cells show a similar pattern 
of expression of CD44 isoforms to those expressed by PrE2.8 cells at 39°C, but 
with higher apparent molecular weight.
4.2.3 Cell surface expression of CD44 protein during  
differentiation of Pre 2.8 cells and in BPH cell cultures
Immunohistochemistry was used to investigate the cell surface expression and
distribution of CD44 in PrE2.8 cells. At 33°C, when the cells are predominantly 
proliferative, weak expression of total CD44 protein is observed at cell-cell 
boundaries and is stronger at the surface of cells in the process of mitosis (Figure
4-3A). Only occasional very weak inter-cellular staining for v5-containing 
isoforms was detected, although there was strong staining in some cells that 
appear to be overlying other basal cells (Figure 4-3B). When the cells are 
switched to the non-permissive temperature of 39°C, the increase in cell size is 
accompanied by an increase in total CD44 protein expression with strong 
intercellular staining of almost all cells (Figure 4-3D). Strong expression of v5 is 
now detected at cell-cell borders, indicating that at least some of the newly
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expressed CD44 consists of the v3-vl0-containing isoform (Figure 4-3E). Primary 
cultures of BPH cells consist of a mixed population of cells at various stages of 
the differentiation process. Total CD44 was expressed on the surface of the 
majority of cells, while the strongest expression of CD44v5 was seen by a 
minority of cells that, again, were overlying other cells (Figure 4-3C and F).
4.2.4 CD44 protein expression in prostate tissue
To confirm that the CD44 isoforms expressed in prostate cells were also
expressed in prostate tissue, RNA was isolated from fresh samples of BPH and 
normal prostate. DNA sequencing of RT-PCR products revealed the same pattern 
of isoform expression as found in the cell cultures. Prostate tissues were therefore 
examined for the distribution of the major v3-vl0 isoform. Because exons v3, v4 
and v5 will be found only where the v3-vl0 isoform is expressed, an antibody to 
v5 was used as a marker. Eight BPH samples were stained for keratin 14, keratin 
19 and CD44 v5 and the sections were scored for distribution of staining. A 
typical example of expression pattern of double staining for keratin 14 and the 
CD44 v5-containing isoform in prostate tissue is shown in Figure 4-3G. Positive 
staining for CD44 v5 was observed in all eight samples. CD44 v5 was expressed 
in basal cells that were negative for keratin 14 in all samples (example shown in 
Figure 4-3G) and five samples also showed areas of keratin 14 positive cells that 
were negative for CD44 v5. In addition, areas of basal cell hyperplasia expressed 
very high levels of CD44 v5 and were negative for keratin 14 (Figure 4-31). 
Interestingly, CD44 v5 was also expressed in epithelial cells located in an 
intermediate position above the keratin 14-expressing basal layer but below the 
luminal layer (Figure 4-3G, arrowhead). These cells are taller than typical basal 
cells and appear to be leaving the basal layer. This expression pattern was almost 
identical to that observed previously (Hudson et al., 2001) for keratin 19 in human 
prostate tissue (Figure 4-3H). To confirm that the staining patterns were not due 
to aberrant growth of cells in BPH, a further six tissue samples were obtained 
from tissues collected from young male cadavers. In all cases alternating staining 
patterns for CD44v5 and K14 were found and this was observed in all three 
glandular zones, central, peripheral and transition zones (Daley-Bums et a l , in 
preparation).
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Figure 4-3: Immunofluorescent staining for cell surface CD44 in prostate 
cells and tissue.
PrE2.8 cells grown at 33°C (A, B) or switched to 39°C for 7 days (D, E) or 
primary cultures of BPH epithelial cells (C, F) stained for total CD44 (antibody 
E l.2) (A, C, D) or CD44v5 (B, E, F). Paraffin-embedded BPH tissue (G, H, I) 
double stained for K14 (green) and CD44v5 (red). In BPH tissue (G), CD44v5 
(red) is seen in cells not expressing K14 (green) in a similar pattern to that seen 
for K19 (H, red). Arrowheads in G indicate limit of luminal cells. CD44v5 is seen 
in areas of K 14-negative basal cell hyperplasia in BPH tissue (I). Original 
magnifications: A-H X 400; J X 200.
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4.3 Discussion
The expression of CD44 during normal human prostate epithelial cell 
differentiation was investigated. RT-PCR analysis and DNA sequencing revealed 
four CD44 isoforms expressed by both the immortalised PrE2.8 cells and primary 
cultures of BPH. The shortest isoform corresponds to the standard form of the 
gene whereas the three other isoforms represent alternatively spliced CD44 
variants. None of these variants expressed exon v l, which is consistent with the 
report that this exon contains a stop codon (Screaton et al., 1993). The CD44 
transcripts expressed were also observed at the protein level as determined by 
Western blot analysis, the largest isoform being expressed more abundantly by 
day 14 at 39°C when PrE2.8 cells are further along the differentiation pathway 
(Alam et al., 2004). Three major isoforms were expressed at similar levels in 
primary cultures of BPH epithelial cells. However, these cultures contain a mixed 
population of proliferating and differentiating cells and it was only by using a 
model in which differentiation could be induced that we could examine the 
changes in expression of the isoforms.
Whereas RT PCR revealed that the CD44 variants expressed by the cells 
were all of equal size, an apparent shift in molecular weight was observed by 
Western blot analysis. This may be due to differences in post-translational 
modification of the CD44 protein. CD44 contains a number of N- and O-linked 
glycosylation sites all of which contribute to further diversity in protein 
expression. The results show that the isoforms expressed by PrE2.8 cells grown at 
the non-permissive temperature have an increased electrophoretic mobility and 
therefore a lower molecular mass, compared to those grown at 33°C and to the 
primary BPH cultures. This difference may be the result of altered glycosylation 
'of the CD44 variants, perhaps caused by aberrant activity of glycosylation 
enzymes at 39°C.
The in vitro studies suggested that the CD44 v2-vl0 isoform may play a 
role in the differentiation of normal prostate epithelial cells as demonstrated by 
the PrE2.8 cell culture model system. In order to confirm whether the v5- 
containing CD44 isoform may also play a role in vivo, the expression of the v5- 
containing variant in prostate tissue specimens was investigated. Positive staining 
for CD44 v5 was seen in basal epithelial cells in BPH and normal prostate tissues.
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This is consistent with reports that CD44 isoforms are expressed by the 
proliferating compartments of epithelia, specifically the basal layer (Mackay et 
al., 1994). However, many v5-positive cells were negative for keratin 14, a 
marker for the least differentiated basal cells. Also in a number of patients, v5- 
positive staining was seen in epithelial cells that lay above the basal layer but 
below the luminal layer. These cells were larger and taller than the 
characteristically small spindle-shaped basal cells. This suggests that the v5- 
positive cells may be in the process of differentiation from the basal to the luminal 
layer. It has previously been shown that this cell type also stains positive for 
keratin 19 and has thus been postulated that they represent an epithelial cell 
population that are in the process of differentiation (Hudson et al., 2001).
Taken together, these results provide evidence of early differentiation- 
associated changes in CD44 expression during normal prostate epithelial cell 
differentiation. More importantly, the CD44 v5-containing isoform may be a 
marker of cells in the early stages of this differentiation process. CD44 has 
previously been used as a target for separating basal from luminal prostate cells 
using immunomagnetic bead-based cell-sorting (Collins et al., 2001). We have 
now extended this to show that different isoforms of CD44 are in fact expressed 
in different basal cell populations. The identification of a CD44 isoform as a cell 
surface marker specific for the transit amplifying population in the prostate will 
provide a valuable tool for the further characterisation of the differentiation 
process. Furthermore, the results confirm that the PrE2.8 prostate epithelial cell 
line provides a model for the study of the differentiation process in the normal 
human prostate. This led to a more global approach to the study of gene 
expression in the PrE2.8 cell model using cDNA microarray analysis.
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5 M ic r o a r r a y  A nalysis  o f  
D iff e r e n tia l  C h a n g e s  in  G en e  
Ex p r e s s io n  in  t h e  P r E2.8 C ell  
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5.1 Introduction
Analysis of temperature-dependent changes in gene expression in the PrE2.8 
cells, as determined by differential display (Chapter 3), resulted in only three 
genes that were positively identified to be differentially expressed. The technique 
also yielded a high number of false positive results. In order to overcome this 
problem, and to gain a global picture of the changes occurring in gene expression 
in the PrE2.8 cells during proliferation and differentiation, microarray analysis 
was employed.
Microarrays allow the simultaneous analysis of changes in expression levels 
of thousands of genes within a test and reference sample and offer an insight into 
cellular function. Various types of DNA microarrays exist, such as cDNA arrays 
_and oligo arrays. In this case, cDNA arrays were employed. Figure 5-1 outlines 
the general principle of the technology: mRNA from the sample of interest is 
converted into cDNA in a reverse transcription reaction that incorporates one 
specific fluorescent dye. The sample of interest by consensus is labelled with Cy5 
dye, which fluoresces at a wavelength of 635 nm, and is visualised as a red colour 
in the scanned computerised image of the array slide. A control or reference 
mRNA source is also converted to cDNA. This time the reaction incorporates a 
different fluorescent dye, Cy3, which fluoresces at a wavelength of 532 nm and is
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visualised as a green colour. The two different labelled samples are then mixed 
and hybridised together onto the microarray where the labelled cDNA sequences 
bind to their respective probes on the array. Since two differently labelled cDNAs 
are applied to the same array, competitive hybridisation occurs for each probe.
The level of hybridisation of labelled cDNA to each array probe is 
determined by laser-scanning the array. The lasers stimulate the Cy5 and Cy3 
dyes at their corresponding wavelengths and the amount of emission/fluorescence 
is measured. This relates to the amount of sample bound to each probe on the 
array. If a gene is expressed at a high level in the experimental sample, but at a 
low level in the control/reference sample, the spot on the array will be 
predominantly red. If a gene is expressed at a low level in the experimental 
sample but a high level in the control/reference sample, the spot on the array will 
be predominantly green. Equal levels of gene expression in the sample of interest 
and reference sample results in a yellow spot on the array due to equal amounts of 
red and green hybridisation.
The microarrays used in the following experiments were obtained from the 
Institute of Cancer Research (UK) (http://icr.ac.uk/array.array.fatm 1) and consisted 
o f 5,603 IMAGE cDNA clones acquired from, the Human Genome Mapping 
Project Resource Centre (httpi/ /w ww.hgm p.m rc.ac.uk ) and from Research 
Genetics (http:// w w w. re seen.com). The arrays contained cDNA clones with 
defined biological functions which were selected in preference to anonymous 
expressed sequence tags (ESTs) (5,321 known function; 282 anonymous ESTs). 
mRNA, extracted from total RNA, from PrE2,8 cells grown at 39°C for 4 days 
was labelled with Cy5 (experimental sample) and mRNA from the cells grown at 
33°C (control/reference sample) was labelled with Cy3.
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Reference/control cells Sample cells
Extract RNA, reverse transcribe 
and fluorescently label
Cy5 labelledCy3 labelled
Mix in equal amounts 
and hybridise to arrays
Process images
Data analysis
Figure 5-1: Schematic of microarray process.
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5.2 Results
5.2.1 Image processing and scatter display of microarray gene 
expression data
Array experiments were carried out in triplicate; three hybridisations were 
performed for each RNA sample. Following hybridisation, the arrays were 
scanned using a Genepix 4000 Series microarray scanner (Axon Instruments, 
Foster City, CA) and the image analysed using the Genepix Pro 3.0 microarray 
image analysis software (Axon Instruments, Foster City, CA). The output images 
are stored as 16-bit image files, one for each dye, which are viewed as ‘raw data’ 
(Figure 5-2). The image processing stage extracts measures of transcript 
abundance hybridised to each gene spotted on the array. The software uses a spot 
finding algorithm to define the location and edge boundaries of each array spot. 
For each dye, the signal for any given spot is measured by the sum of the pixel 
intensities for each emission wavelength within the spot. The sum represents the 
total amount of cDNA hybridized to the spotted DNA sequence. A number of 
calculations can also be derived from the measured intensities of Cy3 and Cy5 
dye for each spot. For example, the ratio of the medians and the ratio of the means 
of the Cy3 and Cy5 channels can be derived, as well as the standard deviation of 
the values. The algorithm also defines an area around the spot to measure the local 
background signal. This was subtracted from the foreground spot intensity for 
data analysis. Background correction was carried out because each spots’ 
measured fluorescence intensity, in each of the two channels, includes a 
contribution which is not specifically due to the hybridisation of the target to the 
probe. For example, fluorescence of the background may occur due to other 
chemicals and the glass of the microarray slide.
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Figure 5-2: Scan of microarray slide.
Following hybridisation, arrays were scanned using a Genepix 4000 Series 
microarray scanner (Axon Instruments, Foster City, CA) and the image analysed 
using the Genepix Pro 3.0 microarray image analysis software (Axon Instruments, 
Foster City, CA). The output images were stored as 16-bit image files (A). (B) 
shows an enlarged area of image (A).
A control array experiment was also performed in which RNA extracted 
from the reference/control sample (PrE2.8 cells cultured at 33°C) was divided into 
two, labelled with Cy3 or Cy5 dyes then mixed and co-hybridised to the array. 
The Cy3 and Cy5 intensity data from this experiment can be viewed by plotting 
the background-subtracted log2 intensities for the Cy5 sample verses the Cy3 
sample for each gene spotted on the array. In this case, all intensity ratios should 
equal one, i.e. have a log2(Cy3) = log2(Cy5) relationship between the intensities.
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This data can be compared to that derived from the three experimental arrays and 
in this way, verify that outliers in the three experimental graphs are likely to be 
due to differential gene expression (Figure 5-3). The next stage was to normalise 
the gene expression data prior to determination of which outliers, or genes, are 
differentially expressed in the PrE2.8 cells between the two growth temperatures 
of 33°C and 39°C.
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Figure 5-3: Scatter plots of cDNA microarray expression data.
The graphs show relative intensities of Cy3 verses Cy5 dyes for (A) the control 
hybridisation of PrE2.8 (33°C) cDNA labelled with Cy3 and PrE2.8 (33°C) 
labelled with Cy5. Experimental hybridisations were carried out with PrE2.8 
(33°C) labelled with Cy3 and PrE2.8 (39°C) labelled with Cy5; these experiments 
were replicated three times (B, C, D).
5.2.2 Log transformation of gene expression data
The log ratio of the median intensity values for each feature on the array is used
for data analysis. This is preferable to using raw intensity values (Figure 5-4) 
since these are not normally distributed where as log transformed intensities 
approach a normal distribution. This can be seen in Figure 5-5 where the linear or 
log intensity ratios of Cy3 and Cy5 gene expression ratio of three sets of data are 
plotted. Although they are different, with different mean and median values, the
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actual shape and spread of the sets of data in the histograms is very similar, i.e. 
the two data sets have similar standard deviations. Therefore, log transformation 
aids the comparison between arrays and the array normalisation processes. Log 
ratios also facilitate the interpretation of relative increases or decreases in gene 
expression from different samples. Logarithms to base 2 are used rather than 
natural or decimal logarithms (log to base 10), which allows the interpretation of 
gene expression ratio changes between genes from different samples. For 
example, gene X may be up-regulated by a factor of 2 relative to the reference 
sample and therefore will have a ratio of 2 (15000 Cy5/7500 Cy3) and a log2 
(ratio) of 1, where as gene Y may be down-regulated by a factor of 2, and 
therefore will have a ratio of 0.5 and a log2 (ratio) of -1. This gives a much more 
intuitive view of gene expression as the magnitudes for under and over expression 
are identical whilst also allowing a log transformation into a normal distribution 
of the expression data. A gene whose expression value is unchanged will have a 
gene expression ratio of 1 and a log2 (ratio) of 0.
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Figure 5-4: Histograms of unlogged microarray expression data.
Histograms are plotted showing the frequency of gene expression ratios 
(Cy5/Cy3) for the three replicate microarray experiments. The majority of spots 
on each array have a gene expression ratio of approximately 0.
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5.2.3 Data normalisation
Like all other biological experiments, gene expression measurements using 
microarrays are subject to both random and systematic variations which affect 
measured gene expression levels. For example, experimental differences in the 
absolute amounts of mRNA used for each array, efficiency of reverse 
transcription reactions and differences in array hybridisations and washing can 
occur. Systematic differences between the physical properties of the two 
fluorescent dyes can also occur such as heat and light sensitivity as well as 
excitation and emission half lives. Therefore the process of normalisation is used 
to minimise systematic variations in the gene expression levels of the two samples 
hybridised to the array and to allow the comparison of such data across arrays, 
prior to data analysis.
A number of methods exist for data normalisation and are based on certain 
assumptions about the underlying data (Quackenbush, 2001). Normalisation 
methods take advantage of the fact that when log transformed, gene expression 
data approaches a normal distribution and therefore the entire gene expression 
data distribution can be shifted to the left or right of the population mean or 
median without changing the standard deviation.
The Global normalisation method was used normalise the gene expression 
data obtained from the three replicate experiments. This normalisation method 
assumes that the Cy5 and Cy3 intensities on a slide are related by a constant factor 
(Cy5 = kCy3) and that the log2 expression ratio of the average (mean) or median 
gene of the population is zero or the Cy5/Cy3 ratio for the average gene is 1 (i.e. 
the expression levels of the majority of genes will not change when comparing 
two mRNA populations and only a small proportion of genes are expected to be 
differentially expressed). Therefore:
Log2 (Cy5/(kCy3)) = log2 (Cy5/Cy3) -  a 
where, as indicated above, a common choice for ‘a’ is the median or mean of the 
log2 ratios of all the data (i.e. a = log2k). These calculations were carried out using 
the Microsoft Excel software. Figure 5-5 shows the expression data of the three 
data sets before and after global normalisation. After normalisation, the data sets 
should be centred around a log2 ratio of zero in order that the three replicate 
experiments can be compared with each other for data analysis. From Figure 5-5 
it can be seen that following global normalisation of the expression data, the
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average gene expression ratios are not exactly centred at zero. This is particularly 
prominent in experiment three (Figure 5-5 C (ii)).
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Figure 5-5: Histograms of Iog2 expression data before and after 
normalisation.
Histograms are plotted showing the frequency and distribution of log2 transformed 
gene expression ratios (Cy5/Cy3) for the three replicate microarray experiments 
(A, B, C), before (i) and after (ii) global normalisation.
In order to rectify this, a more advanced method of normalisation was used 
known as LOWESS (Locally Weighted Least Squares) normalisation (Cleveland 
WS, 1979) using the statistical package R (Ihaka & Gentleman, 1996). This 
method works on the observation that when looking at data from an individual 
slide, there is not an absolute linear relationship between log2 ratio values and 
intensity. Lowess is a scatter plot smoother method which is used to produce 
location-specific estimates of the log2 ratios for various intensities and uses these
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as distinct local normalisation values dependent on overall intensity. Essentially, 
LOWESS divides the scatter-plotted values into subgroups and produces a low- 
degree polynomial to this subset of data (Figure 5-6).
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Figure 5-6: Lowess normalisation of microarray data.
Graphs show Lowess scatter plots of microarray expression data for the three 
replicate microarray experiments before (A, C, E) and after (B, D, F) Lowess 
normalisation.
A third normalisation method was used in parallel with the Lowess method 
which takes into account the variability in hybridisation of dyes across the array,
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i.e. hybridisation is not uniform over the array and there may also be areas of high 
background hybridisation. A way of making such systematic differences visible is 
by applying the 2dimensional (2d) normalisation method (Wemisch et al., 2003). 
This method fits a trend surface to log ratio values over the array sets. Log2 ratios 
are then normalised by subtracting the surface values from the log2 ratio values 
(Figure 5-7).
Figure 5-7: 2d normalisation of microarray data.
Images show 2d Lowess surface fitted to log ratio values from the three replicate 
microarray experiments before (A, C, E) and after (B, D, F) normalisation.
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5.2.4 Data analysis
Following normalisation, the microarray expression data was analysed to identify 
statistically significant differential gene expression. An analysis of variance 
(ANOVA) approach was used, as proposed by (Kerr et al., 2000), using a 
statistical software package known as R. To account for the multiple sources of 
variation in a microarray experiment, the following model is implemented by R: 
L ° g  O W  =  I* + A, + Dj + V k + Gg +  (AG)jg + (V G )kg+ eUkg 
Where \i is the overall average signal, A, represents the effect of the i* array, Dj 
represents the effect of the j* dye, Vk represents the effect of the k* variety, Gg 
represents the effect of the g* gene, (AG)ig represents a combination of array i and 
gene g (i.e. a particular spot on a particular array), and (VG)kg represents the 
interaction between the k* variety and the g* gene. The error terms sijkg are 
assumed to be independent and identically distributed with mean 0 (Kerr et al., 
2000).
The array effects A; account for differences between arrays averaged over 
all genes, dyes and varieties. The dye effects Dj account for differences between 
the average signal from each dye; one dye may be inherently brighter than the 
other, and this is taken into account in the analysis. The terms Vk account for 
overall differences in the varieties. Such differences could arise if some varieties 
have more transcription activity in general, or because of differential 
concentration of mRNA in the labelled sample. The terms Gg account for average 
effects of individual genes spotted on the arrays in the experiment. The (AG)ig 
account for the average effect of the spot on array i for gene g. Essentially this is a 
“spot” effect, and may arise because there is not complete control over the amount 
and concentration of cDNA immobilized from one array to the next (Kerr et al.,
2000). All of these effects are generally not of interest, but account for sources of 
variation in microarray data.
ANOVA analysis of gene expression data revealed 47 genes up-regulated in 
the PrE2.8 cell line at 39°C and 52 genes down-regulated at this temperature 
(Table 2). Differential gene expression of a number of genes was confirmed by 
sequencing and RT-PCR (Figure 5-8). To understand the biological significance 
of overall changes in gene expression, the differentially expressed genes were 
categorised into functional groups (Figure 5-9).
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Table 2: List of differentially expressed genes detected by m icroarray 
analysis.
Up-regulated genes are shown in red, down-regulated in green.
CLONE ID GENE NAME P VALUE FOLD CHANGE
562729 S100 calcium-binding 
protein A8 (S100A8) 3.17E-51 16.020225
813614 Small proline-rich 
protein 1B (SPR1B) 1.14E-30 8.715104
119530 inward rectifier 
potassium channel 5.52E-27 7.668213
204335 brain mRNA 
homologous to 3'UTR 
of human 2.49E-23 6.697957
814798 Aldehyde 
dehydrogenase 6 
(ADH) 3.57E-23 6.657645
812965 V-myc avian 
myelocytomatosis 
viral oncogene 1.14E-16 5.088454
RTP/dDrq-1/NDRG1 4.24E-11 3.881768
729942 small proline rich 
protein II 7.97E-11 3.825207
2556976 tissue inhibitor of 
metalloproteinase 3 
(TIMP3) 5.09E-10 3.660203
188036 bullous 230 kDa 
pemphigoid antigen 
(BPAG1) 4.14E-09 3.475968
811096 Integrin beta-4 
subunit (INTB4) 8.54E-09 3.412956
810960 serine protease-like 
protease 1.25E-08 3.380107
244307 Plasminogen 
activator inhibitor,
1.03E-07 3.198071
417226 similar to gb:K02276 
myc proto-oncoqene 1.89E-07 3.14558
810131 Keratin 19 9.25E-07
840708 Superoxide 
dismutase 2, 
mitochondrial 1.24E-06 2.985414
489519 Tissue inhibitor of 
metalloproteinase 3 1.23E-05 2.791254
Keratin 10 1.75E-05 2.761044
868212 Transforming growth 
factor, beta-induced 2.17E-05 2.742902
757873 Cyclin-dependent 3.61 E-05
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kinase 5, regulatory 
subunit
590369 similar to gb:X12701
plasminogen
activator 5.62E-05 2.662983
345957 Cytostatin A (CSTA) 2.09E-04 2.552578
51865 Carbonic anhydrase 
II 2.16E-04 2.549545
841664 Caveolin, caveolae 
protein, 22kD 5.14E-04 2.47667
122428 Jun B proto­
oncogene (JunB) 5.59E-04 2.469739
161456 Serum amyloid A 
protein precursor 6.10E-04 2.462339
2266734 Laminin-5 beta3 
chain 6.22E-04 2.460694
Fos-related antigen 2 8.99E-04
415851 RhoE (ARHE) 1.54E-03 2.384366
814595 RACK-like protein 
PRKCBP1 1.69E-03 2.376335
460398 Small inducible 
cytokine A3 3.08E-03 2.325879
201727 B cell lymphoma 
protein 6 3.08E-03 2.325732
786067 M-phase inducer 
phosphatase 2 3.92E-03 2.305528
505225 Arg/Abl-interacting
protein
ArgBP2a ArgBP2a 5.50E-03 2.276827
298268 B-cell translocation 
gene 1, anti-prolif 
(BTG) 5.51 E-03 2.276684
51448 Activating
transcription factor 3 8.77E-03 2.237247
194214 TGIF protein 9.39E-03 2.231452
842820 inducible poly(A)- 
binding protein 1.29E-02 2.204303
Annexin I (lipocortin I) 1.36E-02
APEG-1 2.02E-02 2.166405
589362 Clusterin
(complement lysis 
inhibitor; t 2.20E-02 2.159021
Metallothionein 1L 2.77E-02
741497 Neutrophil
gelatinase-associated
lipocal 2.82E-02 2.137818
35185 Gamma-aminobutyric 
acid (GABA) A 
receptor 2.91 E-02 2.135053
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KIAA0303 3.09E-02 2.129965
KIAA0201 4.49E-02 2.097898
CLONE ID GENE NAME P VALUE FOLD
CHANGE
214006 Histone H2B/I (His) 2.34E-28 0.1242249
488964 Histone H2A.2 5.20E-26 0.1350787
52076 clone 23876 neuronal 
olfactomedin-related 1.80E-21 0.1605503
66317 Histone H1D 4.39E-16 0.2017631
970590 Ribosomal protein L37 8.05E-14 0.2243501
789091 Histone 2A-like protein (H2A/I) 1.58E-13 0.2275674
144834 E-MAP-115 1.92E-13 0.2285337
250654 SPARC/osteonectin 6.99E-13 0.2349687
781089 PTTG1 pituitary-tumour 
transforming gene 1.40E-11 0.2511353
815526 V-myb avian myeloblastosis viral 
oncogene 3.25E-11 0.2560321
342640 KIAA0101 (KIA) 2.08E-10 0.2674162
36393 T-complex protein 1, alpha 
subunit 6.65E-10 0.274979
769921 cyclin-selective ubiquitin carrier 
protein 1.33E-09 0.2796725
796694 effector cell protease receptor-1 
EPR-1 4.85E-09 0.2888255
129865 AURORA/IPL1-related kinase 1.18E-07 0.3138659
380797 putative RNA binding protein 
RNPL 1.86E-07 0.3177405
742132 Interferon-induced 17 KD Protein 2.25E-06 0.3407656
810142 Major histocompatibility complex, 
class 2.27E-06 0.3408335
365641 DNA primase polypeptide 1 
(49kD) 1.03E-05 0.3563402
530282 NADH dehydrogenase 1.46E-05 0.3601765
242578 tastin 3.68E-05 0.3705727
970591 High-mobility group (nonhistone 
chromoso 1.26E-04 0.385318
379920 Thymidine kinase 1, soluble 1.61E-04 0.3884757
796646 Ornithine decarboxylase 1 1.94E-04 0.3908095
978715 similar to gb:K00558 Tubulin 
alpha-1 CHA 2.02E-04 0.3913712
789204 translocation protein-1 2.39E-04 0.3935074
306358 Eukaryotic initiation factor 4A- 
LIKE NUK 3.62E-04 0.3989898
208161 _1 Tyrosine 3-
monooxygenase/tryptophan 5- 
mo 6.78E-04 0.4075865
878798 BETA-2-microglobulin precursor 1.28E-03 0.4166855
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755093 neuronal apoptosis inhibitory 
protein 1.54E-03 0.4193681
810142_1 Major histocompatibility complex, 
class 2.17E-03 0.4245433
753620 Insulin-like growth factor binding 
protein 3.00E-03 0.4295576
241826 non-histone chromosomal 
protein HMG-17 3.44E-03 0.4316979
39798 Serine hydroxymethyltransferase 4.59E-03 0.4362667
1476053 Replication protein A 7.77E-03 0.4449367
853906 MHC class I protein HLA-A 9.47E-03 0.4482777
843049 CDC21 Homologue 1.03E-02 0.4496614
783696 Ornithine aminotransferase 1.21E-02 0.4525226
471196 Weakly similar to putative 1.24E-02 0.4529436
856447 Gamma-interferon-inducible 
protein IP-30 1.35E-02 0.454435
815501 Laminin, beta 2 1.41E-02 0.4552018
796278 General transcription factor IIH, 
polype. 2.01 E-02 0.4615597
449058 roundabout 1 2.24E-02 0.4634822
630013 DNA repair protein MSH2. 2.68E-02 0.4667963
280507 Hypoxanthine
phosphoribosyltransferase 1. 2.74E-02 0.4672098
436121 Adrenal specific 30 KD protein 3.29E-02 0.470685
47681 putative splice factor 
transformer2-beta. 3.42E-02 0.4713933
839623 Neuroblastoma RAS viral (v-ras) 
oncogene. 3.45E-02 0.4715956
77805 Coatomer beta subunit 4.21 E-02 0.4753881
837923 putative ribulose-5-phosphate- 
epimerase. 4.27E-02 0.4756727
884766 Testis enhanced gene transcript. 4.31 E-02 0.4758585
760148 Uroporphyrinogen
decarboxylase. 4.33E-02 0.4759556
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Days at 39°C: 
1Kb 0 4 7 10
Days at 39°C: 
1Kb 0 4 7 10
S100A8
K S SPR1B
NDRG1
TIMP3
ITGB4
KLK10
Nexin/Serpine 1 a
CBX5
Histone 1 (H2bc
KIAA0101
AURORA/STK6
Tastin/TROAP
SPARC
GAPDH
BTG1
ALDH
BPA1/DST
CSTA
GAPDH
Figure 5-8: Expression of mRNA species in the PrE2.8 cell line cultured at 
33°C then transferred to 39°C and sampled over 10 days.
RT-PCR analysis was carried out for a range of target sequences identified in 
microarray experiments to be either (A) up-regulated or (B) down-regulated in 
PrE2.8 cells following incubation of the cell line at 33°C and then transferred to 
39°C for 4, 7 and 10 days. PCR products were resolved on 1.4% agarose gels.
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9%
11%
■ Cell structure/cytoskeleton
■ Transcription factor
□ Differentiation
□  Transport
■  Stress response
□  Tumour suppressor
■  Cell adhesion
□  Cell cycle
■  Metabolism
■  Kinases/phosphatases
□  Signal transduction
19%
(B)
11%
37%
■  DNA replication/proliferation
■  Cell structure/cytoskeleton
□  EST
□  Metabolism
■  Immune response
□  Transcription factor
■  DNA repair
13%
Figure 5-9: Pie charts of gene functional groups.
Differentially expressed genes were categorised into functional groups. The pie 
charts show the percentage of genes in each functional group for over-expressed 
(A) and under-expressed (B) genes.
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5.3 Discussion
The genetic reprogramming that brings about the differentiated phenotype in 
human prostate epithelial cells is likely to be extensive and complex. 
Differentiation of prostate epithelial cells remains a poorly defined process at the 
biochemical and molecular level; changes in signalling pathways, interaction with 
the extracellular matrix, metabolic process and apoptotic pathways remain only 
partially characterised. Hence understanding these events would enhance the 
knowledge of the mechanisms of maintenance of prostate epithelial cell 
homeostasis, as well as the pathogenesis of prostate tumourigenesis. Typically, 
differentiation of prostate epithelial cells is accompanied by the expression of 
prostate specific genes such as PSA, PAP and the androgen receptor. However, 
few other markers of differentiation in this cell type have been identified. 
Therefore, microarray technology in combination with the PrE2.8 cell line model 
system was used to gain additional insight into the genetic reprogramming that 
accompanies prostate epithelial cell maturation. Analysis of the microarray data 
revealed that 47 genes (0.8%) out of the 5,603 on the array, were statistically 
significantly up-regulated in the Pre2.8 cells when switched from 33°C to 39°C, 
and 52 genes (0.9%) were significantly down-regulated. To understand the 
biological significance of the overall changes in gene expression in the Pre2.8 
cells between the two growth temperatures, these genes were categorised into 
functional groups (Figure 5-9).
Of particular interest, analysis of the functional groups showed that a 
number of genes up-regulated in the PrE2.8 cells at 39°C, have been documented 
to play a role in cellular differentiation. The small proline-rich protein IB and the 
calcium binding protein S100A8 (discussed in chapter 6) were up-regulated 16- 
fold and 8.7-fold, respectively. Both genes are located on chromosome lq21 
within a gene complex designated the “epidermal differentiation complex”; genes 
within this chromosomal region are up-regulated during differentiation of 
keratinocytes (Mischke et al., 1996). An additional gene showing over-expression 
was Drg-1 (differentiation-related gene 1), up-regulated 3.8-fold in the PrE2.8 cell 
line at 39°C. The gene has been mapped to chromosome 8q24.2 and encodes a 
cytoplasmic 43 kDa protein. Drg-1 was also identified as a reducing and 
tunicamycin-resoponsive gene (RTP) (Kokame et al., 1996); (Sato et al., 1998) as
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well as an N-myc downstream-regulated gene 1 (NDRG1). van Belzen et al 
(1997) originally described Drg-1 to be expressed in normal colon cells at the 
terminal stage of differentiation, just preceding apoptosis and shedding of cells in 
the colon lumen (van Belzen et al., 1997). Drg-1 is expressed predominantly in 
epithelial cells and by most organ systems including the digestive tract, immune, 
reproductive, and urinary systems with the kidney, and in particular the prostate 
and ovary exhibiting the highest levels (Lachat et al., 2002). Although, cellular 
expression of Drg-1 has been found to be mainly cytoplasmic, a strong association 
with the plasma membrane has also been noted, predominantly adjacent to 
adherens junctions and desmosomes, whilst in other epithelia, such as the 
prostate, predominant nuclear staining has been detected. Also, in the prostate 
Drg-1 has been shown to be expressed mainly by luminal epithelial cells (Lachat 
et al., 2002), consistent with reports that this is a differentiation-related gene. 
Furthermore, over-expression of Drg-1 has been reported in a variety of cancers, 
including prostate, breast, lung, brain, liver and renal cancers (Cangul et al., 
2002). However, the exact biological function of Drg-1 remains obscure and 
further studies of its expression in normal and aberrant prostate epithelial cell 
differentiation will help elucidate its role in differentiation and as a marker of this 
process.
The up-regulation of differentiation-related genes in the PrE2.8 cell line was 
accompanied by a concomitant decrease in genes involved in DNA replication 
and repair. Genes involved in chromatin assembly were down-regulated including 
the histones H2A, H2B and HID. Similarly, and consistent with DNA repair 
being most active in rapidly proliferating cells, DNA repair genes, such as DNA 
repair protein MSH2. Genes with a role in DNA synthesis and replication 
included DNA primase polypeptide 1 and replication protein A.
An additional functional category that showed significant enrichment at 
39°C in the PrE2.8 cell model were genes involved in maintaining cell structure 
and cytoskeleton. Genes up-regulated included keratin 19 and keratin 10. This is 
consistent with observations that in the epidermis, keratin 10 expression is 
associated with the loss of proliferative capacity and the onset o f terminal 
differentiation (Kartasova et al., 1992). In addition, keratin 19 has been implicated 
in the differentiation of a number of epithelial cell types, such as oral epithelium 
and mammary gland ducts (Stasiak et al., 1989). In the prostate, (Hudson et al.,
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2001) identified a sub-population of keratin 14-negative basal epithelial cells 
which expressed keratin 19 and continued expression into the luminal layer. It 
was therefore postulated that keratin 19 may be a potential marker for the 
amplifying non-stem-cell basal population. Genes active in extracellular matrix 
(ECM) formation were also up-regulated. Differentiating epithelium must adhere 
to the newly synthesized basal lamina, components of the ECM, in order to 
establish polarity (Streuli, 1999). Interactions between epithelial cells and the 
ECM are crucial for biological processes such as cell migration, proliferation and 
differentiation. In line with this, microarray analysis revealed the up-regulation of 
tissue inhibitor of matrix metalloproteinase 3 (TIMP-3), integrin beta-4 subunit and 
laminin 5(33 in the PrE2.8 cells at 39°C. TIMP-3 binds to the ECM and it has also 
been reported to initiate apoptosis. In addition, laminin 5-mediated activation of 
a3|31 integrins has been reported as a key step in the differentiation process of 
colon epithelial cells (Gout et al., 2001). These results suggest that increased 
expression of ECM-associated genes is a feature of prostate epithelial cell 
differentiation.
The study of normal prostate epithelial cell differentiation has been hindered 
by a lack of model systems. However, the PrE2.8 cell line may provide a suitable 
and highly informative alternative for such studies. Furthermore, organization of 
the microarray data into functional groups enabled changes in biological 
processes to be more clearly visualized. This approach revealed that prostate 
epithelial cell differentiation is likely a highly organized and complex process. 
Elucidating the role of the signal transduction molecules and transcription factors 
triggering such events may reveal the pathways driving these reprogramming 
events. The challenge of future studies will be to dissect the contribution of these 
individual pathways and their interaction to the overall maturation program.
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6 Ex p r e s s io n  o f  S 100A 8 in 
P r e 2.8 c e l ls  a n d  prostate  
TISSUE
6.1 Introduction
The S I00 proteins comprise a family of 20 low molecular weight (9-13 kDa) 
proteins that share a common structure defined in part by the Ca2+-binding EF- 
hand motif. Thirteen S100 proteins (S100A2-A4, S100A6-A12, S100A15, S100B 
and SI OOP) are located within the epidermal differentiation complex, on human 
chromosome lq21, so called due to the involvement of genes in this region in the 
differentiation of basal keratinocytes (Mischke et al., 1996). Within cells, most 
S I00 proteins exist as homodimers, however, some form heterodimers, as is the 
case with the S100A1/S100B, S100A8/S100A9, S100B/S100A6, 
S100A1/S100A4 and the S100B/S100A11 dimers (Deloulme et al., 2000; Hunter 
and Chazin, 1998; Isobe et al., 1981; Propper et al., 1999; Tarabykina et al., 2000; 
Wang et al., 2000; Yang et al., 1999a). Upon calcium binding, they interact with 
target proteins to regulate cell function.
The S100 proteins are expressed in a discriminate fashion in specific cells 
and tissues, and act intracellularly as Ca2+-signalling or Ca2+-buffering proteins. 
However, the most unusual characteristic of certain S I00 proteins is their 
occurrence in the extracellular space. Several S100 proteins, such as S100B, 
S100A4, S100A8, S100A9, S100A12 and S100A13, are secreted and act in a 
cytokine-like manner. For example, the S100A8/A9 heterodimer acts as a 
chemotactic molecule in inflammation (Newton and Hogg, 1998), S100B exhibits 
neurotrophic activity (Huttunen et al., 2000) and S100A4 has angiogenic effects 
(Ambartsumian et al., 2001). A multiligand receptor mediating the extracellular 
activities of S100 proteins was recently identified; S100B binds to the 
extracellular domain of the receptor for advanced glycation end products (RAGE)
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and activates different intracellular signalling pathways, including MAP-kinase or 
NFkB (Arumugam et al., 2004; Hoffmann et al., 1999; Hsieh et al., 2003; Sorci et 
al., 2003). In addition to Ca2+, many S100 proteins display high affinities towards 
Zn2+ and Cu2+ ions, which could influence their activity in the extracellular space.
Whilst the exact functions of the S I00 protein family remain to be 
characterised, these proteins have been implicated in a number of processes such 
as the immune response, differentiation, cytoskeleton dynamics, enzyme activity, 
Ca2+ homeostasis, growth and cancer. Observations of alterations in SI00 protein 
expression both within primary and metastatic disease are suggestive of a 
potential marker of diagnostic and prognostic outcome (Diederichs et al., 2004).
Expression of S100A8 and S100A9 has been observed in neutrophils, 
activated macrophages and endothelial cells, in the epidermis, particularly in the 
course of psoriasis, and also in malignant disorders as well as in inflammatory 
brain diseases and Alzheimer’s disease (Akiyama et al., 1994; Kerkhoff et al., 
1998; Passey et al., 1999; Postler et al., 1997). The S100A8/ S100A9 complex 
has been found in sera from patients with cystic fibrosis, rheumatoid arthritis, and 
chronic bronchitis as well as at sites of acute inflammation (Kerkhoff et al., 1998; 
Passey et al., 1999). During the inflammatory process, the S100A8/S100A9 
heterodimer may be involved in leukocyte trafficking through the transport of 
arachidonic acid to target cells (Kerkhoff et al., 1999).
S100A8 and S100A9 expression has also been reported in monocytes during 
the early stages of differentiation (Lagasse and Clerc, 1988) and in infiltrating 
monocytes, but not in resident tissue macrophages (Zwadlo et al., 1988). This 
suggests that the expression of S100A8 and S100A9 and the formation of the 
S100A8/S100A9 complex are related to a definite functional stage of 
macrophages and participate in the inflammatory response. In addition, deletion 
of the S100A8 gene results in embryo resorption by day 9.5 post-coitum in 100% 
of homozygous null embryos (Passey et al., 1999). These observations indicate 
that S100A8 has a role in the prevention of maternal rejection of the implanting 
embryo, and also of protecting the embryo from immune attack by maternal cells.
Microarray analysis of gene expression levels in the PrE2.8 conditionally 
immortalised cell line revealed that the calcium binding protein S100A8 was 
over-expressed 16-fold at 39°C, when the cells appear to undergo changes
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consistent with differentiation, compared with 33° C when the cells are 
predominantly proliferating. The small proline-rich protein IB (SPR1B) was also 
over-expressed by the PrE2.8 cells (8.7-fold). However, due to the lack of 
availability of an antibody targeting SPR1B, we chose to concentrate on further 
investigating the gene and protein expression levels of S100A8 in the PrE2.8 cell 
line, as well as its distribution in human prostate tissue.
6.2 Results
6.2.1 Expression of S100A8 in PrE2.8 cells
Microarray analysis of gene expression in the PrE2.8 cell line revealed that the 
small proline-rich protein IB (SPR1B) and the Ca2+-binding protein S100A8 were 
significantly over-expressed in cells cultured at 39°C compared with 33°C. The 
differences in S100A8 and SPR1B gene expression levels were confirmed by 
semi-quantitative RT-PCR. PrE2.8 cells were incubated at growth temperatures 
of either 33°C or 39°C for periods of up to 4, 7, 10 or 14 days; RNA was then 
extracted at the time points indicated. Following reverse transcription of total 
RNA isolated from the PrE2.8 cells, the amplified PCR products were 
electrophoresed on a 1.5% agarose gel as shown in Figure 6-1. PCR products 
revealed bands corresponding to S100A8 and SPR1B, respectively, expressed at 
39°C. In comparison, very weak or no expression was observed in PrE2.8 cells 
cultured at 33°C throughout the time-course whereas strongly elevated levels of 
S100A8 and SPR1B gene expression were observed at 39°C at all time points 
examined i.e. 4-14 days. In light of these observations, S100A8 expression in both 
the PrE2.8 cells and in prostate tissue was further examined.
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Days at 39'C:
1kb 0 4 7 10 14
S100A8
SPR1B
_____________________________________ GAPDH
Figure 6-1: RT PCR analysis of S100A8 and SPR1B in PrE2.8 cells.
RT PCR was performed using 25-35 cycles on reverse transcribed mRNA from 
PrE2.8 cells incubated at 33°C or 39°C after 4, 7, 10 and 14 days of culture. PCR 
products were resolved on a 1.5% agarose gel. Amplifications are shown for 
S100A8 and SPR1B. GAPDH was used as a control.
6.2.2 S100A8 protein expression in PrE2.8 cells
Immunohistochemistry was used to investigate the protein expression and 
distribution of S100A8 in PrE2.8 cells. At 33°C, when the PrE2.8 cells are mainly 
proliferating, very weak or no expression of S100A8 was observed. However, 
when the cells were switched to the non-permissive temperature of 39°C, 
^  cytoplasmic staining of S100A8 protein was observed in 100% of PrE2.8 cells 
(Figure 6-2), indicating that S100A8 may be involved in the differentiation 
process of human prostate epithelial cells. It is well documented that S100A8 and 
S100A9 exist as a heterodimer in many cell types. The expression of the 
S100A8/S100A9 complex was therefore also investigated in the PrE2.8 cells. 
However, at both the permissive (33°C) and non-permissive temperature (39°C), 
no S100A8/S100A9 expression was detected in these cells. The absence of 
positive staining towards the S100A8/S100A9 complex may be due to the fact
117
6 Expression of S100A8 in Pre2.8 cells and prostate tissue
that in human prostate epithelial cells, S100A8 does not form a heterodimer 
complex with S100A9, or that the latter protein is not expressed at all in human 
prostate epithelial cells.
-p
Figure 6-2: Immunocytochemistry of S100A8 protein in PrE2.8 cells.
S100A8 protein was detected in the PrE2.8 cell line using immunocytochemistry. 
Cells were incubated at 33°C or 39°C for 4 days. S100A8 protein was weakly 
expressed in a small number of cells at 33°C (A) whereas moderate to strong 
positive staining (brown) was observed in almost all cells at 39°C (B).
S100A8 protein expression was further investigated in the PrE2.8 cells 
using Western blot analysis. Cell extracts of PrE2.8 cells were cultured at 33°C or 
39°C for periods of up to 4, 7, 10 or 14 days were resolved on SDS-PAGE gels, 
transferred to Immobilin P membrane and probed with anti-S100A8 antibody. 
Equal amounts of protein (estimated to be 30 pg) were loaded in all lanes. Under 
the conditions employed in this study, a band that would signify the presence of 
S100A8 protein was not apparent in extracts of the PrE2.8 cells cultured at 33°C, 
thus agreeing with the above observations of little or no gene expression under 
these conditions. However, in PrE2.8 cells cultured at 39°C protein expression 
4evels increased progressively in a time-related fashion resulting ultimately in the 
observation that protein extracts obtained following 14-day culture exhibited the 
most abundant SI00A8 levels, as indicated by the 8 kDa band (Figure 6-3).
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Days at 39°C:
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Figure 6-3: S100A8 protein expression in PrE2.8 cells.
Western blotting analysis of S100A8 protein in PrE2.8 cells grown at 33°C and 
39°C. No protein expression is detected at 33°C or 39°C at day 4. However, by 
day 7, S100A8 is strongly expressed, with days 10 and 14 showing the most 
abundant expression, p-actin was used as a control.
6.2.3 S100A8 protein expression in prostate tissue
Paraffin embedded samples were obtained from patients undergoing transurethral 
resection of the prostate. Eight BPH samples and seven from patients suffering 
from prostate cancer were stained for S100A8 and the sections were analysed for 
staining distribution. Examples are shown in Figure 6-4 and Figure 6-5. All the 
BPH and benign regions of cancer samples analysed in this study were observed 
to exhibit some positive staining for S100A8. A staining pattern whereby protein 
expression appeared to be restricted to the secretory luminal cells of the prostate 
gland was apparent (Figure 6-4, A). This was further characterised by the 
observation that the strongest expression occurred at the outer luminal tips of the 
luminal cells (Figure 6-4, B). From these observations in these tissue samples, 
one could surmise that the intracellular protein is packaged into vesicles prior to 
being secreted into the glandular lumen. In support of this idea are the 
observations of a very dense S100A8 staining pattern in the lumen of several acini 
(Figure 6-4, B, C). This suggests that the S100A8 protein is secreted into the 
lumen of the prostate gland. Although positive staining was observed in luminal 
cells, the basal cells and stroma of the corresponding prostate tissues were 
consistently negative for S100A8 protein.
S100A8 protein expression was significantly reduced in the tumour samples 
examined with the majority of tissues being negative for S100A8. However, 
occasional positive staining was observed in a small number of epithelial cells 
(Figure 6-5, (a)). Interestingly, despite negative staining in tumours, strong 
positive staining was observed in cells of blood vessels within cancerous areas as
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well as in occasional cells within the tumour region, which may represent 
infiltrating monocytes. These observations are consistent with reports of S100A8 
and S100A9 expression in infiltrating monocytes, but not in resident tissue 
macrophages (Zwadlo et al., 1988).
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Figure 6-4: Immunocytochemistry of S100A8 protein in prostate tissue.
Paraffin-embedded prostate tissue from patients with BPH was stained for 
S100A8 protein. Positive staining is shown in brown. Cytoplasmic staining was 
observed which was restricted to the luminal cells (A). Expression was most 
abundant in the outer luminal tips of the luminal cells (B). A dense staining 
pattern was also observed in the lumen of several acini (B, C). D shows the 
negative control.
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Figure 6-5: Immunocytochemistry of S100A8 protein in prostate tumour 
tissue.
Paraffin-embedded prostate tumour tissue was stained for S100A8 protein. 
Positive staining is shown in brown. The majority of tumour samples were 
negative for S100A8. However, occasional staining was observed a small number 
of glands (a). In addition, S100A8 protein was detected in cells within blood 
vessels as well as in occasional cells within tumours (b).
6.3 Discussion
The distribution and expression levels of the calcium binding protein S100A8 in 
the PrE2.8 cell line and in human prostate tissue were investigated. Microarray 
analysis and RT-PCR revealed that S100A8 is expressed at very low levels in the 
PrE2.8 cells at the proliferative temperature of 33°C. However, at 39°C, when the 
PrE2.8 cells appear to be undergoing changes consistent with cellular 
differentiation, S100A8 gene expression is elevated 16-fold. This was further 
characterised at the protein level where immunohistochemical analysis 
demonstrated that S100A8 protein is expressed very weakly or not at all in the 
majority of PrE2.8 cells at 33°C; at 39°C, all PrE2.8 cells strongly express 
S100A8 protein. Consistent with the immunohistological findings, immunoblot 
-detection of S100A8 revealed minimal expression at 33°C, but elevated 
expression was observed in the PrE2.8 cells at 39°C cultured over the time course 
of 4-14 days. These results are suggestive of a role of S100A8 during the process 
of human prostate epithelial cell differentiation.
The presence of S100A8 within the cluster of genes known as the epidermal 
differentiation complex on chromosome lq21, further supports this hypothesis. 
This Chromosomal band consists of three gene families involved in terminal 
differentiation of the human epidermis. They encode precursor proteins of the
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comified cell envelope, including SPR1B, intermediate filament-associated 
proteins and thirteen members of the SI00 family (Mischke et al., 1996). SPR1B 
belongs to a family of small proline-rich (SPR) proteins consisting of two SPR1 
genes (SPR1A and -IB ), seven SPR2 genes (SPR2A to -2F) and one SPR3 gene, 
all located on chromosome lq21 within the epidermal differentiation complex 
(Mischke et a l , 1999). In this study, SPR IB was over-expressed 8.7-fold by the 
PrE2.8 cells at 39°C. The SPR genes are cross-bridging, structural proteins 
involved in the comification of the cell envelope, a structure synthesized at late 
stages of keratinocyte differentiation, of stratified squamous epithelia (Cabral et 
al., 2001; Steinert, 1998). Despite few reports in the literature regarding the 
expression and possible functions of SPR IB, expression has also been reported in 
non-squamous cells such as mammary epithelium (Anisowicz et al., 1999), 
Chinese hamster ovary (Tesfaigzi and Carlson, 1996) and smooth muscle cells 
(Koizumi et al., 1996), suggestive of a role other than cell comification. For 
example, in the breast, SPR IB is expressed in normal epithelium but expression is 
down-regulated or inactivated in breast tumours. Interestingly, SPR IB expression 
in breast tumours could be re-activated by phorbol 12-myristate 13-acetate (PMA) 
or UV irradiation via a transcriptional mechanism, suggesting SPR IB and its 
downstream targets may be useful for therapeutic manipulation in these cancers 
(Anisowicz et al., 1999).
The expression and possible functions of the S I00 proteins have been more 
extensively studied. For example, in normal epidermis, S100A8 and S100A9 have 
been reported to be expressed at low levels, however in psoriatic tissue, both 
proteins are expressed at high levels (Broome et al., 2003). Also, in the psoratic 
epidermis, both proteins are expressed at the plasma membrane, consistent with 
the idea that some SI00 proteins may be secreted (Katz and Taichman, 1999). The 
expression pattern of S100A8 in BPH tissue samples in this study showed the 
protein is restricted to the luminal cells of the prostate epithelium, with the 
strongest expression being observed at the tips of the luminal cells. This suggests 
that the intracellular protein may be packaged into vesicles prior to being secreted 
into the glandular lumen. In support of this idea are the observations of a very 
dense S100A8 staining pattern in the lumen of several acini. This further suggests 
that the S100A8 protein is secreted into the lumen of the prostate gland. This is
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consistent with reports that several SI00 proteins, including S100A8, are secreted 
into the extracellular space where they have further effects on target proteins 
(Marenholz et al., 2004). For example, in the form of an S100A8/S100A9 
complex, the protein propagates inflammation and enhances CD1 lb expression in 
human monocytes through the targeting of arachidonic acid to inflammatory cells. 
The non-oxidised S100A8 homodimer has been reported as a potent chemotactic 
agent for leukocytes by binding to heparan sulphate glycosaminoglycans on 
endothelial cells. The extracellular S1000A8/S100A9 heterodimer has also been 
reported to inhibit immature monomyelocytic HL-60 cell proliferation and 
mitogen-stimulated lymphocyte proliferation, and to have cytostatic activity 
towards bacteria and fungi (Donato, 2003).
Several members of the SI00 family have also been implicated to play a 
role in certain tumour types. For example, S100A4 expression has been reported 
in several cancers such as breast (Nikitenko et al., 2000), lung, (Takenaga et al., 
1997), gastric (Yonemura et al., 2000), medulloblastoma (Heman et al., 2003), 
prostate (Gupta et al., 2003) and bladder (Davies et al., 2002). More specifically, 
S100A4 has been suggested to play a role in tumour invasion. This hypothesis is 
supported by studies in which inhibition of the S100A4 gene by antisense RNA in 
a highly metastatic cell line, resulted in a decrease in cell motility and 
invasiveness in vitro (Takenaga et al., 1997). S100A4 is thought to exert its 
tumour-promoting activity through the inhibition of p53 (Grigorian et al., 2001). 
S100A7 has also been found to be expressed in tumours such as squamous cell 
carcinoma (Alowami et al., 2003), melanoma (Brouard et al., 2002), gastric 
cancer (El-Rifai et al., 2002) and breast cancer (Enerback et al., 2002). In breast 
cancer, S100A7 is predominantly expressed in the pre-invasive component of 
primary breast cancer (Enerback et al., 2002) and is one of the most abundantly 
expressed genes in ductal carcinoma in situ (Leygue et al., 1996). Furthermore, 
the S100A7 protein product has been found to be nuclear and cytoplasmic as well 
as being secreted in breast tumours (Al-Haddad et al., 1999). S100A2 on the other 
hand is typically down-regulated in carcinomas compared with normal tissues. 
This expression profile has been observed in breast (Ilg et al., 1996), prostate 
(Gupta et al., 2003) and lung tumours (Feng et al., 2001). It has therefore been 
hypothesized that S100A2 may be a tumour suppressor and down-regulation of 
the gene is thought to occur primarily via hypermethylation of the promoter at
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CpG sites (Wicki et al., 1997). Interestingly, re-expression of S100A2 in head and 
neck squamous cell carcinoma lines was reported to exert an inhibitory influence 
on cell motility, possibly via an effect on the polymerisation/depolymerisation 
dynamics of the actin microfilamentary cytoskeleton (Nagy et al., 2001).
However, there is sparse information with regards to the role of S100A8 and 
cancer. Nonetheless, recent reports indicate that S100A8 and S100A9 are over­
expressed in gastric cancer (El-Rifai et al., 2002), skin carcinogenesis (Gebhardt 
et al., 2002) and at the invasive margin of colorectal carcinoma (Stulik et al., 
1999). It remains to be elucidated whether S100A8, or indeed SPR1B, may also 
play a role, not only in normal epithelial differentiation in the prostate, but also in 
the aberrant differentiation observed in prostate carcinoma.
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7 D is c u s s io n
7.1 Summary
The identification of markers that would point to the early development and 
progression of invasive adenocarcinoma of the prostate remains an important 
challenge. This project set out to identify markers associated with the early steps 
in prostate epithelial cell differentiation using the PrE2.8 cell line as a model 
system. Such markers might improve the understanding of the aetiology of BPH 
and prostate cancer. It is believed that in most tissues or organs, stem cells are a 
rare sub-population of the total cells. Stem cells possess a much greater capacity 
for proliferation than other cells, give rise to other cell types within that tissue and 
are responsible for maintaining regenerative capacity. There is also a hypothesis 
that either aberrant stem cells or cells that acquire stem-cell-like characteristics, 
give rise to cancer (Al-Hajj and Clarke, 2004; Fiala, 1968; Reya et al., 2001). 
However, changes occurring in cells and signalling pathways further along the 
differentiation process could also give rise to BPH and/or prostate cancer. This 
study has identified a number of genes that are associated with epithelial cell 
differentiation. These genes may provide valuable targets for future therapies 
aimed at inhibiting aberrant cellular proliferation and inducing cellular 
differentiation.
7.2 The use of cell lines in prostate disease research
Immortalised cell lines represent a valuable tool in scientific research and possess 
advantages when compared to the use of primary cells. Primary prostate cells are 
limited in their lifespan and display characteristics that may differ from batch to 
batch based on differing genotype and/or phenotype due to their different original 
donors. Although the important need to examine and elucidate mechanisms in real 
cells is unquestioned, one is also reliant on a continuous supply of fresh tissues. 
Overcoming such limitations would require that enormous numbers of tissue 
samples need to be obtained from large cohorts of individuals. This approach
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would be required to overcome the problems of limited primary-cell lifespan and 
inter-individual variation. These limitations would in all probability make the 
identification of underlying biological mechanism(s) much more difficult to 
ascertain and/or delineate. Some of these limitations can be overcome by the use 
of immortalised cell lines since they exhibit an infinite capacity to proliferate in 
culture, allowing them to be well characterised. However, cell lines also have 
disadvantages. With increasing time in culture, such cells often acquire 
progressive changes due to an accumulation of genomic alterations. It is therefore 
necessary to monitor these changes and to use cell lines, where possible, within a 
number of passages to limit these changes.
From the mid-1970s, many groups have established immortalised prostate 
epithelial-cell lines. The most widely used prostate cancer cell lines PC3 (Kaighn 
et al., 1978), LNCaP (Horoszewicz et al., 1980) and DU145 (Stone et a l , 1977) 
exhibit an advanced cancer phenotype and were all derived from metastases. In 
recent times, efforts have been made to develop a more representative cell model 
for experimental studies aimed towards understanding prostatic disease states, 
including the immortalisation of human prostate epithelial cells by expression of 
c-Myc (Gil et al., 2005). Although these newer cell lines provide useful tools for 
identifying genes that may play a role in carcinogenesis, many of these represent 
cells with either a secretory luminal or non-secretory intermediate luminal 
phenotype. The relevance of such a terminally differentiated phenotype to explore 
mechanisms of carcinogenesis may be questionable. Hitherto, appropriate in vitro 
cell models of prostate growth and differentiation that would allow for the 
identification of lineage-specific markers have not existed.
7.3 The PrE2.8 cell line as a model of differentiation
Derived from BPH tissue, the PrE2.8 epithelial-cell line was immortalised by 
transfection with a temperature-sensitive SV40 large T-antigen construct. Thus, at 
a permissive temperature of 33°C, these cells proliferate whereas at 39°C, the cells 
cease to proliferate and apparently undergo prostate epithelial-cell differentiation. 
Their growth characteristics have similarities to those of primary cultures in that 
at 33°C they appear as tightly-packed colonies while at 39°C, PrE2.8 cells become 
less dense and increase in size. Keratin-staining profiles have been used to
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correlate such morphological changes with differentiation. The observation of a 
down-regulation of K14 compared to increases in the expression of cell 
differentiation-associated markers, including K8/K17/K19, p2lWafl/Cipl and PSCA 
in cells grown at the non-permissive temperature point to the usefulness of this 
cell line. The up-regulation of PSCA is of particular interest since it is a prostate- 
specific cell surface antigen and has been shown to be a marker of an intermediate 
sub-population of transit amplifying cells (Tran et al., 2002). This observation 
lends further support to the PrE2.8 cell line as a model system of the early stages 
of prostate epithelial cell differentiation. The lack of further prostate-specific 
differentiation markers in these cells, such as AR and PSA, is therefore not 
surprising since almost all tissue-specific differentiation markers are expressed in 
terminally differentiated cells. Thus, PrE2.8 cells provide a relatively reproducible 
tool to examine previously unidentified lineage-specific markers in cells isolated 
from prostate tissue itself. The objective of this project was to identify the 
differences in gene expression between PrE2.8 cells cultured at 33°C (a 
proliferative basal cell phenotype) and 39°C (a differentiated phenotype).
7.4 Expression analysis
Initial investigations used differential display to investigate differences in gene 
expression. This method was applied to RNA transcripts isolated from PrE2.8 
cells cultured at either 33°C or 39°C. From a panel of 25 potential genes, three 
candidates were subsequently verified using semi-quantitative RT-PCR. Of these 
three candidate genes, two (calcium-binding protein S100A8 and small proline- 
rich protein IB (SPRIB)) were up-regulated and one (cyclooxygenase-2 (COX- 
2)) was down-regulated in the PrE2.8 cells at 33°C. The genes encoding S100A8 
and SPR IB are located on chromosome lq21 in a region termed the epidermal 
differentiation complex (EDC) (Marenholz et al., 1996). Interestingly, both genes 
are up-regulated during differentiation of keratinocytes. On the other hand, COX- 
2 has been shown to be involved in the catalytic conversion of arachidonic acid to 
prostaglandins and is over-expressed in a variety of tumours including bladder, 
colorectal, breast and prostate cancers (Eltze et al., 2005; Kundu et al., 2001; 
Srinath et al., 2003; Wu et al., 2004). Whilst this candidate gene does not 
represent a novel marker of epithelial-cell differentiation, the observation that this
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tumour progression-associated marker is down-regulated in the PrE2.8 
differentiated phenotype, provides evidence supporting the concept that PrE2.8 
cells differentiate at 39°C. Although differential display identified some candidate 
genes for further investigation, this method is limited by the high proportion of 
false positives that subsequently have to be eliminated using RT-PCR.
To identify additional markers of prostate epithelial cell differentiation, the 
more recently developed technology of microarray analysis was applied. Using 
this approach, several genes were found to be either up-regulated (n=47) or down- 
regulated (n=52) in this PrE2.8 model of cell differentiation. To facilitate 
mechanistic analysis, these genes were grouped according to function (Figure 5- 
9). Interestingly, several genes previously associated with cellular differentiation 
were identified to be up-regulated in the cells grown at 39°C, including S100A8 
and SPR1B. In addition, the gene, Drg-1 (differentiation-related gene 1), 
originally described to be expressed in normal colon cells at the terminal stage of 
differentiation, just preceding apoptosis and shedding of cells in the colon lumen 
(van Belzen et al., 1997), was also up-regulated.
S100A8 and SPR1B are located on chromosome lq21 in a region 
designated the EDC (Marenholz et a l , 1996). This 2 Mb region consists of three 
gene families: the first family consists of thirteen genes, involucrin, loricrin and 
the three classes of small proline-rich (SPR) proteins comprising two SPR1 genes, 
eight SPR2 genes and one SPR3 gene. They encode structural proteins of the 
comified cell envelope in the human epidermis (Eckert and Green, 1986; Gibbs et 
al., 1993; Kartasova et al., 1988; Yoneda et al., 1992), providing the skin with a 
protective barrier against dehydration and other environmental factors (Roop, 
1995; Simon et al., 1994). The second gene family of the EDC consists of 
profilaggrin and trichohyalin. These genes encode intermediate filament- 
associated proteins that are synthesized in the granular layer of the epidermis and 
conjoin with the keratin filaments during comification (Fietz et al., 1992; 
McKinley-Grant et al., 1989). The third gene family of the EDC consists of the 
S I00 family of small calcium-binding proteins (Mischke et al., 1996). It was 
initially suggested that these genes are likely to be involved in signal transduction 
and cell cycle progression (Kligman and Hilt, 1988). Several functional roles for 
the S100A genes have since been proposed as discussed in Chapter 6. 
Interestingly, it has been shown that the SI00A genes begin to be expressed at an
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early stage of keratinocyte differentiation, while expression of the cornified 
precursors begins later in differentiation (Mischke, 1998). The expression of 
S100A8, and indeed SPR1B, in the PrE2.8 cells at 39°C suggests that members of 
the EDC may also be involved in the early stages of prostate epithelial cell 
differentiation. These observations lend further support for the PrE2.8 cells as a 
model for the study of early changes in gene expression during prostate epithelial 
cell differentiation. In addition, it has been suggested that due to the co­
localisation of these functionally and structurally related genes in the EDC, and 
their co-ordinated expression during epidermal differentiation, these gene families 
may be subject to coordinated transcriptional control mechanism (Mischke, 1998; 
Zhao and Elder, 1997). Further investigation of the transcription factors identified 
in this study through microarray analysis, and their possible involvement in the 
control of S100A8 expression may shed light onto the pathways/mechanisms 
involved in prostate epithelial cell differentiation; these pathways may be 
deregulated during BPH and prostate cancer and represent an avenue of 
investigation into the initiation of these disease processes.
More recently, S100A8 and S100A9 have been shown to be up-regulated in 
prostate cancer (Hermani et al., 2005). The expression of S100A8 and A9 
appeared to be significantly increased in adenocarcinoma compared with 
surrounding benign prostatic tissue, with increased expression of the S100 
proteins in high-grade compared with low-grade tumours. In addition, positive 
staining of the SI00 proteins was observed in prostatic intraepithelial neoplasias 
(Hermani et al., 2005). These findings are in contrast to the present study 
however, where, as shown in Chapter 6, the expression of S100A8 was markedly 
reduced in the prostate cancer specimens examined compared with benign 
prostatic tissue, and S100A9 was not detected. Hermani et al (2005) also 
observed expression of SI00A8 and A9 in basal cells of benign prostate tissue and 
in luminal cells of adenocarcinoma. Again, this is in contrast to the present study 
(Chapter 6) where positive S100A8 staining was seen in the luminal cells of 
benign prostatic epithelium. These discrepancies, however, may be due to the fact 
that different antibodies were used in both studies; re-examination of the 
expression pattern of S100A8 and A9 using a panel of anti-S100A8/A9 antibodies 
will need to be carried out in order to resolve such discrepancies. Interestingly, 
Hermani et al (2005) found significantly increased concentrations of S100A9 in
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the serum of cancer patients compared with the serum of patients with BPH and 
healthy individuals, suggesting that this protein may also represent a novel marker 
for the diagnosis of prostate cancer. It is intriguing that S100A8 was not detected, 
particularly in light of observations in the present study that suggest that S100A8 
may also be secreted into the serum. The intense staining patterns of S100A8 in 
secretory luminal cells, in particular, in the outer luminal tips, together with a very 
dense S100A8 staining pattern in the lumen of several acini, suggest that S100A8 
may also be secreted. Examination of S100A8 in the serum of healthy subjects 
compared with that of patients with BPH and prostate cancer could, if shown, 
represent an additional prognostic/diagnostic marker.
In this study, a candidate gene approach was also employed in order to 
further investigate the PrE2.8 cell line as a model of prostate epithelial cell 
differentiation. Among the genes investigated, CD44 revealed an intriguing 
pattern of gene expression in the PrE2.8 cells. Depending on whether the 
proliferative or non-proliferative phenotype was being examined, an interesting 
pattern of alternatively spliced isoforms was observed. CD44 expression was 
therefore further investigated in this model system.
CD44 is a transmembrane glycoprotein that is widely expressed in virtually 
all cell types. It functions as an extracellular matrix receptor and is involved in 
cell-cell and cell-matrix interactions. CD44 may also participate in growth 
regulation by presenting growth factors to their cell surface receptors (Lesley et 
al., 1993). The CD44 protein is encoded by a single gene that consists of 20 
exons, located on chromosome l ip  13. However, through extensive alternative 
splicing of exons 6-14 (also referred to as exons v2-vl0), the extracellular 
membrane domain is highly variable, producing multiple protein isoforms that are 
expressed in a tissue-specific manner (Screaton et al., 1992; Tolg et al., 1993). It 
was found that an alternatively spliced CD44 v2-vl0 isoform was expressed 
specifically in a subset of basal cells, many of which were negative for keratin 14, 
a marker for the least differentiated basal cells. This v5-containing isoform was 
also observed in epithelial cells that are situated just above the basal layer and 
below the luminal layer. This observation is suggestive that the v5-positive cells 
may be in the process of differentiation from the basal to the luminal layer. It has 
previously been shown that this cell type also stains positive for keratin 19. It has 
been postulated that these cells represent an epithelial cell population in the
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process of differentiation from the stem cell compartment to the terminally 
differentiated luminal cell layer (Hudson et al., 2001). Further investigation of the 
CD44 v2-vl0 isoform in a larger panel of prostate tissue, normal as well as 
cancer, will reveal whether this variant is specifically expressed in normal 
prostate epithelial cell differentiation. More importantly, the CD44 v2-vl0 
isoform represents a putative marker of the transit amplifying (TA) population of 
prostate epithelial cells and as it is expressed at the cell surface, represents a 
valuable tool for the isolation and separation of TA cells from stem cells and fully 
differentiated luminal cells.
7.5 Further work
The discoveries uncovered in this project have revealed a number of avenues to be 
further investigated in order to evaluate putative genes, and pathways, involved in 
the control of human prostate epithelial cell differentiation. Microarray analysis 
revealed a number of genes up-regulated in the PrE2.8 cell line at 39°C when the 
cells appear to undergo changes consistent with early differentiation. Further 
investigation of these gene families in prostate tissue will give a better insight into 
the sequence of events controlling the differentiation process. The arrays used in 
this study contained 5,603 IMAGE cDNA clones. However, repeating these 
experiments using arrays with a greater number of targets, such as Affymetrix 
GeneChip arrays, which contain ^60, 000 transcripts, would provide a more in 
depth analysis of the changes in gene expression occurring in the PrE2.8 cells at 
39°C. An additional point to note is that the present study investigated gene 
expression in PrE2.8 cells grown at 39°C for a period of 4 days. A time-course 
experiment, where RNA is extracted from cells grown at 39°C from day 1 to day 
14, would provide information on genes and regulatory pathways that are up- or 
down-regulated early on in this model system, as well as changes in gene 
expression further along the time course/differentiation process. These genes, if 
validated through confirmation of protein expression in prostate tissue, could 
potentially provide markers of subpopulations of epithelial cells at different stages 
of the differentiation process in the prostate.
Cell surface markers, such as the CD44 v2-vl0 isoform identified in this 
study, would be of particular value as tools to isolate subpopulations of cells
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along the differentiation pathway. This would allow these subpopulations to be 
characterised further. For example, growing these cells in culture to investigate 
whether they can undergo terminal differentiation, thus confirming their 
progenitor cell status. In addition, subpopulations of isolated cells believed to be 
at the very early stages of the differentiation pathway could be further 
characterised in xenograft experiments. For example, such subpopulations could 
be grown as xenografts in mice, together with stromal cells, in order to investigate 
whether these cells are able to differentiate further, or even regenerate into a 
prostate gland.
Other genes identified in this study and/or future studies may shed light on 
the mechanisms driving the differentiation pathway. Manipulation of these genes 
and/or pathways will also provide valuable information about the differentiation 
process, both in normal and diseased prostate. For example, these genes may 
represent potential targets for the development of new drugs for the treatment of 
proliferation-related prostate epithelial-cell disorders. The PrE2.8 cell line could 
be used as an initial screening assay to verify these gene targets; compounds that 
may block/inhibit genes involved in the normal pathway of differentiation may be 
useful as potential drugs for the treatment of BPH/prostate cancer, if those same 
genes are involved in these diseases. In addition, over-expression of putative 
genes in cell lines would be of interest in order to evaluate the function of these 
genes and potentially identify genes that are crucial to the differentiation process.
Additional studies that could be carried out include in vivo gene knockout 
experiments. Key genes identified through microarray analysis and verified in 
prostate tissue could be deleted in mouse models. This would be a valuable 
method of evaluating the consequences of such deletions on the differentiation 
process in prostate epithelial cells as well as on the development and functioning 
of the prostate gland. Finally, the delineation of a central underlying pathway in 
differentiation might result in the development of targets for intervention or 
prevention of prostatic disease states.
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